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Das menschliche Genom kodiert für ~ 20.000 lange nicht-kodierende RNAs (lncRNAs), ihre 
molekularen Funktionen, insbesondere im Immunsystem, sind jedoch weitgehend unbekannt. 
In dieser Studie wurden zwei Hauptaspekte untersucht: die Beteiligung von lncRNAs an der 
Differenzierung myeloischer Immunzellen und deren Beteiligung an der 
entzündungsfördernden Aktivierung menschlicher Makrophagen. In Bezug auf den ersten 
Aspekt dieser Studie wurden RNA-Sequenzierdaten von verschiedenen 
Immunzellpopulationen analysiert. Diese Daten zeigten, dass lncRNAs und Protein-kodierende 
Transkripte die Identität von Immunzellen gleichermaßen spezifizieren. Klassischerweise 
werden die Leukozyten-Populationen anhand von Oberflächenrezeptoren unterschieden, 
welche als spezifische Marker dienen. In dieser Studie wurde die nicht-kodierende RNA 
LINC00211 als spezifischer Marker für die myeloide Abstammung von Immunzellen 
identifiziert. Die funktionelle Charakterisierung zeigte, dass diese lncRNA die Expression 
mehrerer Gene reguliert, einschließlich CHI3L1 und S100A9, welche eine Rolle in der 
Differenzierung myeloider Zellen spielen. Außerdem konnte gezeigt werden, dass LINC00211 
durch PU.1, einen Transkriptionsfaktor mit essentiellen Funktionen in der 
Immunzellentwicklung, reguliert wird. Darüber hinaus konnte LINC00211 als Biomarker für 
Lungenentzündungen charakterisiert werden, da in bronchoalveolarer Spülflüssigkeit von 
infizierten Personen und in Lungenextrakten von IPF-Patienten eine hohe Expression 
beobachtet wurde, die mit dem Grad der Neutrophileninfiltration korreliert.  
Um die Beteiligung von lncRNAs an der entzündungsfördernden Aktivierung menschlicher 
Makrophagen zu untersuchen, wurden RNA-Sequenzierungen durchgeführt und mehrere 
differentiell exprimierte lncRNAs in ruhenden und immunaktivierten menschlichen 
Makrophagen identifiziert. Darüber hinaus wurde ein mehrdimensionaler Ansatz entwickelt, 
um humane lncRNAs nach ihrer subzellulären Lokalisation und Co-Sedimentation mit 
zellulären Proteinkomplexen in Makrophagen zu kategorisieren. Diese Daten zeigten, dass 
lncRNAs eine sehr heterogene Klasse von RNAs darstellen, die mit verschiedenen zellulären 
Komponenten, einschließlich Ribosomen, co-sedimentiert. Anhand dieser Daten wurde 
lncRNA MaIL1 als hoch immunreaktive, zytosolische und nicht Ribosomen-gebundene 
intergenische lncRNA (lincRNA) identifiziert. Die funktionellen Analysen assoziierten MaIL1 




Antisense-Aufreinigung und Massenspektrometrie (RAP-MS) zeigten, dass MaIL1 mit 
Optineurin interagiert, einem Protein, dass bekanntermaßen für die Signalübertragung 
innerhalb des TBK1-IRF3-Signalweges erforderlich ist, und dadurch die Typ I 
Interferonproduktion steuert. Insbesondere reguliert MaIL1 die Optineurin-Ubiquitinierung, 
eine Modifikation, die für die Optineurin-Funktion wesentlich ist. Ein Knockdown von MaIL1 
beeinträchtigte die durch den Optineurin-TBK1 Komplex vermittelte IRF3-Phosphorylierung 
und somit die Typ I Interferonproduktion. Darüber hinaus erwies sich MaIL1 als essentiell für 
die Abwehr von Legionella pneumophila, einem gramnegativen Bakterium, das sich im 
menschlichen Wirt vorwiegend in Alveolarmakrophagen repliziert und Lungenentzündung 
verursacht. Darüber hinaus waren die MaIL1-Spiegel während Lungeninfektionen erhöht und 
korrelierten linear mit den IFNβ-mRNA-Spiegeln in humaner bronchoalveolarer Lavage. In der 
vorliegenden Arbeit wird MaIL1 daher als kritischer Regulator von TLR-induzierten IFN-
Reaktionen auf Infektionen identifiziert. Zusammenfassend liefern beide Studien detaillierte 
neue Informationen über die Funktion von lncRNAs in myeloischen Immunzellen und 
etablieren eine umfangreiche Ressource, sowie Leitfäden für zukünftige Untersuchungen zu 







The human genome encodes for ~ 20.000 long non-coding RNAs (lncRNAs), yet their 
molecular functions, especially in the immune system, remain largely unknown.  In this study, 
two main aspects were addressed: the participation of lncRNAs in the differentiation of myeloid 
immune cells and their involvement in pro-inflammatory activation of human macrophages. In 
order to address the first aspect, RNA sequencing results from distinct immune cell subsets 
were analysed. These data showed that lncRNAs define immune-cell identity equally well as 
protein-coding genes, such as surface receptors considered as precise markers of leukocyte 
subsets. In the present work, non-coding RNA LINC00211 was identified as a specific myeloid 
cell lineage marker. Functional characterisation demonstrated that this lncRNA regulates the 
expression of several genes, including CHI3L1 and S100A9, which participate in myeloid cell 
differentiation. Furthermore, LINC00211 was regulated by PU.1, a transcription factor with 
fundamental roles in immune cell lineage commitment. Additionally, LINC00211 could be 
characterised as a biomarker of pulmonary inflammation, since high expression was observed 
in bronchoalveolar lavage fluid from infected individuals and in lung extracts from IPF patients, 
correlating with the degree of neutrophil infiltration.   
In order to investigate the involvement of lncRNAs in pro-inflammatory activation of human 
macrophages, RNA sequencing experiments were performed and unveiled several differentially 
expressed lncRNAs in resting and immune-activated human macrophages. Furthermore, a 
multidimensional approach was established to categorize human lncRNAs according to their 
subcellular localization and co-sedimentation with cellular protein complexes in macrophages. 
The resulting data revealed that lncRNAs constitute a highly heterogeneous class of RNA co-
sedimenting with various cellular machineries, including ribosomes. Using these data, lncRNA 
MaIL1 was identified as a highly immune-responsive, cytosolic and non-ribosome associated 
intergenic lncRNA (lincRNA). Functional analysis associated MaIL1 with type I interferon 
production after Toll-like Receptor (TLR) activation. RNA antisense purification and mass 
spectrometry (RAP-MS) showed that MaIL1 interacts with Optineurin, a protein known to be 
required for signal transduction within the TBK1-IRF3 axis, thus facilitating type I interferon 
production. More specifically, MaIL1 regulates Optineurin ubiquitination, a modification 
essential for Optineurin function. When MaIL1 was knocked down, IRF3 phosphorylation and 




essential for defence against Legionella pneumophila, a Gram-negative bacterium that 
predominantly replicates inside alveolar macrophages and causes pneumonia. In addition, 
MaIL1 levels were increased during pulmonary infections and correlated linearly with IFNβ 
mRNA levels in human bronchoalveolar lavage fluid. Thus, the present work identifies MaIL1 
as a critical regulator of TLR-induced IFN responses to infection. In summary, both studies 
revealed detailed information about the function of lncRNAs in myeloid immune cells and 
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1.1 The immune system 
1.1.1 Generation of the immune cell lineages 
During a life-span, the human organism is faced by countless attempts of microorganisms to 
colonize and breach the skin and mucosal surfaces. In order to survive attacks from different 
microorganisms vertebrates have evolved a sophisticated innate and adaptive immune system. 
While central components of the innate immune system are found in many life forms, ranging 
from plants to molluscs and primates, the adaptive immune-system evolved late in the chordate 
lineage of organisms. Professional cells of the innate and adaptive immune system are generated 
continuously or during embryonic development in a process referred to as haematopoiesis. In 
primates, during early development, there is the primitive wave of haematopoiesis, which 
entails an erythroid progenitor that arises from the yolk sack and gives rise to erythrocytes and 
macrophages (Palis et al., 2001, Galloway and Zon, 2003, Jagannathan-Bogdan and Zon, 2013). 
The main function of the primitive wave of haematopoiesis is to produce erythrocytes, in order 
to allow the embryo to receive oxygen (Orkin and Zon, 2008). After the primitive wave, there 
is a second wave, also referred to as the “permanent” or “definitive wave” (Orkin and Zon, 
2008). This wave may be divided into two arms. The first arm consists of a transient wave that 
produces erythroid-myeloid progenitors (EMPs) (Bertrand et al., 2007 McGrath et al., 2011). 
The second arm, which is initiated later and maintained during adulthood, starts from 
Haematopoietic Stem Cells (HSCs), which are characterised by pluripotency and self-renewal 
and give rise to all professional immune cell types generated during adult lifespan (Keller et al., 
1990, Cumano and Codin, 2007). During embryogenesis haematopoiesis starts after the 
gastrulation when specific mesodermal cells are committed to become blood cells. Later in 
embryogenesis, the Pre-HSCs emerge in the aorta-gonad mesonephros (AGM) region in 
humans, whereas in mice Pre-HSC are also found in placenta and in yolk sac (Mikolla and 
Orkin, 2006). The permanent definitive wave of haematopoiesis starts at the AGM and then 
continues in the fetal liver and finally the bone marrow. Upon expansion in the fetal liver HSCs 
form a stable, self-renewing population in the bone marrow (Figure 1.1), which constitutes the 
primary source of immune cells during adulthood.  
In the bone marrow, HSCs, depending on the signals that they receive, differentiate into two 




and the Myeloid Stem Cell (MSC) or Common Myeloid Progenitor (CMP) (Figure 1.2) 
(Iwasaki and Akashi, 2007). 
 
Figure 1.1: Schematic representation of the HSC development during embryogenesis. 
After gastrulation, specialised cells of mesoderm create the hemangioblasts, which are 
multipotent precursor cells that can differentiate both into hematopoietic and endothelial cells. 
On day 21 of human and on day 7.5 of mouse embryonic development the first Pre-HSC appear. 
In human, pre-HSC come from the AGM whereas in mice they are present both in the placenta 
and yolk sac. After day 26 in human and day 10.5 in mouse embryonic development the first 
mature HSC appear in AGM, yolk sac, placenta and fetal liver. On day 40 (or day 12.5 in mice) 
the HSC start to proliferate in fetal liver. Later, on day 70 (or 15.5 in mice), the cells migrate to 
the bone marrow where they remain in a quiescent state and have the ability for self-renewal. 
 
The CLP can generate the different T-lymphocyte subsets (T-cells), B-lymphocytes (B-cells), 
and Natural Killer cells (NK cells). Its counterpart, the CMP, can generate the different 
granulocytic populations (Basophils, Eosinophils, and Neutrophils), the monocytes (that may 
later differentiate to macrophages and dendritic cells), platelets and erythrocytes (Iwasaki and 
Akashi, 2007). The differentiation processes may be triggered by extrinsic signals (Kondo et 
al., 2000) or intrinsic signals (Fairbairn et al., 1993, Maraskovsky et al., 1997), which are 
controlled by transcription factors essential for lineage-specific differentiation (Dahl et 
al.,2003, Laslo et al., 2006). Well- studied examples for those transcription factors are PU.1, 
C/EBPα, and C/EBPβ. Mice lacking PU.1 and C/EBPα show a severe dysregulation of myeloid 
cell development. PU.1 knock out mice die during the late stage of embryonic development or 
immediately after birth and show impaired formation of granulocytes, monocytes, B-cells and 




Colucci et al., 2001). On the other hand, mice lacking C/EBPα do not develop neutrophils or 
eosinophils (Zhang et al., 1997), indicating an important function in myoblast differentiation.  
C/EBPβ knock out mice display normal haematopoiesis and C/EBPβ expression in the C/EBPα 
gene locus also confers normal haematopoiesis, and thus it can rescue C/EBPα function (Jones 
et al., 2002). A possible explanation for this is the differential expression of the two genes 
during the development. C/EBPα is upregulated gradually upon HSC to CMP differentiation 
but C/EBPβ is downregulated (Hirai et al., 2006). Furthermore, mice lacking C/EBPα can 
produce neutrophils in presence of high concentrations of cytokines and C/EBPβ 
overexpression. Thus, C/EBPβ is important for stress induced neutrophil production, which can 
be important during the course of an infection (Hirai et al., 2006). PU.1 and C/EBPα also 
regulate maintenance of the HSC population. Disrupting PU.1 expression at birth can lead to 
loss of the HSC population (Iwasaka et al., 2005), whereas loss of C/EBPα may cause expansion 
of HSCs (Zhang et al., 2004). 
 
Figure 1.2 Schematic representation of immune cell populations. Early during 
differentiation, a common progenitor, termed Hematopoietic Stem Cell (HSC), can divide to 
create another HSC or differentiate either into a Lymphoid Stem Cell (LSC) or a Myeloid Stem 
Cell (MSC) depending on incoming signals. LSCs and MSCs are responsible for the generation 
of the lymphoid and myeloid cell lineage, respectively. After undergoing several cycles of 






In the bone marrow the different immune cell populations during their differentiation receive 
divert signals from the stromal cells that are located in the bone marrow medullary cavity. 
Stromal cells are comprised of osteoblasts, endothelial cells, reticular cells, fibroblasts and 
adipocytes. These stromal cells provide the signals for leucocyte differentiation and migration 
from the bone marrow to the blood stream (Zhao et al., 2012). A very well- studied example of 
a signal from stromal cells that controls haematopoiesis is the stromal cell-derived factor 1 
(SDF-1, also known as CXCL12) (Nagasawa et al., 1996, Bleul et al., 1996). SDF-1 is a 
chemoattractant for CD34+ haematopoietic precursors, mature B-cells and T-cells, and 
monocytes (Aluti et al 1997, D’Apuzzo et al., 1997). All these cell types express C-X-C 
chemokine receptor type 4 (CXCR-4) and the interaction between the receptor and SDF-1 is 
responsible for chemoattraction and retention of B-cells and granulocytic precursors within the 
bone marrow microenvironment (Ma et al., 1998, Ma et al., 1999). Whereas B-cells, NK cells, 
and the cells from the CMP lineage initially mature in the bone marrow until they receive the 
appropriate signals to migrate to the blood stream, T-cell precursors first migrate to the thymus 
for their maturation (Donskoy et al., 1992, James et al., 2018). The precursors of T-cells in the 
thymus are called thymocytes.  During the prenatal period, γδT-cells and αβT-cells mostly 
migrate from the fetal liver, and during adulthood the main source of T-cells is the bone 
morrow, from where αβT-cells enter the thymus. In the thymus, αβT Cells undergo positive and 
negative selection. Negative selection is the process were thymocytes undergo apoptosis when 
they recognize a peptide of the Major Histocompatibility Complex (MHC) with high affinity. 
Negative selection is very important for elimination of self-reactive thymocytes. On the other 
hand, positive selection occurs if the T-cell receptor (TCR) binds to a peptide–MHC ligand 
with low affinity. This engagement is a signal for survival and differentiation. If the thymocytes 
bind to a peptide MHC class I ligand they become CD8+ T-cells, whereas if they bind to 
peptide-MHC class II ligand CD4+ T-cells are generated (Palmer, 2003). Only the mature T-
cells can leave the thymus and enter the blood stream. 
Generally, the major immune-cell populations after maturation can be found in the blood stream 
and from there may reach different tissues and the secondary lymphatic organs. Specific signals 
from the tissues may initiate terminal differentiation programs. For example, monocytes from 
the blood stream can migrate through the endothelium in a process referred to as diapedesis and 
differentiate into macrophages within the tissue environment. (Ebert and Florey, 1939). 
Research over the past few years indicates however, that the bone marrow derived immune cells 
cannot be the only source of immune cells found in the tissues (Davies et al., 2013). For 




In 1968, Ralph van Furth and Zanvil Cohn, proposed that macrophages generally derive from 
monocytes which infiltrate the tissues and differentiate into macrophages (Mononuclear 
Phagocyte System, MPS). This model was in dispute though, because as mentioned earlier, 
macrophages do exist in the yolk sac before primitive haematopoiesis. Furthermore, evidence 
existed that macrophages can proliferate within tissues (Sawyer et al., 1982, Czernielewski et 
al. 1987) and gain self-renewal capacity (Merad et al., 2002). A clear evidence for the existence 
of tissue resident macrophages, originating from a precursor different from HSCs, came from 
Myb-deficient mice, which lack HSCs (Schulz et al., 2012). In this model, yolk sac 
macrophages gave rise to a distinct macrophage population expressing F4/80hi, and found in 
many adult tissues, including skin (Langerhans cells), brain (microglia), spleen (red pulp 
macrophages), lung (Alveolar macrophages), pancreas and kidney. This F4/80hi population had 
a gene expression signature found in yolk sac macrophages, but not in F4/80low (blood-derived) 
macrophages. Thus, the model of macrophage origin is presently being revised in order to 
include prenatal lineages of resident macrophages, which arise from a distinct embryonic 
macrophage lineage during embryonic development. 
It is evident that the generation of immune cells is a highly complex process with many 
underlying layers of positive and negative control. The diversity of signals that control all stages 
of haematopoiesis predict sophisticated genetic control mechanisms ensuring proper immune 
cell development and activation to prevent from e.g. auto-immunity or over-shooting 
inflammatory reactions. In the next chapters, some of the most important features of the distinct 
leukocyte populations and the molecular circuitries underlying their proper activation are 
explained. 
1.1.2 Cells of the immune system 
As mentioned in the previous chapter, several different immune cell types exist. Each major 
cell type however can be further sub-classified depending on distinct surface marker expression 
(e.g. CD4+ Th1 and Th2 cells). Some subtypes share some common characteristics depending 
on either their origin or the way they respond to danger signals. In the following, the major 
immune cell types and their most important characteristics are described. 
T cells can be divided into two main subpopulations, the CD4+ T-cells or T helper cells (Th 
cells) and the CD8+ T-cells or cytotoxic T-cells. Mossman and Coffman in 1986 showed that 
CD4+ T-cells can be subdivided into two groups. The first group produces IFNγ as signature 




to as Th2 cells. Later it became evident that T-cells are even more diverse. Naïve CD4 T-cells 
receive signals during development to differentiate into Th1, Th2, Th17 and T regulatory cells 
(Tregs). These four populations express different cytokines and are involved in different 
pathological conditions. Th1 cells produce mainly IFNγ and IL-2, are involved in autoimmune 
diseases and are critical for defence against intracellular microorganisms. Th2 cells produce IL-
4, IL-5, IL-13, IL-25, IL-10 and amphiregulin and play role in asthma and allergies, but also in 
defence against extracellular parasites. Th17 cells express mainly IL-23, IL17a, IL-17f, and IL-
22, are also involved in autoimmunity and play a critical innate function in protection against 
extracellular bacteria and fungi (Weaver et al., 2006). Lastly, Tregs have an immunomodulatory 
role and are involved in lymphocyte homeostasis and immune tolerance. These cells express 
TGFβ, IL 35, IL10 and are distinguished from the other CD4+ populations by expression of the 
forkhead box P3 (Foxp3) gene (Chen et al., 2003). 
CD8+ T-cells, on the other hand, are a more homogenous population. Naïve CD8+ T cells 
recirculate through secondary lymphoid organs and are activated via interaction of their T cell 
receptor (TCR) with an antigen that is presented to them by dendritic cells. Once activated, 
CD8+ T cells start to proliferate and differentiate into effector cells named cytotoxic T 
lymphocytes (CTLs). These cells are able to kill infected or malignant cells and thus provide 
protection against infections or cancer (Zhang et al., 2011). Most CTLs generated during 
primary infection are short-lived and are contracting, leaving behind a smaller population of 
‘memory’ CD8 T cells that can respond rapidly during a secondary infection. Memory CD8+ 
T cells can be subdivided into ‘central memory’, ‘effector memory’ and ‘resident memory’ 
CD8+ T cells. ‘Central memory’ and ‘effector memory’ cells express different receptors and 
are located in different tissues (Obar et al., 2010).  ‘Resident memory’ CD8+ T cells are found 
permanently in non-lymphoid tissues after specific infections (Mueller et al., 2013). CTLs 
undergo rapid expansion after activation and they migrate to the inflamed or infected tissues. 
To find their targets chemokines and chemokine receptors, like CXCL10, CXCR3 and CXCR5, 
are thought to be involved (Harris et al., 2012, Hickman et al., 2015). CTL-mediated killing 
requires direct contact between the TCR on the CTL and the peptide–MHC class I complex on 
the target cell. After the contact is established, the CTL realises several biochemical mediators, 
such as perforin and granzyme in order to induce the cell death. Except the mediators, it is 





The main cell population responsible for adaptive humoral immune responses are B-cells. This 
type of cells is also generated from CLPs and is a population of cells that express clonally 
diverse cell surface immunoglobulin (Ig) receptors recognizing specific antigenic epitopes. 
During development, the CLP becomes committed to differentiate into B-cells by the 
expression of paired box protein 5 (Pax5) (Cobaleda et al., 2007). B-cell development occurs 
through sequential maturation steps within the bone marrow before release of immature B cells 
into the circulation that travel to the spleen for maturation. Developing B cells progress through 
rearrangement of immunoglobulin heavy- and light-chain gene segments (variable V, diversity 
D, joining J) from pro-B to pre-B to immature B cells, leading to the expression of IgM mature 
B cell receptor BCR. The contact between B-cells and bone marrow stromal cells is important 
for maturation of B-cells, since these cells are the suppliers of integrins, growth factors, 
chemokines, and cytokines (Hoffman et al., 2016). The random rearrangement process of 
immunoglobulin genes during B-cell development is responsible for the diversity of BCR 
receptors that can recognise a large number of epitopes. B-cells are also going through positive 
and negative selection. BCR receptors with high affinity to own epitopes undergo negative 
selection whereas BCRs with low affinity undergo positive selection. The negative selection 
process is important for elimination of autoreactive BCRs that can potentially lead to 
autoimmune diseases. The humoral immunity provided by B-cells is due to production of 
antibodies that develop through recombination events of V, D, and J gene segments in the H 
(Heavy) chain locus and the V and J gene segments in the L (Light) chain loci (Brack et al., 
1978). Five classes, of antibodies exist, the IgM, IgD, IgG, IgA, and IgE class. They may be 
distinguished according to the C-terminal regions of the heavy chains, which are constant and 
do not participate in antigen binding, but are important e.g. for activation of other immune cells 
like macrophages. Furthermore, there are four subclasses or isotypes of IgG antibodies (IgG1, 
IgG2, IgG3, and IgG4). Antibodies can neutralize their targets (e.g., they bind to a virus and 
prevent it from entering a cell), they can activate macrophages and other immune cells or 
activate the classic pathway of the complement system (Laßien and Tedder, 2008).  
Another member of the lymphoid lineage is the NK population. NK cells account for 
approximately 10-15% of circulating lymphocytes in healthy adults and even though they share 
many common features with T-cells, especially CD8+ T cells, they follow a different path 
during development and have distinct genetic background.  The maturation of NK cells takes 
place outside the thymus and they do not express a rearranged TCR (Ritz et al., 1985). Major 
functions of NK cells are to produce IFNγ and mediate cellular cytotoxicity. To facilitate their 




lectin-like receptors formed primarily by the combination of CD94 with either NKG2A 
(inhibitory) or NKG2C (activating); and the large and highly diverse family of killer 
immunoglobulin-like receptors (KIRs) (Colonna et al., 1999). NK cells act based on the 
hypothesis of ‘missing self’, which refers to the ability to recognise and destroy cells that have 
downregulated MHC class I molecules (Ljunggren and Kärre, 1990). Because of this ability, 
they are of high importance to the elimination of cancer cells. In 2002, Ruggeri and his 
colleagues showed that NK cells are critical to successful outcomes following T cell-depleted, 
MHC haploidentical, allogeneic, hematopoietic stem cell transplantation (allo-HSCT) in acute 
myeloid leukaemia (AML) therapy. Patients who received donor-differentiated NK cells that 
demonstrate alloreactivity in the graft-versus-leukaemia direction had a better survival rate 
compared to the ones that received NK cells without alloreactivity. In the last few years, it 
became evident that NK cells are a very heterogeneous population with different phenotype, 
function and developmental path (Freud et al., 2017). The population can be divided into 
conventional NK cells (cNK), and tissue-resident NK cell (trNK). The first identified were the 
cNK cells in the circulation and were divided into two populations the CD56brightCD16lo/- and 
CD56dimCD16+ (Lanier et al., 1983, 1986). The two populations show differential expression 
of receptors and cytokines with CD56bright cNK cells being more immunomodulatory and 
CD56dim cNK cells serving more of a cytotoxic effector role (Cooper et al., 2001). More 
recently, trNK cell populations have been described in human secondary lymphoid tissues, bone 
marrow, spleen, lung, and liver (Cuff et al., 2016, Lugthart et al., 2016, Lunemann et al., 2013, 
Marquardt et al., 2015, 2017, Stegmann et al., 2016). These cells share some features with each 
other but they are different from cNK cells, especially with CD56bright cNK cells. 
Granulocytes are cells of the myeloid cell lineage and are comprised of three distinct 
morphologically and functionally populations, the neutrophils, eosinophils and basophils. They 
are responsible for clearing pathogens and have immunomodulatory functions (Geering et al., 
2013). The cells mature in the bone marrow and fully differentiate in the blood circulation. In 
the blood, they do not proliferate since they are arrested in G0 phase of the cell cycle and their 
lifespan is between 1-5 days. Granulocytes migrate from the blood circulation into tissues in 
response to chemoattractants, such as interleukin (IL)-8 (neutrophils) or eotaxin (eosinophils 
and basophils).  At the site of inflammation, they secrete a variety of toxic molecules against 
pathogens, which can also harm the host tissue and thus the balance between antimicrobial 
defence and host damage is important. Lifespan of granulocyte is important during the course 
of infection. Several cytokines and proinflammatory mediators can regulate the survival of 




macrophage colony stimulating factor (GM-CSF) (Simon, 2001). All three cytokines can 
increase the lifespan of eosinophils but only GM-CSF is important for neutrophil survival. In 
Basophils, by contrast, only IL-3 seems to have a significant effect on survival (Didichenco et 
al., 2008). Granulocytes express pathogen recognition receptors (PRRs) and can recognise 
pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns 
(DAMPs). Another important characteristic of neutrophils and eosinophils, which it is essential 
for the fight against microorganisms is the formation of extracellular DNA traps, which are 
called neutrophil extracellular traps (NETs) (Brinkmann et al., 2004, Yousefi et al., 2008). This 
phenomenon is described as a special form of neutrophil death that is different from apoptosis 
and necrosis and it is called NETosis. NETs are a form of innate response were microorganisms 
are trapped inside the released DNA, which prevents microorganisms from spreading, and 
facilitates to their death because of high local concentration of antimicrobial agents. 
Blood monocytes also belong to the myeloid cell lineage and they are considered precursors of 
some populations of macrophages and dendritic cells (Sprangers et al., 2016). In human 
peripheral blood, three different subsets of monocytes have been identified and characterized 
based on their expression of surface markers CD14 and CD16. The main monocytes, the 
classical monocytes, expresses high levels of CD14 and no CD16 (CD14++CD16−). The 
intermediate monocytes express relatively high levels of CD14 and some CD16 
(CD14+(+)CD16+) and the nonclassical monocytes are characterised by low levels of CD14 and 
high levels of CD16 (CD14+CD16++) (Ingersoll et al., 2010, Wong et al., 2012). During 
inflammation or injury, first the classical monocytes are recruited to the inflamed tissue and 
induce immunological responses. Intermediate monocytes are recruited later, and they are 
mainly responsible for antigen presentation, high secretion of proinflammatory cytokines and 
chemokines and wound healing. Nonclassical monocytes constantly survey the endothelium for 
any threat in order to induce the rapid recruitment of other immune cells. During inflammation, 
monocytes differentiate into macrophages and dendritic cells in response to several stimuli such 
as INFγ, produced from NK cells, and collaborate with the existing tissue resident macrophages. 
The recruitment of monocytes is controlled by the chemokine receptor CCR2 and its ligands 
CCL2 and upon recruitment they produce high levels of proinflammatory cytokines, such as 
interleukin IL-1 and TNF-α. In addition, they phagocytose dead cells and produce IL-18 to 
activate NK cells (Serti et al., 2014). When the acute inflammation resolves, the number of 
classical monocytes is reduced and they are subsequently replaced by intermediate and 




ligand CX3CL1. The non-classical monocytes secrete IL-10 and transforming growth factor 
TGF-β and induce tissue repair (Sprangers et al., 2016).  
Monocyte-derived Dendritic Cells (DCs) are professional antigen-presenting cells and link the 
innate and adaptive immune system. DCs are separated into at least two populations, the 
classical and plasmacytoid DCs (cDCs and pDCs respectively) (Colin et al., 2013). The 
plasmacytoid DCs are not derived from monocytes but originate from precursor cells in the 
bone marrow (Christiakov et al., 2014). cDCs can arise from monocytes during inflammation 
and are different from the DCs that are produced in steady state. In vivo experiments have shown 
that injected monocytes migrate to inflammatory sites and differentiate into DCs in various 
models of inflammation (Hou et al., 2012). As part of the innate immune system, monocyte-
derived DCs during inflammation secrete high amounts of the anti-inflammatory cytokine IL-
10 and engulf apoptotic erythroid cells. Accordingly, blocking differentiation of monocytes into 
DCs leads to tissue damage, increased cytotoxic T cell activity, and reduced life expectancy 
(Ohyagi et al., 2013). The different subtypes of monocytes give rise to different types of DCs. 
Classical monocytes are differentiated into more immune responsive DCs and non-classical 
monocytes generate DCs with better immune tolerance (Jakubzik et al., 2008). 
Monocyte-Derived Macrophages are a population of macrophages that is distinct from tissue 
resident macrophages.  Monocyte derived macrophages are constantly recruited to the tissues 
when required and together with their resident counterparts contribute to tissue homeostasis and 
fight against threats. In some tissues, classical monocytes can differentiate into macrophages 
also in steady state, but in most cases, the differentiation occurs during inflammation (Sprangers 
et al., 2016). Macrophages derived from classical monocytes express higher levels of CD14 
compared to macrophages derived from nonclassical monocytes when cultured in vitro 
(Frankenbergen et al., 2012). Furthermore, macrophages from classical monocytes exhibit 
phagocytic, proteolytic, and inflammatory functions, whereas macrophages derived from 
CD16- expressing monocytes promote tissue repair (Nahrendorf et al., 2010). The 
heterogeneity of macrophages is important in pathological conditions. For example, infection 
with parasites, such as Schistosoma mansoni and Heligmosomoides polygyrus induce invasion 
of classical monocytes into the adult murine heart, were they differentiate into macrophages 
and drive inflammation and tissue damage (Lavine et al., 2014). These macrophages have 
limited capacity to promote tissue repair (Mylonas et al., 2015). On the other hand, in the 
concept of different pathological condition such as cardiac pressure overload, nonclassical 




macrophages derived from the different monocyte subsets have been shown to maintain some 
of the properties of their progenitors. 
All different types of immune cells interact in order to provide a complete immune response.   
This interaction is mediated through cytokines, chemokines and receptors that are expressed on 
the surface of the cells. The synergy between the different cell types and the timing of their 
respective responses is tightly regulated, in order not only to defeat foreign invaders but also to 
avoid self-destruction. 
1.1.3 The innate immune system 
The immune system may be divided into two parts: the innate and the adaptive immune system. 
These two systems are composed of different cell types and are activated at different time points 
in response to distinct signals. The innate immune system provides the first line of defence, 
whereas adaptive immunity is usually fully induced later on. Furthermore, adaptive immunity 
is much more specific than innate immunity, recognizing a virtually infinite number of different 
epitopes, whereas the innate immune system recognises primarily conserved features of 
pathogens and cellular stress. Ilya Mechnikov was the first who described the innate immune 
system in 1908, but for many years it was neglected due to the impressive discoveries made in 
the field of adaptive immunity. The innate immune system is evolutionary ancient and 
conserved core concepts of innate immunity are found in all eukaryotic species, whereas the 
adaptive immune system is restricted to vertebrates (Janeway and Medzhitov, 2002, Turvey et 
al., 2010).  
The innate immune system comprises not only cells derived from haematopoietic stem cells but 
also other cell types, such as epithelial cells. Physical barriers like the skin, but also mucociliary 
clearance, low stomach pH, lysozymes in tears and saliva and other non-cellular components 
are also part of the innate immune system. Leukocytes primarily involved in innate immune 
responses are macrophages, dendritic cells, mast cells, neutrophils eosinophils, basophils, NK 
cells and Natural Killer T-cells (NKT cells). As mentioned above, cells of the innate immune 
system can recognise a variety of conserved features on the surface of pathogens, which are 
called pathogen-associated molecular patterns (PAMPs). PAMPs can be recognised by specific 
receptors on the surface of the cells that are called pattern recognition receptors (PRRs). 
Downstream immunity is either cell-mediated, for example through phagocytosis and 
cytotoxicity, or involves extracellular factors like antimicrobial peptides (AMPs) (Dubos, 




chitinases/chitinase-like receptors (Suzuki et al., 1984), complement factors, proteases, 
cytokines/ chemokines and other molecules (Gasteiger et al., 2016). 
1.1.4 Pathogen recognition by Pattern Recognition Receptors 
Several cell types, including epithelial cells, and many cells of the haematopoietic cell lineage 
express PRRs. The signalling cascades downstream of these receptors are highly important for 
host defence. PRR signalling is not only important for the activation of the innate immune 
system but also for the adaptive, since it induces e.g. maturation of dendritic cells, which can 
trigger the secondary line of defence, or activation of T- and B-cells. Different types of PRRs 
exist. Toll-like receptors (TLRs) were the first to be identified (Lemaitre et al., 1996). To date 
several types of TLRs have been characterised (10 in humans and 12 in mice). The different 
types of TLRs can recognise a variety of different PAMPs. TLR1, 2 and 6 can recognise 
lipoproteins, TLR3 double stranded (ds) DNA, TLR5 flagellin, TLR7 and 4 lipopolysaccharide 
(LPS), TLR7 and 8 single stranded (ss) RNA and TLR9 can recognise DNA (Kawai and Akira, 
2011). TLR2 recognises many PAMPs both in Gram-positive and Gram-negative bacteria, such 
as lipoproteins and peptidoglycans (present in both Gram-positive and negative), as well as 
lipoteichoic acid (present only in Gram-positive). In order to distinguish between the different 
PAMPs, TLR2 forms heterodimers. For example, TLR2-TLR1 heterodimer can recognise 
triacylated lipopeptides from Gram-negative bacteria, whereas TLR2-TLR6 heterodimer 
recognises diacylated lipopeptides from Gram-positive bacteria (Akira et al., 2006).  
Some of the TLRs are localised on the surface of the cells, like TLR1, 2, 4, 5 and 6, whereas 
others, like TLR3, 7, 8 and 9 are expressed within intracellular vehicles, such as the 
endoplasmic reticulum (ER), endosomes, lysosomes and endolysosomes (Kawai and Akira, 
2011). The intracellular localisation of these receptors is of high importance, since the 
intracellular recognition of nucleic acids provides the cell with a means to sense and eliminate 
infectious agents within phago/endosomal cargo. These receptors are sequestered in the ER and 
are transferred to endosomes via the Golgi apparatus. After entering the endosome, the 
receptors are being further modified in the N-terminal region by different proteases, such as 
cathepsins and asparagine endopeptidase to generate functional receptors that can induce 
signalling (Ewald et al., 2011). When TLRs recognize their respective PAMPs, a signalling 
cascade is activated and leads to induction of mediators of host defence. The TLR response is 
initially activated by recruitment of adaptor proteins that have TIR-domains, such as myeloid 
differentiation primary response 88 (MyD88), Toll/interleukin-1 receptor domain-containing 




TRIF-related adaptor molecule (TRAM). MyD88 is essential for the signalling of all TLRs, 
except TLR3, and leads to nuclear factor kappa beta (NF-κB) and mitogen activated protein 
(MAP) kinase activation. TLR3 and TLR4 can use TRIF as an adaptor protein and activate 
IRF3 to induce the production of type I interferons (IFNs) (Kawai and Akira, 2011). TIRAP is 
used as an adaptor protein by TLR2 and TLR4 to recruit MyD88 and TIRAM connects TLR4 
and TRIF. TLR4 is the only member of the TLR family that can activate both the TRIF-
dependent and the MyD88 dependant pathway (Figure 1.3). The two pathways have different 
kinetics. First, MyD88 is activated and recruits the IRAKs, TRAF6 and TAK1 complex and 
leads to NF-κB and MAP kinase activation. In the second phase, TLR4 gets endocytosed and 
forms a complex with TRAM and TRIF, which leads to recruitment of TRAF3 and 
subsequently the kinases TBK1 and IKKε, which phosphorylate IRF3 and lead to expression 
of type I IFNs (Kawai and Akira, 2011). TRAM-TRIF also recruit TRAF6 in order to induce a 
late-phase NF-κB and MAP kinase activation. In the second phase, TLR4 is delivered from 
endosomes to phagosomes with the help of RaB11a GTP-ase and this delivery is important for 
type I interferon induction (Husebye et al., 2010). A splice variant of TRIF, TAG can disrupt 
the TRAM-TRIF interaction, which leads to inhibition of the TRIF-Dependent pathway and 
subsequently type I IFN production (Palson-McDermott et al., 2009). 
The Heterodimers TLR2-TLR1 and TLR2-TLR6 signal through TIRAP and MyD88 to induce 
inflammatory cytokines. However, TLR2 alone can induce type I IFNs in inflammatory 
monocytes (Barbalat et al., 2009). TLR2 is internalised and induces activation of IRF3 and 
IRF7 through MyD88. TLR7 and TLR9 signal also through MyD88, which forms a complex 
with TRAF3, TRAF6, IRAK1 and IKKα and leads to IRF3 phosphorylation and Induction of 
type I IFNs. TLR9 can actually activate two pathways in two different cellular compartments. 
In the early endosomes, after CpG DNA stimulation, TLR9 triggers MyD88-TRAF6 dependent 
NF-κB activation and IL12p40 production. Later, TLR9 travels to lysosome-related organelles 
(LRO), where it utilises TRAF3 to activate IRF7 and subsequently induce type I IFNs (Sasai et 
al., 2010). TLR5 induces inflammatory cytokines through MyD88-TRAF6 dependent NF-κB 
activation but in intestinal epithelial cells can also recruit TRIF, which leads to NF-κB 





Figure 1.3: Simplified schematic representation of the TLR4 signalling pathway. Upon 
LPS stimulation, TLR4 can induce in early phase MyD88-TRAF6 dependent NF-κB activation 
and MAP kinase activation. After TLR4 gets endocytosed, it forms a complex with TRAM and 
TRIF, which leads to IRF3 phosphorylation and type I IFN induction.  
 
Other PRR types are the nucleotide-binding oligomerisation domain (NOD) proteins that 
belong to the NOD-like receptor (NLR) family. NOD1 and NOD2 are the best-studied members 
of this family (Bertin et al., 1999, Inohara et al., 1999, Ogura et al., 2001). Both receptors have 
a caspase activation and recruitment domain (CARD), a nucleotide binding domain (NOD) and 
multiple leucine-rich repeats (LRRS) (Caruso et al., 2014). These two receptors can activate 
NF-κB in response to peptidoglycans (Inohara et al., 2001). NOD1 can recognise γ-D-glutamyl-
meso-diaminopimelic acid (iE-DAP), a motif present in many Gram negative and some Gram 
positive bacteria (Chamaillard et al., 2003, Girard et al., 2003), and NOD2 can recognise 
muramyl dipeptide (MDP) which is present in both Gram negative and Gram positive bacteria 
(Inohara et al., 2003). The two receptors are oligomerised upon PAMP sensing and recruit 
receptor-interacting serine/threonine-protein kinase 2 (RIPK2). RIPK2 then leads to activation 





C-type lectin receptors (CLRs) are another class of PRRs. These proteins were first identified 
as a family of calcium-dependant carbohydrate-binding proteins (Drickamer et al., 1999). Later, 
because of sequence homology the term got more general and is now used for any protein that 
contains one or more C-type-lectin-like domain (CTLD) (Zelensky and Gready, 2005). CLRs 
are a divert group of receptors that can recognise various PAMPs on the surface of pathogens. 
For example, Mannose-binding lectin (CD206) binds to various sugars (such as N-acetyl-D-
glucosamine, mannose, N-acetyl-mannosamine, fucose and glucose) found on the surface of 
some viruses, bacteria, fungi and protozoa (Robinson et al., 2006). The signal transduction 
downstream of CLRs is not shared upon the members of the family, but rather depends on the 
type of the receptor. Some lectins, like Dectin-1, can induce Spleen tyrosine kinase (SyK)- 
dependant cytokine production (Rogers et al., 2005). SyK activation can recruit adaptors, like 
Fc receptor γ chain (FcRγ), which have and immunoreceptor tyrosine-based activation motif 
(ITAM) or can act via a single tyrosine based motif found in the cytoplasmic domains of some 
lectins (hemITAM). Other lectins bind to immunoreceptor tyrosine-based inhibitory motif 
(ITIM) and recruit phosphatases, such as Src homology 2 (SH2) domain containing inositol 
polyphosphate 5-phosphatase 1 and 2 (SHIP1 and SHIP2) and negatively regulate the 
inflammatory signals and some others act directly without a clear evidence of binding to a motif 
(Sancho and Reis e Sousa, 2012). 
The RIG-I-like receptors Retinoic inducible gene I (RIG-I), melanoma differentiation 
association gene 5 (MDA5) and laboratory of genetics and physiology 2 (LPG2) are important 
PRRs for recognition of viruses. These proteins belong to DExD/H box helicase subfamily and 
can sense viral RNA (Loo and Gale, 2011). The receptors of this family have three distinct 
domains: an N-terminal region consisting of caspase activation and recruitment domains 
(CARD), a central DExD/H box RNA helicase domain and a C-terminal repressor domain (RD) 
within the C-terminal domain (CTD). RIG-I was originally characterised in stimulation 
experiments with synthetic dsRNA poly I:C (Yoneyama et al., 2004). This PRR preferentially 
recognises 5’ triphosphorylated (5’ppp) RNA (Hornung et al., 2006), but it can also recognise 
monophosphate and diphosphate RNAs, although these modifications are not able to induce its 
full signalling potential (Pichlmair et al., 2006). RIG-I can also bind to single stranded (ss) RNA 
(Kato et al., 2006).  MDA5 can interact with synthetic dsRNA poly I:C but preferentially 
recognises high molecular weight poly I:C fragments and does not bind to (ss) RNA.  For LPG2 
little is known about its RNA ligands, but it seems to bind a variety of RNA species (Murati et 
al., 2008, Pippig et al., 2009, Takehasi et al., 2009). The signalling of RIG-I, which is better 




CARDs and RD (Saito et al., 2007). At steady state RIG-I is hold in closed conformation and 
upon RNA binding, its conformation opens and it interacts with its adaptor protein MAVS and 
induces type I IFN production (Scott, 2010).  
1.2 The Non-coding genome 
1.2.1 Non-coding RNA species 
In recent years the central dogma of genetics, stating that DNA is transcribed into RNAs, which 
are translated into protein or participate in protein-synthesis, was significantly challenged. It is 
now evident, that only 4% of the human genome is actually protein coding. At least 90 % of 
the remaining non-protein-coding genome, large parts of which were previously thought to 
constitute ‘junk’ DNA, is transcribed (Barbagallo et al., 2018). This ‘non-coding genome’ gives 
rise to a variety of RNA species that are functionally and morphologically different and are 
called the non-coding RNAs (ncRNAs). It is thus reasonable to believe that important clues to 
understand several pathophysiological phenomena are hidden within this region. NcRNAs are 
found in all domains of life, which further underlines the importance of these molecules 
(Barbagallo et al., 2018). The first non-protein-coding RNA species to be discovered were the 
transfer RNAs (tRNAs) and the ribosomal RNAs (rRNAs), back in the 1950s (Zamecnik et al., 
1954, Scherrer and Durnell, 1962).  Later in the 1980s, Yang and his colleagues discovered 
small nuclear RNAs (snRNAs) (Yang et al., 1981). Until the early 2000s, very few other non-
protein-coding RNAs were discovered. One of the most important finding in this research field 
was the discovery of Xist, an RNA that is responsible for X chromosome inactivation in 
mammals (Brockdorff et al., 1992, Brown et al., 1992). After the development of next 
generation sequencing (NGS), the identification of non-coding RNAs expanded dramatically. 
To date several classes of non-coding RNAs have been identified, such as micro (miRNAs), 
small nucleolar RNAs (snoRNAs), small Cajal body-specific RNAs (scaRNAs), enhancer 
RNAs (eRNAs), small interfering RNAs (siRNAs), piwi-interacting RNAs (piRNAs), vault 
RNAs (vtRNAs) and long non-coding RNAs (lncRNAs). The snoRNAs and scaRNAs together 
with tRNAs, rRNAs and snRNAs belong to the group of housekeeping RNAs, which are 
constitutively expressed and play critical roles in the production of proteins. On the other hand, 








1.2.2 Small regulatory RNAs 
The family of small regulatory RNAs comprises the subfamilies of miRNAs, siRNAs and 
piRNAs. The first miRNA, lin-4, was first discovered in C. elegans in 1993 (Lee et al., 1993) 
and since then the field has expanded dramatically. MiRNAs are endogenous, non‐coding, 
single‐stranded RNA molecules with a length of 20‐24 nucleotides that negatively regulate 
mRNA levels. MiRNAs are conserved among species and are expressed in a tissue‐specific or 
developmental‐stage‐specific manner. In humans, over 2,500 matured miRNAs (based on 
miRBase.org, released August 2010, Last Update: November 2010) have been identified so far 
and it is estimated that about 60% of the human proteome is regulated by them (Friedman et 
al., 2009). MiRNAs can be transcribed either from independent miRNA genes or are found 
within introns, and occasionally exons of other genes (Carthew and Sontheimer, 2009). Several 
genes can be targeted by a specific miRNA, and several miRNAs can target one gene (Krek et 
al., 2005). Most of the times, miRNAs reduce protein expression but their binding can also 
favour enhanced translation (Lytle et al., 2007, Vasudevan et al., 2007, Lin et al., 2011). 
MiRNAs are also important regulators of adaptive and innate immunity. They are considered 
as fine tuners of the immune responses against pathogens but also involved in the differentiation 
and polarisation of leukocytes. Well-studied examples of such miRNAs are miR-155 and miR-
146a (Taganov et al., 2006, O’Connell et al., 2007). Both miRNAs are upregulated downstream 
TLR4 activation but may control the inflammatory responses in opposite directions. MiR-146a 
is a negative regulator of the NF-κB signalling through targeting multiple proteins of the 
pathway like TLR4, MyD88, IRAK‐1, and TRAF6 (Curtale et al., 2013). MiR-155, on the other 
hand, may promote the inflammatory responses via targeting suppressor of cytokine signalling 
1 (SOCS1) and Src homology 2 domain‐containing inositol‐5′‐phosphatase 1 (SHIP1) (Wang 
et al., 2010, McCoy et al., 2010). Other reports however suggest that miR-155 has a negative 
feedback function as well, similar to miR-146 (Janga et al., 2018, Schulte et al., 2013). Other 
miRNAs, like miR-125, are involved in the control of haematopoiesis. For example, miR-125 
is able to control stem cell numbers by negatively regulating BCL2-antagonist/killer 1 (BAK1), 
a gene regulating apoptosis (Guo et al., 2010).  
While miRNAs are regulators of endogenous gene expression, siRNAs and piRNAs are 
defenders of genome integrity in response to foreign or invasive nucleic acids such as viruses, 




miRNAs (Fire et al., 1998). The size of siRNAs is 21-25 nucleotides. The mechanism of action 
of siRNAs is called RNA interference (RNAi). SiRNA biogenesis and their mode of action 
have many similarities with miRNAs. In both cases the RNA target is recognised by Watson-
Crick base pairing and similar proteins participate in their biogenesis.  
The last type of small regulatory RNAs are piRNAs, which are 21–35 nucleotides long and in 
contrast to miRNAs and siRNAs, they are animal specific. piRNAs bear 2ʹ-O-methyl-modified 
3ʹ termini and guide PIWI-clade Argonautes (PIWI proteins) rather than the AGO-clade 
proteins, which function in the miRNA and siRNA pathways (Aravin et al., 2001, Aravin et al., 
2006, Girard et al., 2006, Vagin et al., 2006, Ozata et al., 2019). Whereas miRNAs and siRNAs 
derive from double-stranded RNA precursors, piRNAs are processed from long single-stranded 
precursor transcripts, except the piRNAs in C. elegans, which are made one at a time from 
single-stranded precursors of 25–27 nucleotides in length, each of which is transcribed from its 
own gene (Gu et al., 2012). The main function of piRNAs is to silence transposon elements in 
the germline. Transposons are dangerous for the integrity of the genome since they can induce 
DNA breaks, disruption of expression of open-reading frames or dysregulation of gene 
expression and thus animals rely of piRNAs in order to silence them (Davis et al., 2017). In the 
past few years it has become evident that piRNAs also have other functions such as gene 
regulation. In mice, piRNAs can induce both DNA and H3K9me3 histone methylation, which 
leads to gene silencing (Aravin et al., 2008). In some species, like mosquitos, piRNAs have 
been implicated in antiviral defence were two mosquito PIWI proteins - Piwi5 and Ago3 - 
participate in a heterotypic ping-pong and consume viral (+) and (-) strand RNAs to produce 
piRNAs (Miesen et al., 2015, Lewis et al., 2018). 
Generally, small regulatory RNAs have been implicated in many pathophysiological conditions 
and for more than two decades, researchers try to unravel the mechanisms of their regulation 
and function. The discovery of small regulatory RNAs made the scenery of genome regulation 
more complex. To this big family of ncRNAs another member was added: the long non-coding 
RNAs. This class of RNA molecules is the most recently discovered (even though founding-
members of the family, such as XIST, have been known for almost 30 years), and adds an 







1.2.3 Long non-coding RNAs 
The development of NGS technologies made it possible to identify novel regulatory RNAs at a 
genome scale. Some of the discovered RNAs were called long non-coding RNAs (lncRNAs), 
defined as regulatory RNAs that are longer than 200 nucleotides and have no coding potential. 
As mentioned above, prior to the development of NGS technologies only few members of this 
family were known, such as Xist (Brockdorff et al., 1992, Brown et al., 1992) and H19 (Brannan 
et al., 1990), but even after the existence of lncRNAs as an abundant class of cellular transcripts 
was verified their functions remained under debate. The ability of RNA polymerase to (Pol II) 
to transcribe most of the genome and the low copy numbers of some lncRNAs rise questions 
regarding their functionality (Struhl, 2007). Today it is believed that numerous lncRNAs are 
functional and to distinguish them from transcriptional noise several parameters should be taken 
into account. For example, if the expression of an lncRNA is evidently regulated by 
transcription factors (TF) or if there are chromatin signatures, such as DNaseI hypersensitivity 
or characteristic histone modifications like H3K9ac, H3K4me3, and H3K36me3 with the gene 
body, the chances of the transcript to be functional increase (Struhl, 2007, Guttman et al., 2009, 
Kung et al.,2013). Depending on their functionality lncRNAs are divided in three categories: 
non-functional lncRNAs which are the result of transcriptional noise, lncRNAs for which the 
act of transcription alone is sufficient for their function but the transcript itself does not fulfil a 
further function and lncRNAs that can act in cis and/or in trans as regulatory cellular 
biomolecules (Quinn and Chang, 2016). 
The biogenesis of lncRNAs is similar to messenger RNAs (mRNAs), as their transcription is 
largely mediated by Pol II. Furthermore, lncRNAs can be polyadenylated, 5′-capped and 
alternative cleaved and spliced, leading to different isoforms. In most instances, they lack any 
biochemical distinction from mRNAs besides the absence of a translated open reading frame 
(Quinn and Chang, 2016). Despite these similarities, lncRNAs and mRNAs exhibit several 
differences, both in their expression profiles and the chromatin status of their loci. 
Transcriptome-wide studies showed that lncRNAs in general exhibit more specific expression 
profiles than mRNAs, in that they are expressed in a more cell type-, tissue-, developmental 
stage- or disease state-specific manner (Cabili et al., 2011, Quinn and Chang, 2016). 
Furthermore, lncRNAs are evolutionary less conserved and less abundant than mRNAs (Ulitsky 
and Bartel, 2013). Recent studies were also able to distinguish lncRNAs from mRNAs on 
chromatin level. In one study, a comparison of lncRNAs with mRNAs that are expressed at 




to lncRNA promoters than to mRNA promoters (Mele et al., 2017). However, H3K9me3, a 
histone modification typically associated with transcriptional repression, is more enriched at 
the promoters of lincRNA loci than at those of mRNAs. Moreover, lncRNAs have weaker 
internal splicing signals and thus they are less efficiently spliced than mRNAs. In addition, 
U2AF65, an important splicing factor binds less in lincRNAs than in mRNAs (Mele et al., 
2017). In another study, it was shown that lincRNAs and pre-mRNAs are transcribed by 
different Pol II phospho-c-terminal domain (CTD) isoforms (Schlaskow et al., 2017). Pol II is 
associated with the spliceosome through a serine 5 P (S5P) CTD, and mRNA 3′ ends are 
generated cotranscriptionally by cleavage and polyadenylation specificity factor subunit 3 
(CPSF73) and this promotes Pol II termination (Schlaskow et al., 2017). In contrast, most 
lncRNAs are weakly spliced and polyadenylated, and thus they are degraded by the nuclear 
exosome on chromatin. Interestingly, the termination of transcription of many lncRNAs is 
independent from CPSF73 and the threonine 4-phosphorylated (T4P) CTD mark, which 
correlates with protein-coding gene termination, is distributed more evenly across the gene 
body of lncRNAs (Schlaskow et al., 2017). The functional lncRNAs should overcome these 
limitations in order to accumulate in high levels in specific cell types (Yang and Chen, 2017).  
In recent years there has also been a dispute about how many of the RNAs that are classified as 
lncRNAs are actually non-coding. Recent studies show that some of the lncRNAs may code for 
small peptides or proteins (Bazzini et al., 2014, Anderson et al., 2015, Jackson et al., 2018). In 
these studies ribosomal foot printing unveiled that, some of the putative lncRNAs are associated 
with ribosomes, and thus there is a high chance for them to be translated to proteins. The 
misclassification of these transcripts as lncRNAs may be because these proteins have non-
canonical open reading frames. It is still not clear how many of the existing annotated lncRNAs 
are actually protein coding. 
Because of the diversity of the lncRNAs when it comes to their function or their structural 
properties, their classification is based on their genomic loci in association with coding genes.   
Thus, depending on their location in the genome, lncRNAs have been divided in different 
subfamilies (Figure 1.4). A lncRNA is typically classified as intergenic when it is expressed as 
a distinct unit from the ‘empty’ space between two coding genes and intronic when it is 
expressed from an intron of a protein coding gene. Furthermore, lncRNAs can be classified as 
antisense when expressed from the opposite strand of a coding gene and bidirectional when a 
lncRNA is derived from the same promoter as a coding RNA but is transcribed from the 




genomic transcriptional enhancers, most of the times in close proximity to protein-coding genes 
(Spurlock et al., 2016).  
 
Figure 1.4: Subtypes of lncRNAs. The lncRNAs can be divided into five different groups 
depending on their location in the genome. Long- intergenic non-coding RNAs (lincRNAs) are 
distinct transcriptional units that do not overlap with coding genes. Intronic lncRNAs are 
transcribed from an intron of a protein-coding gene. Both antisense and bidirectional lncRNAs 
are transcribed from the opposite strand of the coding gene: an antisense lncRNA transcript 
overlaps with the transcript of a coding gene whereas the bidirectional lncRNAs share the 
promoter with a coding gene on the opposite strand. Finally, enhancer RNAs (eRNAs) are 
transcribed from an enhancer region, from one or 2 directions, usually in close proximity to an 
mRNA promoter.   
 
Another important characteristic of lncRNAs is their secondary structures. Several studies have 
tried to reveal the secondary structures using methods like selective 2′-hydroxyl acylation 
analysed by primer extension (SHAPE) (Wan et al., 2011, Watts et al., 2009). LncRNAs can 
generally form stem loops, like Xist, in order to bind to protein binding partners (Maenner et 
al., 2010). Cloverleaf elements, like the ones found in tRNAs, are also common architectures 
of lncRNAs. One of the purposes of this secondary structure is the 3'-end maturation of the 
lncRNAs transcripts, which has been demonstrated in the case of MALAT1 and NEAT1 




secondary element at its 3'-end. This structural element is responsible for recruiting RNase P, 
which is involved in maturation of tRNA molecules, for cleavage and generation of mature 
MALAT1 transcripts (Wilusz et al., 2008). Other structures like helical segments, terminal 
loops, internal loops and junction regions were identified in other lncRNAs like steroid receptor 
RNA activator (SRA) (Navikova et al., 2012). 
In recent years after the development of epitranscriptomics, RNA editing and RNA 
modifications were recognized as important for the dynamic regulation of RNA activity, 
depending on the signal-induced cellular changes. Most of the RNA molecules, including 
lncRNAs, undergo some form of editing or modification during their lifespan, either co-
transcriptionally or post-transcriptionally. Specific modifications can alter the function of the 
RNA because of alterations in the protein binding capability or changes in the secondary 
structures (Meyer et al., 2012, Dominissini et al., 2012, Squires et al., 2012). The most common 
type of RNA editing is the deamination of adenosine to inosine in Alu repeat elements found 
in introns or intergenic regions (Picardi et al., 2014). Due to different preferences in base pairing 
between the adenosine and inosine the secondary structure of RNA may change (Levanon et 
al., 2004). This modification is important for preventing the immune response against self-
RNAs that can be recognised by cytosolic RNA sensors, like MDA5 (Liddicoat et al., 2015).  
The adenosine-deaminase (ADAR) family, comprising ADAR1, which is found in both nucleus 
and cytoplasm and ADAR2, which is found only in the nucleus, is responsible for the 
adenosine-to-inosine deamination (Pulsen et al., 2001, Desterro et al., 2003). There is evidence 
that ADAR affects tissue specific expression of lncRNAs (Goldstein et al., 2017). One way of 
ADAR function is through changing the ability of lncRNA to bind to mRNA and the best 
example is the intronic lncRNA PCR3 that has been implicated in prostate cancer (Salameh et 
al., 2015). The lncRNA forms an RNA duplex with the coding gene PRUNE2, which is 
transcribed from the same genomic locus, and leads to its degradation. Low levels of PRUNE2 
are found in prostate tumours. The complex formation is regulated by ADAR, and thus the 
depletion of ADAR leads to higher levels of PRUNE2 (Salameh et al., 2015). Other 
modifications have been found in different RNA species like rRNAs and tRNAs but the field 
is still young. 
 
1.2.4 Functions of Long-non coding RNAs 
Long non-coding RNAs are a highly diverse family, and thus they have several functional 
repertoires, unlike the classes of small non-coding RNAs, which have a common mechanism 




features shared by several RNAs. LncRNAs can serve as scaffolds, guides and decoys (Rinn 
and Chang, 2012). As scaffolds, lncRNAs bring together two or more proteins into RNA–
protein complexes. A well-studied lincRNA of this class is HOTAIR, which can bind both the 
polycomb repressive complex 2 (PRC2) and the LSD1-CoREST complex (Tsai et al., 2010).  
The binding is facilitated by the structure of the lncRNA and leads to gene silencing via 
induction of H3K27 methylation and H3K4me2 demethylation (Tsai et al., 2010). To this 
category belong several other lncRNAs that form complexes with proteins, such as NEAT1 
(Clemson et al., 2009) which is essential for paraspeckles formation and interacts with SFPQ 
and HEXIM1 to form a complex essential for IRF3 phosphorylation (Morchikh et al., 2017). 
LncRNAs with decoy functions titrate away e.g. DNA-binding proteins from DNA, including 
transcription factors. Gas5 is a good example of this family since it binds to the glucocorticoid 
receptor through its harpin structure and inhibits the transcription of metabolic genes during 
starvation (Kino et al., 2010). Guide lncRNAs are responsible for proper localization of specific 
protein complexes. This class has two molecular properties: interaction with another protein 
and a mechanism to interface with selective regions of the genome. These lncRNAs are 
involved in dosage compensation and imprinting and serve as guides to target gene silencing 
activity in an allele-specific fashion. Xist for instance functions as a guide lncRNA, which is 
responsible for X-chromosome inactivation in females (Penny et al., 1996). 
Another major classification of lncRNAs is made according to the proximity of their regulated 
target genes compared to their own transcriptional genomic loci. According to this 
classification, lncRNAs can act in cis or in trans. When lncRNAs target neighbouring genes 
then they are considered to act in cis, whereas when they regulate expression of distant genes, 
they act in trans. Despite this separation, it is evident today that a cis acting lncRNA may also 
regulate genes further away from its genomic locus due to chromatin looping, which brings the 
lncRNA locus and the target gene locus into close proximity (Nagano et al., 2008). 
The lncRNA mechanisms of action are highly diverse and thus no classification can include all 
the unique functional properties. For example, lncRNAs have also the ability to bind to RNA 
molecules, such as mRNA, miRNAs and other lncRNAs, and control their availability, 
expression and function. A good example is the antisense lncRNA Uchl1 which binds to 
UCHL1 gene mRNA and this interaction is essential for the association of the mRNA with 






Figure 1.4: Models of lncRNA mechanisms of action. LncRNAs can act as scaffolds in order 
to bring different proteins into close proximity or facilitate a protein complex formation. They 
can act as guides to bring transcription factors or other molecules to the desired genomic loci 
in order to activate or inhibit transcription. Finally, lncRNAs can act as decoys binding to 
transcription factors and driving them away from the genomic loci.  
 
The functional diversity of lncRNAs makes their characterisation more complicated compared 
to other members of the ncRNA family, like miRNAs and siRNAs that have a specific way of 
regulating gene expression. Another obstacle for the functional characterisation of lncRNAs is 
the lack of methodological approaches, even though due to rapid development of new 
technologies, such as CRISPR/Cas9, this may no longer be a hindrance. 
1.2.5 Long-non coding RNAs in immunity 
Over the last decade, several lncRNAs have been implicated in regulation and function of the 
immune system. As lncRNAs are often cell-type specific, different lncRNAs have been 
identified in the distinct immune cell populations. They can have significant functions in the 
immune responses or be responsible for the cell differentiation fate. 
In order to have a productive immunity HSCs differentiate into highly specialised immune cells. 
This process is tightly controlled through the expression of cell-type-specific genes, and 
evidence suggests that lncRNAs might also have an important role in this process. For example, 
the lncRNA H19 has been implicated in the quiescence of adult HSCs (Venkatraman et al., 
2013). H19 is highly expressed in long-term HSCs and it is downregulated when they 




leads to a loss of long-term HSCs and subsequently gain of short-term HSCs. H19-deficient 
long-term HSCs lose the ability to self-renew and differentiate into downstream cell types 
(Venkatraman et al., 2013). Two other lncRNAs, lncHSC-1 and lncHSC-2 were implicated in 
HSC regulation (Luo et al., 2015). Depletion of lncHSC-1 resulted in dysregulation of myeloid 
lineage differentiation, while depletion of lncHSC-2 lead to impaired self-renewal of HSC and 
increased T cell differentiation. LncHSC-2 is important for the recruitment of the transcription 
factor E2A to its targets, which has critical regulatory roles in the HSC and lymphoid-cell 
development (Luo et al., 2015). 
Another lncRNA, Lnc-DC is also involved in differentiation of immune cells. It is upregulated 
during the differentiation of common myeloid progenitor cells or monocytes into DCs and is 
highly expressed in classical DC subsets (Wang et al., 2014). Knock down of lnc-DC reduces 
the expression of several DC-specific genes, such as CD40, CD80, CD86 and CCR7. DCs 
depleted of lnc-DC are unable to efficiently prime CD4+ T cells or secrete inflammatory 
cytokines after pathogen stimulation. Its function is mediated through interaction with STAT3. 
The lncRNA facilitates the STAT3 phosphorylation and its translocation to the nucleus, through 
inhibiting the SHIP1-STAT3 interaction (Wang et al., 2014). On the other hand, lncRNA 
Morrbid, is induced when common myeloid progenitor cells differentiate into terminal cells 
and is highly expressed in neutrophils, eosinophils and monocytes (Kotzin et al., 2016). 
Morrbid knockout leads to a decrease in the number of neutrophils, eosinophils and monocytes 
due to induction of cell death. Morrbid is found mainly in the nucleus, and it acts in cis to 
repress the expression of its neighbouring gene Bcl2l11. Chromosomal looping brings Morrbid 
and Bcl2l11 in spatial proximity, where the lncRNA recruits PRC2 to deposit silencing 
H3K27me3 histone marks on the Bcl2l11 promoter. Morrbid expression can be induced in vitro 
by cytokines such as interleukin 3 (IL-3), IL-5 and GM-CSF, and thus has been associated with 
the hypereosinophilic syndrome. Patients with this syndrome have high concentrations of IL-5 
in their plasma and eosinophils from these patients express significantly more Morrbid than do 
eosinophils from healthy control subjects (Kotzin et al., 2016). 
Several lncRNAs have also been implicated in the differentiation of T-cell subsets. For 
example, lncRNA lincR-Ccr2-5′AS is specifically expressed in the Th2 subset of helper T cells 
(Hu et al., 2013). GATA-3, which is a signature transcription factor of the Th2 cell population, 
regulates lincR-Ccr2-5′AS expression. Knockdown of lincR-Ccr2-5′AS led to dysregulation of 
genes that dependend on GATA-3, such as Ccr1, Ccr2, Ccr3 and Ccr5, which are Th2 cell 




and controls the transcription of its neighbouring genes encoding Th2 cell cytokines, such as 
IL4, IL5, and IL13 (Spurlock et al., 2015). During differentiation of T-cells towards the Th1 
population, the lncRNA linc-MAF-4 seems to play a critical role (Ranzani et al., 2015). Linc-
MAF-4 represses the expression of the Th2 cell transcription factor MAF to promote T cell 
differentiation toward the Th1 cell lineage. The genomic regions of linc-MAF-4 and MAF come 
into close proximity and linc-MAF-4 recruits EZH2-and LSD1 to place repressive chromatin 
marks at the MAF promoter and repress transcription. Thus, knockdown of linc-MAF-4 favours 
T cell differentiation towards the Th2 cell lineage (Ranzani et al., 2015). Together these studies 
suggest that lncRNAs can serve as critical regulators of cell-type-specific differentiation 
programs and are important for immune-cell lineage commitment.  
1.2.6 Long non-coding RNAs in inflammatory responses 
LncRNAs have been involved both in the innate and the adaptive immune system. In adaptive 
immunity, lncRNAs have been implicated in inflammatory responses of both CD4+ T-cells and 
CD8+ T-cells (Gomez et al., 2013, Willingham et al., 2005, Sharma et al., 2011, Wang et al., 
2015). One of the first examples of an lncRNA functioning in the immune response in vivo was 
the lncRNA NeST (Nettoie Salmonella pas Theiler’s), which is expressed in a genomic region 
previously associated with persistence of neurotropic Theiler's virus infection (Gomez et al., 
2013). Two strains of mice show a different susceptibility in Theiler's virus infection. B10.S 
can clear the infection, while SJL/J mice are more susceptible. A known difference between the 
two mouse strains exists in the genomic region that expresses NeST, IFN-γ, and IL-22. Gene-
expression analysis revealed that NeST expression is much higher in T cells from mice that 
retain the locus derived from the SJL strain. NeST regulates the transcription of the Ifnγ gene 
by binding to WDR5 and recruiting the transcription-activation complex to the Ifng promoter 
sequence in trans. Overexpression of NeST increases IFN-γ production in activated CD8+ T 
cells. Moreover, NeST also regulates bacterial infection, since it is responsible for reduction of 
Salmonella enterica pathogenesis (Gomez et al., 2013). Another lncRNA, NRON (Non‐coding 
Repressor Of NFAT), functions as a repressor of the calcium-dependent transcription factor 
NFAT (Nuclear Factor of Activated T-cells) (Willingham et al., 2005, Sharma et al., 2011). 
NRON belongs to a large RNA–protein complex in resting T cells, which sequesters the 
phosphorylated form of NFAT in the cytoplasm. The RNA–protein complex also includes the 
calmodulin-binding protein IQ Motif Containing GTPase Activating Protein 1 (IQGAP1), the 
Leucine Rich Repeat Kinase 2 (LRRK2), and the nuclear-transport factor karyopherin β1. After 




the Ca2+-calmodulin–dependent phosphatase calcineurin. Afterwards, NFAT is transported 
into the nucleus, where it can activate transcription. When NRON is absent, NFAT gets more 
dephosphorylated and higher copies of the transcription factor are found in the nucleus, which 
leads to abarrant production of cytokines (Willingham et al., 2005, Sharma et al., 2011). In 
CD8+ T cells, expression of lncRNA-CD244 is induced by signalling through the T cell 
inhibitory receptor CD244 (2B4) and leads to repression of IFN-γ and TNF (Wang et al., 2015). 
Similar to linc-MAF-4, lncRNA-CD244 physically interacts with EZH2 (Enhancer of zeste 
homolog 2) and recruits it to the IFNγ and TNF promoters for the deposition of repressive 
chromatin marks. Knockdown of lncRNA-CD244 in T-cells of mice, that were infected with 
Mycobacterium tuberculosis led to significantly lower organ bacterial burden in comparison to 
mice that express normal levels of lncRNA-CD244 in their T-cells (Wang et al., 2015). 
In innate immunity, several lncRNAs have been involved in inflammatory responses (Carpenter 
et al., 2013, Li et al., 2013, Krawczyk et al., 2014, Atianand et al., 2016, Castellanos-Rubio et 
al., 2016, Rapicavoli et al., 2013, Liu et al., 2015). One example is lincRNA-Cox2 that is highly 
induced upon TLR1, TLR2, TLR7 and TLR8 activation, but not after activation of TLR3 in 
bone-marrow-derived DCs and bone-marrow-derived macrophages (Carpenter et al., 2013). 
Moreover, transcription of lincRNA-Cox2 is MyD88 and NF-κB dependent. LincRNA-Cox2 
knock-out during inflammatory stimulation leads to dysregulation of 500 genes encoding 
inflammatory molecules. LincRNA-Cox2 interacts with the heterogeneous nuclear 
ribonucleoproteins hnRNP-A/B and hnRNP-A2/B1. Depletion of the two ribonucleoproteins in 
bone-marrow-derived macrophages results in the dysregulation of the same genes as upon 
knockdown of lincRNA-Cox2. Furthermore, overexpression of lincRNA-Cox2 in bone-
marrow-derived macrophages lacking the ribonucleoproteins was sufficient to restore the 
expression of Ccl5 (Carpenter et al., 2013). The lncRNA THRIL is a regulator of TLR2 
signalling that was identified in a gene-expression screen of the THP-1 human macrophage cell 
line treated with Pam3CSK4 (Li et al., 2013). Transcriptome-wide analysis of THRIL-depleted 
THP1 cells identified more than 300 deferentially regulated genes downstream of TLR2, 
including TNF, IL8, CXCL10, CCL1 and CSF1, both upon activation of TLR2 and at steady 
state. Mass-spectrometry studies have identified hnRNPL as a binding partner of THRIL and 
knockdown of hnRNPL resulted in a decreased production of TNF by macrophages. 
Furthermore, THRIL was found to be associated with the TNF genomic locus, and chromatin-
immunoprecipitation analysis of hnRNPL resulted in enrichment of a region within the TNF 
promoter in a THRIL-dependent manner (Li et al., 2013). The lncRNA PACER also acts in the 




(LPS), and it regulates its neighbouring gene PTGS2, which encodes cyclooxygenase 2 (COX-
2) and participates in the inflammatory responses. PACER acts as a decoy and binds to the NF-
κB subunit p50, driving it away from the PTGS2 promoter, where p50 homodimers can repress 
transcription. The reduction of free p50 subunits leads to the formation of p50-p65 
heterodimers, which are recruited to the PTGS2 promoter and lead to transcriptional activation 
(Krawczyk et al., 2014). The lincRNA-EPS is expressed in erythrocytes, macrophages and DCs, 
and it is downregulated after activation of the innate immune system (Atianand et al., 2016). 
LincRNA-EPS-deficient mice display no defects in erythroid development but show hyper-
activation of immune responses in vivo. Bone-marrow-derived macrophages from lincRNA-
EPS-deficient mice stimulated with TLR ligands show higher expression pro-inflammatory 
molecules, such as Il6, Cxcl10, Ccl4 and Irg1 compared to wild-type animals. This was linked 
to higher chromatin accessibility and nucleosome-free chromatin, as well as a greater content 
of H3K4me3 marks, associated with transcriptional activation, in the promoters of pro-
inflammatory genes. LincRNA-EPS is localized to the nucleus and binds to hnRNPL to exert 
these regulatory effects. Thus, lincRNA-EPS acts at the chromatin level and controls chromatin 
accessibility in order to regulate the expression of pro-inflammatory genes in myeloid cells 
(Atianand et al., 2016). The lncRNA lnc13 functions similar to lincRNA-EPS and represses the 
transcription of immune genes. Lnc13 is expressed in macrophages and downregulated after 
activation of the TLR4 pathway (Castellanos-Rubio et al., 2016). In resting cells, lnc13 
localizes to the nucleus and interacts with hnRNPD and the histone deacetylase HDAC1 to 
suppress the transcription of immune related molecules, such as Myd88, Stat1, Stat3 and Tnf.  
Single-nucleotide polymorphisms (SNPs) in the lnc13 gene that generate a transcript with 
impaired ability to bind to hnRNPD have been associated with celiac disease. Patients with 
celiac disease have lower expression of lnc13 and higher expression of lnc13-regulated genes, 
and thus the polymorphism, which leads to impaired lnc13 function, may be important for the 
development of the inflammatory decease (Castellanos-Rubio et al., 2016). The pseudogene 
lncRNA Lethe was induced in mouse embryonic fibroblasts after stimulation with IL-1β and 
TNF. Lethe is induced through NF-κB but knockdown of the lncRNA results in the upregulation 
of NF-κB targets and overexpression leads to a decreased NF-κB activity, which suggests a 
negative feedback loop (Rapicavoli et al., 2013). RNA-immunoprecipitation showed that Lethe 
interacts with p65 homodimers in the nucleus, preventing their accumulation at target-gene loci, 
including Nfkbia, Il6 and Il8. Thus, Lethe acts as a decoy for NF-κB and provides negative 
feedback to restrict inflammatory responses (Rapicavoli et al., 2013). Similarly, lncRNA 




κB (IκB) (Liu et al., 2015). NKILA is induced in breast cancer cells following stimulation with 
IL-1β or TNF and knockdown of NKILA enhances NF-κB activity whereas its overexpression 
inhibits NF-κB. Mechanistically, NKILA masks phosphorylation motifs of IκB from the IκB 
kinase (IKK), which prevents the phosphorylation and degradation of IκB by IKK and results 
in the retention of NF-κB in the nucleus (Liu et al., 2015). 
1.3 Infection model organisms  
1.3.1 Legionella pneumophila 
In infection biology, several bacteria have been established as model organisms to study host-
pathogen interactions. One of the model pathogens to study pneumonia-related inflammatory 
responses is Legionella pneumophila (L. pneumophila). L. pneumophila was first identified in 
1977 during an outbreak in an American Legion convention (Fraser et al., 1977). Legionellosis, 
the disease caused by the bacteria, is a type of community-acquired pneumonia and it is 
responsible for approximately, 2%–15% of all community-acquired pneumonias that require 
hospitalization. The most common source of infection by the bacteria are aerosols and water 
droplets. L. pneumophila also causes Pontiac fever, which is characterised by fever, chills, dry 
cough, myalgia, malaise, and headache but not pneumonia. L. pneumophila is a rod‐shaped 
bacterium with strict growth requirements for iron and cysteine. It is a non‐encapsulated, 
aerobic gram-negative bacillus with a single polar flagellum (Swanson and Hammer, 2000). In 
the soil and water L. pneumophila’s main hosts are amoebae and two species of ciliated 
protozoa (Rowbotham, 1980).  In humans, the main target of L. pneumophila are alveolar 
macrophages and since there is no transmission between humans it is believed that amoebae 
have equipped the bacteria with the necessary factors allowing their replication within alveolar 
macrophages (Newsome et al., 1985, Cianciotto and Fields 1992, Franco et al., 2009). During 
its life cycle, the bacterium can be found in two different forms: the transmissive or virulent 
and replicative or avirulent form. In the replicative form, L. pneumophila replicates within the 
Legionella containing vacuole (LCV) inside the infested host cell or in media and is non‐motile 
and non‐cytotoxic. It remains in this form as long as sufficient nutrients and living space are 
available (Swanson and Hammer, 2000). When nutrients become scarce, L. pneumophila 
changes into the transmissive form and it can infect or re-infect host cells. The first step during 
the infection cycle is the attachment of the bacterium to the host cell. Assisted by important 
factors like flagellae, pili and bacterial surface proteins, such as major outer membrane proteins, 
heat shock proteins, and the mip protein, L. pneumophila enters the host cell (Swanson and 




type of host and the bacterial strain. Macrophages normally take up the bacteria through 
conventional phagocytosis. Other forms can be coiling phagocytosis, zipper‐like conventional 
phagocytosis, opsonin‐dependent phagocytosis and micropinocytosis, which has been observed 
in bone-marrow derived macrophages (Harwitz et al., 1984, Watarai et al., 2001). After the 
internalisation, the bacterium uses its Dot/Icm (Dot: defective in organelle trafficking, Icm: 
intracellular multiplication) type IVB secretion system (T4BSS) in order to form the LCV, 
where L. pneumophila normally replicates. T4BSS together with Lsp type II secretion system 
(T2SS), are the two secretion systems of L. pneumophila and play a major role in bacterial 
pathogenesis (Kubori and Nagai, 2016).  Via the T2SS, proteins translocate across the inner 
membrane and exit the bacterial cell through a specific outer membrane pore (Nivaskumar and 
Francetic 2014). The T2SS secretes over 25 proteins, including 18 enzymes and L. pneumophila 
specific proteins. (DebRoy et al., 2006, Tyson et al., 2013). Via the T4BSS the bacteria secrete 
over 330 effector proteins to promote the formation of the LCV and their own replication. These 
effector proteins modulate the eukaryotic cell in order to acquire nutrients, block microbial 
degradation and host defences, and enable pathogen transmission to other hosts (Ensminger, 
2016). The Dot/Icm systems are highly conserved among all Legionella species (Berger and 
Isberg, 1993, Brand et al., 1994). About 10% of the genome of L. pneumophila encode for these 
effector proteins (Al‐Quadan et al., 2012) and many of them possess eukaryotic‐like domains, 
which allows these proteins to interact with host cell components. (Cazalet et al., 2004, Hubber 
and Roy 2010). The LCV escapes the host cell defence mechanisms because it is negative for 
canonical markers of the endocytic pathways such as Rab5 for early endosomes, Rab7 for late 
endosomes and Lamp‐1 for lysosomes (Clemens et al., 2000) and does not undergo 
acidification, maintaining a pH of ~6.1, which prevents fusion with the lysosome (Horwitz and 
Maxfield 1984). The escape from phagosome-lysosome fusion is a hallmark of Legionella 
pathogenesis and mutants lacking this feature are not able to multiply within human 
macrophages (Horwitz, 1987). When the LCV is established inside the host cell it is surrounded 
by mitochondria, ribosomes and smooth vacuoles derived from the endoplasmatic reticulum 
(ER). This association, allows the LCV to change the thickness of its membrane in order to 
resemble the ER (Tilney et al., 2001). At four hours post infection ribosomes are recruited to 
the LCV resulting in a rough ER‐like vacuole. In the third step of the infection, L. pneumophila 
inhibits the bactericidal activity of the host and converts the phagosome into a safe intracellular 
niche for its replication. After replication within the LCV, when nutrients become limited, L. 
pneumophila differentiates into the flagellated transmissive form and is released from the LCV 




and structural and functional disruption of cytoplasmic organelles, which eventually results in 
osmotic lysis of the host cells. The released bacteria can then infect neighbouring cells and start 
a new cycle of replication.  
L. pneumophila can be recognised by the innate immune system through different PAMPs, such 
as lipopeptides, lipoproteins and LPS, which are expressed on the surface of the bacteria 
(Massis and Zamboni, 2011). The PAMPs are recognised by a variety of PRRs, such as TLR2, 
which recognises the unique L. pneumophila LPS, TLR5, which can sense flagellin, and NLRs. 
The bacterial nucleic acids can also activate the STING pathway and induce type I IFN 
responses (Massis and Zamboni, 2011). As mentioned before, TLR2 is activated by 
lipopeptides and lipoproteins, which are cell wall components of Legionella. Furthermore, lipid 
A signals via TLR2 to induce the expression of CD14. The LPS of Legionella is mainly 
recognized by TLR2, because of its unique structure, which is different from LPS derived from 
other bacteria, such as Salmonella enterica Typhimurium. (Zahringer et al., 1995, Akamine et 
al., 2005, Shim et al., 2009). Mice deficient in the tlr2 gene showed impaired cytokine 
production and an increased susceptibility to bacterial replication in the lungs (Hawn et al., 
2006). TLR5 sensing of flagellin is important for L. pneumophila infection in humans, since a 
stop codon polymorphism in the gene of TLR5 increases the susceptibility to Legionnaires’ 
disease (Hawn et al., 2003). The same was observed in mice lacking TLR9 (Newton et al., 
2007).  All mentioned TLRs lead to activation of the adapter molecule MyD88, which mediates 
the downstream NF-κB‐dependent production of pro‐inflammatory cytokines. NLRs, NOD1 
and NOD2, are also activated by L. pneumophila (Frutuoso et al., 2010). Knockout studies with 
mice deficient in both NLRs, NOD1 and NOD2, showed impaired neutrophil recruitment and 
reduced bacterial clearance during lung infection (Frutuoso et al., 2010). The recognition of 
nucleic acids of L. pneumophila is also important for the inflammatory responses of the host. 
Sensor cyclic GMP‐AMP synthase (cGAS) and the RIG‐I‐like receptor family, respectively 
recognise the DNA and RNA of Legionella. The binding of the DNA to cGAS induces the 
production of the second messenger cyclic 2′3′‐GMP‐AMP (2′3′‐cGAMP), which leads to 
activation of a STING‐dependent signalling pathway (Sun et al., 2013, Watson et al., 2015). 
On the other hand, L. pneumophila’s RNA is recognised by RIG-I and MDA5, which leads to 
activation of MAVS and IRF3 and subsequently to the production of type I IFNs, such as IFNα 
and IFNβ (Opitz et al., 2006). The production of Type I IFNs is important for defence against 
L. pneumophila, since when the pathway is blunted the bacteria display higher replication and 
infection rates (Lippmann et al., 2011, Naujoks et al., 2016). There are indications for ncRNAs 




Some miRNAs, like miR146a, are differentially regulated upon L. pneumophila infection (Jung 
et al., 2017), which suggests potential roles in Legionella-host interaction.  
1.3.2 Salmonella enterica serovar Typhimurium 
Another popular bacterium used as an infection model in many studies is Salmonella enterica 
serovar Typhimurium. The genus Salmonella is a relative of the genus Escherichia and 
itsmembers are Gram-negative, non-spore-forming, rod-shaped bacteria belonging to the 
Enterobacteriaceae family (Fabrega and Vila, 2013). Salmonella enterica serovar Typhimurium 
(henceforth Salmonella) is a primary enteric pathogen infecting both humans and animals and 
causing gastrointestinal diseases. The usual origin of infection is upon ingestion of 
contaminated foods or water. The bacteria infect thousands of people every year and cause life-
thretening systemic infections in immune-compromised individuals (Kozak et al., 2013, 
Kariuki et al., 2006). The clinical symptoms after infection include fever, headache, abdominal 
pain, and transient diarrhoea or constipation, and infection can produce fatal respiratory, 
hepatic, spleen, and neurological damage (Ohl and Miller, 2001). After entering the host gastric 
system, the bacteria adjust to the acidic environment by activating the acidic tolerance response 
(ATR), which allows maintaining an intracellular pH higher than the surrounding environment 
(Foster and Hall, 1991). The Salmonellae then adhere to the intestinal epithelial cells and induce 
cytoskeletal rearrangements that allow the engulfment of the bacteriae (Takeuchi, 1967, Finlay 
et al., 1991). When inside the cell, the bacteria form large vesicles called Salmonella-containing 
vacuoles (SCVs). In these vehicles, the bacteria are able to survive and replicate (Francis et al., 
1993, Garcia del Portillo et al., 1994). Initially, the SCVs enter the early endocytic pathway, 
but later they manage to escape the lysosomes (Garcia del Portillo and Finlay, 1995). SCVs are 
located next to the Golgi apparatus and obtain nutrients through endocytic and exocytic 
transport vesicles (Deiwick et al., 2006, Salcedo et al., 2003). When Salmonella crosses the 
epithelium, it interacts with immune cells, like neutrophils, macrophages and dendritic cells. In 
these cells, Salmonella behaves the same way as in epithelial cells, forming SCVs and inducing 
inflammatory responses (Johansson et al., 2006, Rydström and Wick, 2007). When inside the 
phagocytes Salmonella can travel from the blood stream to other tissues and organs.  
Salmonella is a model pathogen for activation of immune responses. Even inside the SCV, the 
pathogen is not completely escaping the host inflammatory responses. In phagocytic cells, 
Salmonella can be recognised by most of the PRRs and thus it induces a robust inflammatory 
response, inducing the release of several cytokines such as IL-1β, IL-8 and TNFα (Broz et al., 




inflammasome and induction of pyroptosis. Inflammasomes are molecular complexes that 
regulate the activation of the proteolytic enzyme caspase-1 (Franchi, 2011). In macrophages, 
Salmonella induces the activation of caspase-1, necessary for the maturation of the 
proinflammatory cytokines IL-1β and IL-18. Caspase-1 dependent pyroptosis is a form of 
programmed cell death with characteristics of both apoptosis and necrosis. During pyroptosis, 
there is formation of pores in the cell membrane, which leads to release of cellular cargo and 
pro-inflammatory cytokines. This process benefits the host since it amplifies the inflammatory 
response by triggering recruitment of other mediators of inflammation and exposing the 
intracellular bacteria to extracellular immune defences (Miao et al., 2010). 
Some non-coding RNAs have been also implicated in the immune responses to Salmonella. For 
example, the let-7 family is downregulated upon Salmonella infection, which relieves negative 
regulation of IL-6 and IL-10 cytokines (Schulte et al., 2011). Another miRNA family, which 
was reported as regulator of Salmonella infection is the mir-15 family. Through regulation of 
the cell cycle, the microRNA family is able to inhibit Salmonella infection (Maudet et al., 
2014).  In mice, lncRNA NeST has been associated with lymphoid cell immunity to Salmonella 
(Gomez et al., 2013). Furthermore, a recent study demonstrated that accumulation of unstable 
nuclear RNAs, like the long non-coding RNAs NEAT1v2 and eRNA07573, is important for 













1.4 Aim of this study 
During the past decade, several lncRNAs have been characterised as important riboregulators 
of many pathophysiological processes. More recently, few lncRNAs have also been implicated 
in the immune system. This study attempts to establish a comprehensive catalogue of lncRNAs 
regulated during leukocyte terminal differentiation and immune-activation, including 
information on their subcellular localization and their formation of functional RNA-subclasses. 
Moreover, a central goal of this project was to determine the precise molecular functions of 
selected lncRNAs in human immunity. Finally, the current work aims at the establishment of a 
reproducible methodological workflow for lncRNA mechanistic analysis, to be employed by 
subsequent lncRNA studies within and beyond the field of leukocyte biology. Together, these 
objectives are expected to broaden the still rudimentary current knowledge about lncRNA 










Materials and Methods 
47 
 
2. Materials and methods 
2.1 Materials 
2.1.1 Instruments and equipment 
Table 2.1.1: List of instruments and equipment  
 Instrument Name Company 
Automated cell counter TC10™ BioRad Laboratories 
Hercules, USA 
Bioanalyzer 2100 Bioanalyzer 
Instrument 
Agilent Technologies 
Santa Clara, USA 
Bioluminescence and 
Chemoluminescence Imager 
ChemoCam Imager 3.2 INTAS Science lmaging 
Göttingen, Germany 
Camera AxioCam MRm Zeiss 
Oberkochen, Germany 
Cell Counting Chamber Neubauer Counting 
Chamber 
Paul Marienfeld GmbH & 
Co. KG Lauda‐Königshofen, 
Germany 
Cell culture bench SAFE 2020 Thermo Fisher Scientific, 
Waltham, USA 
Centrifuge HERAEUS Multifuge X3R Thermo Fisher Scientific, 
Waltham, USA 
Centrifuge Centrifuge 5424R Eppendorf 
Hamburg, Germany 
Centrifuge Sprout® Mini‐Centrifuge  
 
Heathrow Scientific® LLC 
Illinois, USA 
Centrifuge Heraeus Fresco L7 Thermo Fisher scientific 
Waltham, USA 
CO2 Incubator HERAcell 240i Thermo Fisher scientific 
Waltham, USA 
Dispenser Multipette® plus Eppendorf 
Hamburg, Germany 
Dispenser Multipette® Xstream Eppendorf 




FACS Guava easyCyte™ Merck MilliporeTM 
Billerica, USA 
FACS‐Sorter FACS Aria III Cell Sorter Miltenyi Biotec GmbH 
Bergisch Gladbach, 
Germany 
Fluorometer Qubit® 2.0 Fluorometer Thermo Fisher scientific 
Schwerte, Germany 








PerfectBlue Gel System Peqlab 
Erlangen, Germany 
Gel preparation equipment Multiple Gel Casting Peqlab 
Erlangen, Germany 
Gel preparation equipment Gel Trays Peqlab 
Erlangen, Germany 





MaxQ 600 Thermo Fisher scientific 
Schwerte, Germany 
Laboratory roller mixer SRT6D Stuart ® 
Marseille, France 
Laboratory shaker See‐Saw rocker SSL4 Stuart ® 
Marseille, France 
Liquid nitrogen storage 
tanks 
Cryo Plus 2 Thermo Fisher Scientific 
Waltham, USA 
Macs multi stand magnet quadroMacs Miltenyi Biotec GmbH 
Bergisch Gladbach, 
Germany 
Magnetic & Heating Stirrer RCT Standard IKA 
Staufen, Germany 
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Microscope AXIO Vert.A1 Zeiss 
Oberkochen, Germany 
Microscope PrimoVert Zeiss 
Oberkochen, Germany 
Microwave Inverter SHARP 
Hamburg, Germany 
PCR Cycler PeqSTAR 2x Gradient Peqlab 
Erlangen, Germany 




Pipette (0.1 ‐ 1000 μl)  Gilson 
Middleton, USA 
Plate reader Tecan Infinite M200 PRO Thermo Fisher scientific 
Waltham, USA 
Power supplies PeqpowerE300 200/300V Peqlab 
Erlangen, Germany 
Precision Scales  Denver Instruments 
Göttingen, Germany 
Real Time PCR System ViiA7 TM Life Technologies™ 
Darmstadt, Germany 
Real Time PCR System QuantStudio3 Thermo Fisher Scientific 
Waltham, USA 
Spectrophotometer NanoDrop 2000c Thermo Fisher Scientific  
Waltham, USA 
Steam sterilizer Varioklav® HP Medizintechnik GmbH 
Oberschleißheim, Germany 
Surgical preparation set  Fine Science Tools 
Heidelberg, Germany 
Thermomixer (1.5 ml; 2 ml) Thermomixer Comfort Eppendorf 
Hamburg, Germany 
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Vacuum pump AC 04 VACUUBRAND GMBH + 
CO  KG                  
Wertheim, Germany 
Vortex VortexGenie2 Scientific lndustries 
New York, USA 
Vortex IKA®MS3 Agilent Technologies 
Santa Clara, USA 
Vortex Vortex V‐1 plus Peqlab 
Erlangen, Germany 
Water bath  GFL® 
Burgwedel, Germany 
 
2.1.2 Consumables and plastic ware 
Table 2.1.2: List of consumable and plastic ware 
Type Name Company 
15 ‐ 50 ml tube Falcon SARSTEDT AG & Co. 
Nümbrecht, Germany 
6‐well plate, 12‐well plate, 24‐
well plate, 96‐well plate 
CELLSTAR® Cell culture 
plate 
Greiner Bio‐One GmbH 
Frickenhausen, Germany 
96‐well plate for ELISA  Thermo Fisher scientific 
Waltham, USA 
Cap tube for cultivation of 
bacteria 
14 ml PP tube Greiner Bio‐One GmbH 
Frickenhausen, Germany 
Cell culture dish  Greiner Bio‐One GmbH 
Frickenhausen, Germany 
Cell culture flask (T25; T75) TC Flask SARSTEDT AG & Co. 
Nümbrecht, Germany 
Cell scraper (25 ‐ 50 cm)  SARSTEDT AG & Co. 
Nümbrecht, Germany 
Cotton buds Cotton buds, Rotilabo Carl Roth GmbH & Co. 
KG 
Karlsruhe, Germany 
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Cryo‐tubes  SARSTEDT AG & Co. 
Nümbrecht, Germany 
Cuvette (polystyrene)  SARSTEDT AG & Co. 
Nümbrecht, Germany 
Disposal Bags  Carl Roth GmbH & Co. 
KG 
Karlsruhe, Germany 
Dissecting set  Fine Science Tools GmbH 
Heidelberg, Germany 




Inoculation spreader  SARSTEDT AG & Co. 
Nümbrecht, Germany 
Inoculation tube Loop Soft 10 µl VWR International GmbH 
Darmstadt, Germany 




Lintfree tissues Delicate task wipes Kimberly‐Clark 
Professional® 
Roswell, USA 









Parafilm PARAFILM® M VWR International GmbH 
Darmstadt, Germany 
Pasteur pipette  Glaswarenfabrik Karl 
Hecht GmbH & Co KG 
Sondheim, Germany 
qPCR 96‐ well plates (0.1 ml)  Life Technologies™ 




RNA Nano Chip  Agilent Technologies 
Santa Clara, USA 
Serological pipette (5 ml ‐ 25 
ml) 
 SARSTEDT AG & Co. 
Nümbrecht, Germany 
Steril filtration filters (0.2 µm) Filtropur S SARSTEDT AG & Co. 
Nümbrecht, Germany 
Surgical disposable scalpel  B. Braun Melsungen AG 
Melsungen, Germany 
Tips (0.5 ml – 25 ml) Combitips advanced® Eppendorf 
Hamburg, Germany 
Tips (10 µl ‐ 1000 µl)  Safe Seal‐Tips® 
professional 
Tips (10 µl ‐ 1000 µl)  Gilson 
Middleton, USA 
Tips (10 µl ‐ 1000 µl) Diamond® Gilson 
Middelton, USA 
Tips (10 µl ‐ 1000 µl) TOWERPACK™ Gilson 
Middelton, USA 
Tips (5 ml ‐ 50 ml) Tips for PIPETMAN® Gilson 
Middelton, USA 
Tubes  Eppendorf 
Hamburg, Germany 
Tubes (0.5 ‐ 2.0 ml) Safelock Tubes Eppendorf 
Hamburg, Germany 
Tubes (1.8 ml) CryoPure Tubes SARSTEDT AG & Co. 
Nümbrecht, Germany 










Table 2.1.3: List of chemicals 
Chemical Name Company 
2‐Mercaptoethanol  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
ACES  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Acetic acid  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Acetonitrile  Sigma‐Aldrich 
St. Louis, USA 
Acid phenol chloroform  Ambion by life technologies 
Carlsbad, USA 
Acrylamide Acrylamide (Rotiphoresis 
Gel 30,37.5:1) 
Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Agar Agar (Kobe I)  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Agarose Biozym LE Agarose Biozym Scientific GmbH 
Hessisch Oldendorf, 
Germany 
Ammonium bicarbonate  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 





St. Louis, USA 
Ampicilin Sodium Salt  Sigma‐Aldrich 
St. Louis, USA 
Aqua‐PCI Roti® Aqua‐ 
Phenol/Chloroform/Isoam
yl alcohol 
Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
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BSA Albumin Fraktion V Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Calcium chloride  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Charcoal activated  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Chloramphenicol  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Chloroform Trichloromethane Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Complete Mini Protease 
Inhibitor Cocktail 
 Roche Mannheim, Germany 
DMSO Dimethyl sulfoxide Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
ECL Reagent ECL Prime Western 
Blotting 
Detection Reagent 
GE Healthcare Life Science 
Hyclone laboratories 
Logan, USA 
EDTA  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Ethanol Ethanol absolute Sigma‐Aldrich 
St. Louis, USA 
Ethylene Diamine Tetra‐Acetic 
Acid (EDTA) 
 Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Fetal Bovine Serum (FBS) FBS Superior Biochrom GmbH 
Berlin, Germany 
Ficoll LymphoprepTM AXIS-SHIELD  
Oslo, Norway 
GelRed nucleic acid stain GelRed™ Biotium 
Scarborough, Canada 
Gentamicin  Gibco™ life technologies 
Thermo Fisher 
Carlsbad, USA 
Glycerol  Carl Roth GmbH & Co. KG 




GlycoBlue GlycoBlue™ Invitrogen, Thermo Fisher 
Carlsbad, USA 
Isopropanol  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Kanamycin sulphate  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
LB Agar LB Agar (Lennox) Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
LB Broth LB Broth (Lennox) Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Lipofectamine 2000  Invitrogen, Thermo Fisher 
Carlsbad, USA 
Liquid Nitrogen  Linde 
Düsseldorf, Germany 
Loading Dye 6x Mass Ruler Thermo Fisher 
Waltham, USA 
Methanol  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
NormocinTM  Invivogen, San Diego, 
California, United States 
PBS (1x) Phosphate Buffered Saline 
(1x) 
Healthcare Life Science 
Logan, USA 
Pen/Strep Penicillin/Streptomycin Biochrom GmbH 
Berlin, Germany 
Powdered milk  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Sodium Acetate  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Sodium Dodecyl Sulfate 
Pellets 
SDS Pellets Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
T4 DNA Ligase Buffer  New England Biolabs 
Ipswich, USA 









 Carl Roth GmbH & Co. KG 
Karlsruhe, German 
TRIS hydrochloride  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Trizol TRIzol™ Reagent InvitrogenTM , Carlsbad, 
California, United States 
TWEEN 20  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Ultra-Pure water  Biochrom GmbH 
Berlin, Germany 
X-VIVOTM 15 Serum-free 
Hematopoietic Cell Medium 
 Lonza, Basel, Switzerland 
 
2.1.4 Stimulants and cytokines 
Table 2.1.4: List of stimulants and cytokines 
Name Compound Company 
c-di-GMP  Invivogen, 
San Diego, California, 
United States 
gDNA Genomic DNA  





IFNγ Interferon gamma Peprotech, 
Rocky Hill, United States 
Imiquimod (R837)  Invivogen, 
San Diego, California, 
United States 
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St. Louis, USA 
M-TriDAP  Invivogen, 
San Diego, California, 
United States 
Pam3CSK4  Invivogen, 
San Diego, California, 




St. Louis, USA 
Poly I:C Polyinosine- polycytidylic 
acid 
Invivogen, 
San Diego, California, 
United States 
Resiquimod (R848) Invivogen Invivogen, 




Table 2.1.5: List of kits 
Kits Name Company 
PCR purification Gene JET Thermo Fisher 
Gel Extraction Gene JET Thermo Fisher 
Genomic DNA Isolation Nucleospin Tissue Macherey- Nagel 
Plasmid Isolation Nucleospin Plasmid Macherey- Nagel 
RNA Isolation mirVanaTM miRNA isolation Ambion 
Poly A RNA isolation Dynabeads® mRNA DIRECT Ambion 








Table 2.1.6: List of antibodies 





Actin goat IgG     - Santa Cruz 
Biotechnology 
sc‐1616 Western Blot 
Actin  mouse IgG     - Santa Cruz 
Biotechnology 
sc-47778 Western Blot 
IgG rabbit IgG     - Cell signalling 7074 IP 
Flag mouse IgM2     - Sigma-Aldrich F1804 IP 
Tubulin mouse  
 
IgG2a     - Santa Cruz 
Biotechnology 
sc‐5286 Western Blot 
SND1 rabbit IgG     - Sigma-Aldrich HPA002632 Western Blot, 
IP 
SFPQ mouse IgG1     - Abcam ab11825 Western Blot, 
IP 




rabbit IgG     - Cell signalling 5483 Western Blot, 
IP 




rabbit IgG     - Abcam ab76493 Western Blot 
p-p65 rabbit IgG     - Abcam ab86299 Western Blot 
p65 mouse IgG1     - Santa Cruz 
Biotechnology 
sc-8008 Western Blot 
pERK1/2 rabbit IgG     - Abcam ab214362 Western Blot 
ERK1/2 mouse IgG2a     - Santa Cruz 
Biotechnology 
sc-514302 Western Blot 
OPTN-C1 mouse IgG1     - Santa Cruz 
Biotechnology 
sc-271549 Western Blot, 
IP 
OPTN-C2 mouse IgG2b     - Santa Cruz sc-166576 IP 




CD4 mouse IgG2b PE eBioscience 12-0048-41 FACS 
CD8 mouse IgG1 FITC eBioscience 11-0087-42 FACS 
CD11b mouse IgG1 PE eBioscience 12-0118-42 FACS 
CD11c mouse IgG1 APC eBioscience 17-0116-42 FACS 
CD14 mouse IgG1 FITC eBioscience 11-0149-42 FACS 
CD19 mouse IgG1 FITC eBioscience 11-0199-41 FACS 
CD33 mouse IgG2b APC Beckman 
Coulter 
6604121 FACS 
CD56 mouse IgG APC eBioscience 17-0567-41 FACS 
CD66b mouse IgM APC eBioscience 17-0666-42 FACS 
CD169 mouse IgG1 APC BioLegend 346008 FACS 
HLA-DR mouse IgG PE eBioscience 12-9952-42 FACS 
Anti-mouse goat IgG HRP Santa Cruz 
Biotechnology 
sc‐2005 Western Blot 
Anti-rabbit mouse IgG HRP Cell signalling 5127S Western Blot 
 
2.1.7 Primers 
Table 2.1.7: List of primers 
Gene List Name  Sequence Application 
hCXCL8 (IL-8) OBS‐0017 Fwd: ACTGAGAGTGATTGAGAGTGGAC qPCR 
OBS‐0018 Rev: AACCCTCTGCACCCAGTTTTC  qPCR 




SparQ MCS OBS-0659 Fwd: AGGAGGATTTGATATTCACCTG Sanger 
sequencing 
OBS-0660 Rev: ACCTTCTCTAGGCACCCG Sanger 
sequencing 
U6-pX458 OBS-0663 Fwd: ACTATCATATGCTTACCGTAAC Sanger 
sequencing 
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hNEAT1 OBS-0678 Fwd: ACTCTTCTTGTGAGCTCACTCC qPCR 
OBS-0679 Rev: ACAATACCGACTCCAACAGCC qPCR 
hU6 OBS-0712 Fwd: 
GCTTCGGCAGCACATATACTAAAAT 
qPCR 
OBS-0713 Rev: ATATGGAACGCTTCACGAATTTG qPCR 
hIL1β OBS-0720 Fwd: ATGGAGCAACAAGTGGTGTTCTC qPCR 
OBS-0721 Rev: TCAACACGCAGGACAGGTACAG qPCR 
hIFIT1 OBS-0729 Fwd: ATGCAGGAAGAACATGACAACC qPCR 
OBS-0730 Rev: TCTGGACACTCCATTCTATAGCG qPCR 
hMMP9 OBS-0735 Fwd: ACAAGCTCTTCGGCTTCTGC qPCR 
OBS-0736 Rev: TCGCTGGTACAGGTCGAGTAC qPCR 
hCD80 OBS-0768 Fwd: AACCGGACCATCTTTGATATCATC qPCR 
OBS-0769 Rev: TCGTATGTGCCCTCGTCAGA qPCR 
ENSG00000250
274 




hLINC00211 OBS-0808 Fwd: TGAGTGTACTGCCTGGACTCATC qPCR 
OBS-0809 Rev: TAAATGAAGCCTGCCACTTCAG qPCR 
ENSG00000248
323 
OBS-0811 Fwd: ACCCAGCTGGAACTCTTATGG qPCR 
OBS-0812 Rev: TTACCTGTAGCTCAGCATGTAGCC qPCR 
hMALAT1 OBS-0815 Fwd: 
AGGTGCTACACAGAAGTGGATTCAG 
qPCR 
OBS-0816 Rev: CTTCCCGTACTTCTGTCTTCCAGT qPCR 
pX458 
sequencing 
OBS-0842 Fwd: CTGGCCTTTTGCTCACATGT PCR-Sanger 
sequencing 
OBS-0843 Rev: GTCTGCAGAATTGGCGCAC PCR-Sanger 
sequencing 
hLUCAT1  OBS-0849 Fwd: ACCATGTGTCAAGCTCGGATTG qPCR 
OBS-0850 Rev: TTGTGGTCTCTGGTGCCAAG qPCR 
hRP11-
473M20.16 
OBS-0851 Fwd: AGCTCAGTCGGTAGAGCATG qPCR 
OBS-0852 Rev: TGCAAGGTATACGGAGTCACTTCC qPCR 
hMaIL1 OBS-0865 Fwd: AGCTCTGAGGAGTGAATCCAC qPCR 






hLINC00278 OBS-0873 Fwd: AGCCAGGAGTGAAGACGACAG qPCR 
OBS-0956 Rev: TAGGTTCTGTTGTGCTGTCAGAG qPCR 
hLINC00346 OBS-0875 Fwd: TCATGGAGTGAGTGCGGAAGAC qPCR 
OBS-0876 Rev: TGGATCTGATGACACTGCAGC qPCR 
hRP11-
316P17.2 F 
OBS-0887 Fwd: AAGATGACACAGCCTCTGCC qPCR 
OBS-0888 Rev: TGCAGGATCACTCATTGACGTG qPCR 
hRP11-
861A13.4 F 
OBS-0889 Fwd: ATTCTCCTGCCTCACAAGTGC qPCR 
OBS-0890 Rev: TCTGCTCTATGTCTGCACTGG qPCR 
ENSG00000261
222 
OBS-0899 Fwd: TAATAAGCAGCAATTGCAGTTCC qPCR 




OBS-0907 Fwd: AACACTGAGCAATCCTGACCTG qPCR 
OBS-0908 Rev: TATCGGTCCTCCACTCTTGTTC qPCR 
ENSG00000272
908 






OBS-0935 Fwd: AAGCTGTGGCTGTTGTCAGC qPCR 
OBS-0936 Rev: ACACTTGTCTCAGTAGGCCTGG qPCR 
ENSG00000256
039 
OBS-0937 Fwd: TGTCACCTGTGGACAACTTGC qPCR 
OBS-0938 Rev: TTATCTTGACCAGGTGCGAGAC qPCR 

































hAPOE  OBS-1994 Fwd: TTCCTGGCAGGATGCCAGGC qPCR 
OBS-1995 Rev: GGTCAGTTGTTCCTCCAGTTC qPCR 
hIGFBP2 OBS-2075 Fwd: TATGAAGGAGCTGGCCGTGTTC qPCR 
OBS-2076 Rev: ATGGTGGAGATCCGCTCCAGGA qPCR 
hS100A8 OBS-2077 Fwd: AGACTGTAGCAACTCTGGCAG qPCR 
OBS-2078 Rev: TCCAGCTCGGTCAACATGATG qPCR 
hKLF4  OBS-2177 Fwd: AGAGTTCCCATCTCAAGGCAC qPCR 
OBS-2178 Rev: TGCCTCTTCATGTGTAAGGCG qPCR 
hTREM2 OBS-2073 Fwd: TGCTCATCTTACTCTTTGTCAC qPCR 
OBS-2074 Rev: AGTGCTTCATGGAGTCATAGG qPCR 
hCHI3L1 F OBS-2179 Fwd: AGGGACCCTTGCCTACTATGA qPCR 
OBS-2180 Rev: TGGAAGTCATCCAGGTCCAGG qPCR 
hS100A9  OBS-2198 Fwd: ACCAATACTCTGTGAAGCTGG qPCR 
OBS-2199 Rev: TCCTCGAAGCTCAGCTGCTTG qPCR 
hIFNA8  OBS-2200 Fwd: ACTTGACCAGCAGCTGAATG qPCR 
OBS-2201 Rev: TCATGATTTCTGCTCTGACAACC qPCR 
hIFNA1   OBS-2202 Fwd: CAGGAGGACCTTGATGCTC qPCR 
OBS-2203 Rev: TCTGCTGGATCAGCTCATGG qPCR 
hIFNB1  OBS-2204 Fwd: AACATGACCAACAAGTGTCTCC qPCR 
OBS-2205 Rev: TGTCCTTGAGGCAGTATTCAAG qPCR 
hIFNL1  OBS-2206 Fwd; ACTTCCAAGCCCACCACAAC qPCR 
OBS-2207 Rev: ACAGGAGAGCTGCAACTCCAG qPCR 
hIFNA2  OBS-2259 Fwd: TGAAGGACAGACATGACTTTGG qPCR 
OBS-2260 Rev: AGATGAGTCCTTTGTGCTGAAG qPCR 
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hIFNA13  OBS-2261 Fwd: ATGAGCAGAATCTCTCCTTCCTC qPCR 
OBS-2262 Rev: TGAAGATCTGCTGGATCAGCTC qPCR 
hIFNA14 OBS-2263 Fwd: ATGAATGAGGACTCCATCCTG qPCR 
OBS-2264 Rev: ATCTCATGATTTCTGCTCTGAC qPCR 
hNRIR  OBS-2323 Fwd: ACCTTGATCTTGGACTTCCTAG qPCR 
OBS-2324 Rev: ACTGGATGAGACAGAATGCTG qPCR 
hIL10 OBS-0126 Fwd: GACTTTAAGGGTTACCTGGGTTG qPCR 
OBS-0127 Rev: TCACATGCGCCTTGATGTCTG qPCR 
IL23A OBS-1580 Fwd: CTCTGCTCCCTGATAGCCCT qPCR 
OBS-1581 Rev: GGGACTGAGGCTTGGAATCT qPCR 
hIFNL1  OBS-2206 Fwd; ACTTCCAAGCCCACCACAAC qPCR 
OBS-2207 Rev: ACAGGAGAGCTGCAACTCCAG qPCR 
hCD70 OBS-2208 Fwd: TAGCTGAGCTGCAGCTGAATC qPCR 
OBS-2209 Rev: CCTGGATGTGTACCATGTAGA qPCR 
hPU.1 OBS-2399 Fwd: AGAGCCATAGCGACCATTACTG qPCR 
OBS-2400 Rev: ATCTGCTCCAGCTCCATGTG qPCR 
 
2.1.8 siRNAs 
Table 2.1.8: List of siRNAs 
Name Sequence Company 
Silencer™ Select 
Negative Control No. 1 
siRNA 
 Thermo Fisher 
MaIL1-1 UCUUUGAACUGUAUUGUGGAU 
(guide)                            
CCACAAUACAGUUCAAAGAGA 
(passenger) 
Thermo Fisher (custom 
designed)  
MaIL1-2 AAAUACAUGGCUUUCAUGCUA 
(guide)                       
GCAUGAAAGCCAUGUAUUUAA 
(passenger) 
Thermo Fisher (custom 
designed) 




(guide)                    
CACAUAAUAGAAAUGUAAAAG 
(passenger) 




Table 2.1.9: List of Plasmids 
Name  Company 









2.1.10 Buffers and Solutions 
Table 2.1.10: List of prepared buffers and solutions 
Name Composition  
ELISA coating buffer 7.13 g Natriumhydrogencarbonat 
1.59 g Natriumcarbonat 
ad 1 L H2O 
to pH 9.5 with 10 N NaOH 
ELISA dilution buffer 10% v/v FCS 
in 1x PBS 
ELISA wash buffer 0.05% v/v Tween 
in 1x PBS 
FACS blocking buffer 10% v/v FCS 
0.5% v/v Tween 
in PBS 
FACS Fixation buffer 4% v/v PFA 




FACS Permeabilisation buffer  
FACS Wash Buffer 0.5% v/v FCS 
in PBS 
Laemmli Buffer 13.15 % v/v Stacking Buffer 
21.05 % v/v 10 % SDS 
10.5 % v/v Glycerol 
5.75 % v/v 1 % Bromophenol Blue 
LB Agar 3.5 % w/v LB Agar 
in H2O 
LB Medium 2 % w/v LB Broth 
in H2O. 
MACS Buffer 0.5% v/v FCS 
0.2 mM EDTA 
in PBS 
RIPA Buffer 10 mM Tris, pH 7.5 
150 mM NaCl 
1% v/v NP‐40 
1% v/v Desoxycholat 
1 mM EDTA 
TAE buffer (50X) 242 g Tris‐Base 
57.1 ml Ethanoic acid 
100 ml EDTA (0.5 M) 
ad 1 L in H2O 
TBS buffer (10x) 10 mM Tris 
0.9% (w/v) 
90 g NaCl 
ad 1 L H2O 
to pH 7.4 with 37% (v/v) HCl 
TBST‐T 100 ml 10X TBS buffer 
0.1% (v/v) Tween‐20 
ad 1 L in H2O 
Western Blot Blocking Solution 10% (w/v) milk 
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5% (w/v) BSA 
in 1X TBS‐T 
Western Blot Resolving Gel 10 % 4.94 ml ddH2O 
7.56 ml Tris‐HCl pH 8.8 
6.68 ml Acrylamide/Bisacrylamide 
500 μl 10% (v/v) Glycerol 
200 μl 10% (w/v) SDS 
100 μl 10% (w/v) APS 
20 μl TEMED 
Western Blot Running Buffer for SDS‐
PAGE (10X 
250 mM Tris 
1.92 M Glycin 
in H2O 
Western Blot Running Buffer for SDS‐
PAGE (1X) 
100 ml Western Blot Running Buffer for 
SDS‐PAGE 
0.1% SDS 
ad 1 L H2O 
Western Blot Stacking Gel 5 % 5.68 ml ddH2O 
2.5 ml Tris‐HCl pH 6,8 
1.66 ml Acrylamid/Bisacrylamid 
100 μl 10% (w/v) SDS 
50 μl 10% (w/v) APS 
10 μl TEMED 
Western Blot Wet Blot Buffer (10X) pH 8.3 250 mM Tris 
1.92 M Glycin 
ad 1 L H2O 
to pH 7.4 with 37% (v/v) HCl 
Western Blot Wet blot running buffer (1X) 200 ml 10X Wet‐Blot Puffer 
20% (v/v) Methanol 
0.1% (w/v) SDS 
ad 2 L H2O 
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2.1.11 Software  
Table 2.1.11: List of software 
Software Version 
Adobe Photoshop CS 5.1 
Agilent 2100 Expert Software B.02.08.SI648 (SR1) 
Clone manager 9 
SnapGene 5.0.6 
FlowJo v. 7.6.5 2.0 
GraphPad Prism 6 
Microsoft Office 2010  
ViiA7 RUO 1.2 
Windows 7 Professional 
 
2.1.12 Websites 
Table 2.12: List of websites. 
Homepage Link 
Ensembl http://www.ensembl.org/index.htmL  
NCBI https://www.ncbi.nlm.nih.gov/  
Reverse complement https://www.bioinformatics.org/sms/rev_comp.html  
Tm Calculator- Thermo 





Biorender  www.biorender.com 
CPC calculator (http://cpc2.cbi.pku.edu.cn/) 
gRNA design tool (http://crispr.mit.edu/) 
siRNA design tool (http://design.RNAi.jp/) 
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2.2 Methods  
2.2.1 Cell culture 
2.2.1.1 Isolation of primary human monocytes 
Monocytes were isolated from buffy coats provided by donors in the Centre for Transfusion 
Medicine and Haemotherapy in Giessen, Germany. All donors consent to use their blood 
samples for scientific purposes. The buffy coats were diluted 1:1 with PBS and 20 ml were 
carefully transferred into a 50 ml falcon tubes containing 10 ml of Ficoll (Figure 2.2.1). The 
tubes were centrifuged for 30 min at 800 x g with the breaks off. The centrifugation resulted in 
a distinct leukocyte layer. Leukocytes were transferred in a new tube containing PBS and 
centrifuged at 250 x g for 10 min.  
 
Figure 2.2.1: Schematic representation of monocyte isolation by MACS protocol. After 
centrifugation, four distinct layers were visible in the tube (top to the bottom): the plasma layer, 
the layer containing lymphocytes, monocytes and platelets, the Ficoll layer and at the bottom 
the layer of erythrocytes and granulocytes. The layer containing lymphocytes, monocytes and 
platelets was then transferred to a new tube and labelled magnetically with anti-CD14 beads. 
After the labelling, the cells were passed through a column that was placed in a magnet and the 
unlabelled cells were eluted in the flow-through. At the final step, the column was removed 
from the magnet and the labelled cells were eluted.  
The PBS was removed and the pellet was again resuspended in PBS. The washing step was 
repeated until the supernatant was clear. For the isolation of monocytes, a magnetic-activated 
cell sorting (MACS) protocol was used (Miltenyi Biotec #130-050-201). In the final washing 
step the cells were counted and resuspended in an appropriate amount of MACS buffer (400 μl 
for 2*108 cells). Anti-CD14 beads were added accordingly (100 μl for 2*108 cells) and the 
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mixture was incubated for 20 min at 4°C. Labelled cells were magnetically separated in a 
MACS LS column. The column was washed 3 times with 3 ml of MACS buffer. The cells were 
eluted with 5 ml MACS buffer and the number of monocytes was measured. The purity of the 
population was verified by Flow cytometry, using an anti-CD14 antibody.   
2.2.1.2 Macrophage differentiation and culture 
Monocytes isolated as described above were cultured in x-VIVO-15 medium (Lonza) 
containing 5% fetal calf serum (FCS), 25 μg/ml Gentamicin and 15 ng/ml or 100 ng/ml GM-
CSF (Preprotech, #300-03) and cultured for 8 or 6 days, respectively, at 37°C and 5% CO2. 
When cultured for 8 days, on day 5 the cells were supplemented again with 15 ng/ml GM-CSF.  
After 6 or 8 days the morphology of the cells was macroscopically checked. After 
differentiation, the cells were used for further experiments.  
2.2.1.3 Dendritic cell differentiation and culture 
Monocytes isolated as described above were cultured in x-VIVO-15 medium (Lonza) 
containing 5% fetal calf serum (FCS, Biochrom), 25 μg/ml Gentamicin and 15ng/ml or 50 
ng/ml GM-CSF and 20 ng/ml IL-4 (Preprotech, #200-04) and cultured for 6 days at 37°C and 
5% CO2. After 6 days the morphology of the cells was macroscopically checked. 
2.2.1.4 Isolation of other immune cell populations 
For isolation of other immune cell populations MACS was employed again (Miltenyi Biotec). 
The different immune cells were incubated with different beads. For isolation of NK Cells and 
B-cells anti-CD56 (#130-050-401) and anti-CD19 beads (#130-050-301) were used 
respectively. For the T cell populations two rounds of selection were performed. First, the cells 
were incubated with either anti-CD4 (#130-045-101) or anti-CD8 beads (#130-045-201) and 
secondly the CD4+ and CD8+ populations were incubated with anti-CD45RO (#130-046-001) 
to distinguish between the memory and the naive T-cells. The granulocytes were isolated from 
whole blood sample (no Ficoll separation) with anti-CD66 Beads (#130-111-552). 
2.2.1.5 Liver and Brain RNA 
For liver reference tissue collection, cirrhosis was an exclusion criterion. Non-diseased tissue 
from tumour resections was processed. All patients had provided oral and written informed 
consent and the local ethics committee approved the study (Marburg FB20 Ethikkomission Az.: 
Studie 14/17). Professor Dr. Pagenstecher provided the brain RNA samples.  
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2.2.1.6 THP1 and U937 cell culture and differentiation 
THP‐1 cells are immortalized isolates of a one year old infant male with leukemia and used as 
a model for human monocytes (Tsuchiya, al., 1980) and U937 cells have been isolated from the 
histiocytic lymphoma of a 37-year-old male patient (Sundström et al., 1976) for the same 
purpose. The cell lines were purchased from the American Type Culture Collection (ATCC). 
The human monocytic suspension cell lines were cultured in RPMI medium (Thermo Fisher), 
supplemented with 10% (v/v) FCS in T75 tissue culture flasks at 37°C and 5% CO2 at a density 
of 2.5 *105 cells/mL. Cells were splitted regularly to maintain the appropriate density. To obtain 
adherent macrophage‐like cells, THP‐1 and U937 monocytes were stimulated with 20 nM 
Phorbol‐12‐myristate‐13‐acetate (PMA) for 24 h. The morphology of the cells was 
microscopically checked before use for further experiments.  
2.2.1.7 HEK‐293T cell culture 
Human embryonic kidney cells 293T (HEK‐293T) display an adherent epithelial morphology. 
The cell line was cultured in RPMI, supplemented with 10% (v/v) FCS in T75 tissue culture 
flasks at 37°C and 5% CO2 and splitted regularly to maintain 70 ‐ 90% confluency. For splitting, 
the supernatant of the adherent cells was discarded and the cells were detached from the flask by adding 
5 ml of new medium directly on top of the cells and vigorousl pipetting. The HEK‐293T cells were 
used for the Lentiviral production. 
2.2.2 Transcriptome Analysis 
2.2.2.1 RNA extraction by TRIZOL® 
For RNA expression analysis, either by quantitative real time PCR (qRT-PCR) or by RNA 
sequencing, RNA isolation was performed. The supernatant of the cells was removed and 500 
μl of TRIZOL® reagent were added. After 5 min incubation, the lysed cells were transferred to 
a 1.5 ml Eppendorf tube and 200 μl of chloroform was added, followed by vigorous mixing. 
The mixture was centrifuged at 13000 rpm for 15 min at 4°C to separate into the aqueous and 
the organic layer. The aqueous phase, containing the RNA, was transferred into a new tube. 
RNA precipitation was achieved by the addition of 250 µl isopropanol to the aqueous phase. 
Additionally, 1 µl of GlycoBlue™ was added to conjugate and visualize precipitated RNA. The 
precipitation of the RNA was performed at -20oC either for 1 hour or overnight. Afterwards, 
the samples were centrifuged at 13000 rpm for 15 min at 4°C and the supernatant was removed. 
The RNA pellet was washed with 400 µl of 75% ethanol. After the ethanol was removed the 
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pellets were air-dried. To resuspend the pellet 43.5 μl of H2O were added and the sample was 
incubated at 65oC for 5 min while shaking. The samples were either frozen or directly DNAseI 
digested.  
2.2.2.2 RNA extraction by mirVanaTM miRNA kit   
To obtain high quality and purity of RNA for RNA sequencing, mirVANATM miRNA kit was 
used. The supernatant of the cells was removed and the cells were washed with 1 ml of PBS 
and lysed with 600 μl of Lysis/Binding Buffer. After vortexing vigorously, 60 μl of miRNA 
Homogenate Additive was added and the samples were incubated for 10 min on ice. Next 600 
μl of Acid-Phenol:Chloroform was added and the samples were vortexed and centrifuged at 
10000 x g for 5 min. The aqueous phase was then transferred to a new tube and filled with 700 
μl of 100% ethanol. Up to 700 μl was placed into a Filter Cartridge, followed by centrifugation 
for 30 sec at 10000 x g. The flow-through was discarded and the step was repeated until all the 
cell lysate mixture was passed through the column. To wash the column, 700 μl of miRNA 
Wash Solution 1 was applied and centrifuged for 30 sec at 10000 x g. This was followed by a 
second washing step with 500 μl of Wash Solution 2/3 for 30 sec at 10000 x g (2 times). After 
the flow-through was discarded, the column was centrifuged once more at 1000 x g for 1 min.  
Finally, the Filter Cartridge was transferred into a new collection tube and 100 μl of H2O (pre-
warmed at 95oC) were added. The samples were centrifuged and the eluted RNA was either 
stored at -20oC or used for DNaseI Digestion.  
2.2.2.3 DNaseI Digestion 
To remove the DNA from the RNA samples, DNaseI digestion was performed. The reagents 
and the amounts of the reaction are indicated in the table below (Table 2.2.1). 
Table 2.2.1: DNase 1 mixture 
Component  Volume (μl) 
RNA 43.5  
RNAse Inhibitor (Promega #N2511) 0.5 
DNAseI Buffer 10x 5 
DNAseI (Ambion #AM2222) 1 
 
The mixture was incubated at 37oC for 30 min followed by incubation at 75oC for 5 min, to 
inactivate the DNase. After the inactivation 50 μl of ultra-pure water and 100 μl of PCI were 
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added on the top of the samples and mixed vigorously. The mixture was centrifuged at 13000 
rpm for 15 min at 4oC. The upper layer was transferred into a new tube and 300 μl of a mixture 
of 30:1 ethanol / sodium acetate (EtOH/NaAcetate) was added for RNA precipitation. 
Additionally, 1 µl of GlycoBlue™ was added to conjugate and visualize precipitated RNA. The 
next steps are the same as the last steps of RNA extraction by TRIZOL® (see section 2.2.2.1). 
2.2.2.4 RNA quantification and quality check 
The concentration of RNA was determined using a Nanodrop 2000 Spectrophotometer (Thermo 
Fisher Scientific). For samples that were send for sequencing RNA integrity was verified on a 
Bioanalyzer 2100 (Agilent) according to the manufacturer´s protocol. The ratio of intact 18s 
and 28s rRNA was used to calculate the RNA integrity number (RIN). The ratio should be 2:1, 
deviations from that indicate RNA degradation. A RIN of 10 reflects perfect RNA quality, while 
a RIN of 5 means partial degradation. Based on this guideline, samples with RINs > 8 were 
considered to have good-enough RNA quality for sequencing. 
2.2.2.5 cDNA synthesis 
Total RNA was transcribed into cDNA via the High Capacity reverse transcription kit (Thermo 
Fisher). Depending on the RNA amount, 200 – 2,000 ng RNA were used for the transcription.  
Table 2.2.2: Mixture for cDNA synthesis  
Component Volume (μl) 
10X RT buffer 2 
10X Random Primers 2 
100 mM dNTPs 0.8 
50 U/µl Multiscribe Reverse Transcriptase 1 
RNA (250 – 2000 ng) x 
Ultrapure H2O Up to 20 
 
The cDNA reaction was performed according to the following program (Table 2.2.3) 
Table 2.2.3: Thermocycler program 
Cycle step Temperature (oC) Time (min) 
Annealing  25 10 
Elongation  37 120 
Deactivation 85 5 
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Hold 8  
 
The cDNA was then diluted to a final concentration of 5 ng/µl and used for qRT-PCR. 
2.2.2.6 Quantitative Real Time PCR (qRT-PCR) 
For analysing the relative expression of different RNAs qRT-PCR with SYBR Green detection 
reagent was used. The following (Table 2.2.4) shows the reaction mixture. 
Table 2.2.4: QRT-PCR mixture  
Component Volume (μl) 
2X PowerUp™ SYBR™ Green Master 
mix 
10 
10 µM forward primer 0.4 




The reaction mix was pipetted into 96-wells and the plates were run on a ViiA7 Real‐Time PCR 
System. The program is described on the following table (Table 2.2.5). 
 
Table 2.2.5: QRT-PCR program 
 Cycle step Temperature  
(oC) 
Time (sec) 
 denaturation 95 20 
       40 cycles denaturation 95 15 
primer binding/elongation 60 20 
 end of the cycles 60 60 
 melting curve 60-95 0.05 °C/s gradually 
  95 15 
 
In case of low abundant transcripts or low amount of RNA one-step qRT-PCR was used. In this 
case the reaction was performed directly after RNA isolation. The kit that was used in this case 
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was the Power SYBR® Green RNA-to-CT™ 1-Step Kit from Thermo Fisher. The reaction 
mixture is as described in the following table (Table 2.2.6). 
Table 2.2.6: Power SYBR® Green RNA-to-CT™ 1-Step mixture 
Component Volume (μl) 
2X SYBR® Green Master Mix 10 
10 µM forward primer 0.2 
10 µM reverse primer 0.2 
Reverse transcriptase  0.16 
RNA variable 
H20 20 µl final volume 
 
The reaction was performed in 96-wells and the plates were run on a ViiA7 Real‐Time PCR 
System. The program is described on the following table (Table 2.2.7). 
Table 2.2.7: Power SYBR® Green RNA-to-CT™ 1-Step cycler program 
 Cycle step Temperature (oC) Time  
 reverse transcription 48 30 min 
 denaturation 95 10 min 
       40 cycles denaturation 95 15 sec 
primer binding/elongation 60 1 min 
 melting curve 95 15 sec 
  60 1 min 
  95 15 sec 
 
2.2.3 Subcellular fractionation 
To investigate the cellular localisation of different lncRNAs subcellular fractionation was 
performed. In this protocol the cells were separated into nucleus and the cytosol fractions. For 
this purpose, 4*106 cells were spinned down at 250 x g and washed two times with PBS. 
Afterwards, the cells were resuspended in 200 μl of lysis buffer (see table 2.2.8) and incubated 
on ice for 5 min, while gently pipetting up and down. 
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Table 2.2.8 Lysis Buffer 
Name Concentration Company Ordering number 
Tris-HCl pH 8 10 mM Life 
Technologies 
1567-027 
NaCl 140 mM Carl Roth GmbH 
& Co 
9265.1 






2 mM Sigma-Aldrich R3380 
IGEPAL® 0.5% Sigma-Aldrich I8896 
 
From the lysate 30 μl were kept aside and 500 μl of Trizol® were added on the top for total 
RNA isolation. The rest of the lysate was centrifuged at 1000 x g for 3 min at 4 oC to pellet the 
nuclei and the supernatant was the cytosol. To succeed a pure cytosolic fraction the supernatant 
was centrifuged again at 13.000 rpm for 10 min at 4 oC and transferred into a new tube. 
Subsequently, 500 μl of Trizol® were added on top. To obtain pure nuclear RNA, the nuclear 
pellets underwent three additional washes with 160 μl of lysis buffer. Finally, the purified nuclei 
were resuspended in 100 μl of lysis buffer and 500 μl of Trizol® were added on top. The 
procedure was completed by RNA isolation and DNAseI digestion. For determining the 
subcellular localization of specific RNAs, qPCR was performed. The quantification was done 
by comparing the C(t) values of the respective RNA in the cytosol and in the nucleus. For 
validation of the method, RNAs with a known localisation pattern were used.  
2.2.4 Rapid Amplification of cDNA Ends (RACE) 
To identify the exact cDNA sequence of the novel lncRNAs (MaIL1, LINC00211) Rapid 
Amplification of cDNA Ends (RACE) was employed, using the SMARTer® RACE 5’/3’kit 
(Clontech) protocol. First, high quality RNA was extracted and then 5’-RACE-Ready cDNA 
and 3’-RACE-Ready cDNA were prepared (Table 2.2.9). 
 
 




Table 2.2.9: RACE cDNA mixtures 
Reagent  Volume-5’-RACE-cDNA Volume-3’-RACE-cDNA 
RNA 7.5 μl 7.5 μl 
5’-CDS-Primer A/3’-CDS-
Primer A 
1 μl 1 μl 
H2O 2.5 μl 3.5 μl 
 
The mixtures were then incubated at 72oC for 3 min and then at 42oC 2 min. After spinning 
down, for the 5’-RACE cDNA synthesis reaction 1 μl of the SMARTer II A Oligonucleotide 
was added. In the next step another mixture was prepared and added to the two cDNA libraries 
(Table 2.2.10). 
Table 2.2.10: Reverse transcriptase mixture 
Reagent  Volume (μl)  
5X First-Strand Buffer 4  
Pre-mix DTT (100 mM) 0.5 
dNTPs (20 mM) 1 





The mixtures were first incubated at 42oC for 90 min, and then at 72oC for 10 min. The cDNA 
reactions were diluted with Tris-EDTA Buffer depending on the RNA concentration. After the 
cDNA library was prepared, a PCR was performed. For this purpose, a master mix was prepared 
according to Table 2.2.11 
Table 2.2.11: Mastermix of PCR 
Reagent Volume (μl) 
dd H2O 34.5 
10X Advantage 2 PCR Buffer 5 
dNTPs (10mM) 1 
50X Advantage 2 Polymerase Mix 1 
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The mixture was then added to the PCR reaction, which is described on Table 2.2.12 and then 
run in a thermocycler (Table 2.2.13) 
 
 
Table 2.2.12: PCR reaction 
Component Volume-5’or 3’- 





5’ or 3’- RACE 
cDNA 
2.5  2.5  2.5  
10X UPM 5  5  - 
5’or 3’ GSP (10 μl) 1  - 1  
H2O - 1  5  
Master mix Table 
2.2.11 
41.5  41.5  41.5  
 
Table 2.2.13: PCR program 
Cycles Temperature (oC) Time  
     5 cycles       
  
94 30 sec 
72 3 min 
     5 cycles 94 30 sec 
70 30 sec 
72 3 min 
    25 cycles 94 30 sec 
68 30 sec 
72 3 min 
 
After the PCRs were finished, the samples were run on 1% agarose gels. The DNA bands were 
then excised and purified using the Gene JET gel extraction kit (Thermo Fisher) according to 
the manufacturer’s protocol. When the concentration was appropriate, the PCR fragments were 
cloned into a TOPO vector (Strataclone UA PCR cloning kit, Agilent) and send for Sanger 
Sequencing (Mycrosynth Seqlab). Below the full-length sequences, as inferred by RACE PCR, 
of LINC00211 and MaIL1 are shown. 
 
 
Materials and Methods 
81 
 

























































2.2.5 PCR amplification of the full length MaIL1 
To amplify the MaIL1 transcript, poly A RNA was used. For this purpose, 74 μg (in 100 μl of 
H2O) of total RNA isolated from macrophages pre-treated with LPS (100 ng/ml) and IFNγ 
(100ng/ml) were used. The RNA was heated at 65oC for 2 min to disrupt secondary strictures. 
In the meantime, 200 μl of Dynabeads® were prepared. The beads were washed with 100 μl of 
Binding buffer and then diluted in another 100 μl of binding buffer. The RNA was mixed with 
the Dynabeads® and incubated for 5 min at room temperature. The beads were placed in a 
magnet and washed with 200 μl of Washing buffer B. The elution of the poly A RNA was 
performed with 10 μl of 10 mM Tris-HCl pH 7.5 at 80oC for 2 min. The poly A RNA was then 
reverse transcribed to cDNA (Table 2.2.14). 
Table 2.2.14: Reverse transcription mixture 
Name Amount (μl) concentration Temperature- Time 
H2O 11   
65oC for 5 min PolyA RNA 1  
dNTPs 1 10 mM 
Oligo dT 1  
SSIV  buffer 5x 4   
55oC for 10 min 
80oC for 10 min 
DTT 1 100 nM 





Table 2.2.15: PCR mixture for full-length MaIL1 amplification 
Component  Amount (μl) 
5x HF buffer 10 
Phusion Polymerase 0.5 
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Forward primer (OBS-1191) 0.5 
Reverse primer (OBS-1182) 0.5 
dNTPs 10mM 1 
DMSO 1 
cDNA 2 
H2O Up to 50 
  
After the cDNA was transcribed, a PCR was performed with primers that bind to the two ends 
of MaIL1. The PCR mixture and the conditions are described in table 2.2.15 and 2.2.16, 
respectively. 
Table 2.2.16: PCR program for full-length MaIL1 amplification 
 Cycle step Temperature (oC) Time  
 denaturation 95 3 min 
       30 cycles denaturation 95 30 sec 
annealing 54 30 sec 
extension 72 1.5 min 
 final extension 72 3 min 
 
2.2.6 Lentiviral Transduction 
2.2.6.1 Lentiviral production- small scale 
To transduce cells lines in order to overexpress a specific gene (LINC00211 and MaIL1) 
lentiviral particles were produced in a small scale. For this purpose, HEK-293T cells were 
cultured as described in section 2.2.1.3. One day prior to transfection, the cells were counted 
and 5*105 cells/well were plated in a 6 well plate. The next day the confluency of the cells was 
checked under microscope. If the cell confluency was between 70-85% then the cells were used 
for transfection. The amount of the plasmids used is described in the table below (Table 2.2.17). 
Table 2.2.17: Lentiviral production plasmids for small scale protocol 
Plasmid Amount (μg) 
pCMV-VSVG 1.5 
Pspax2 3 
SparQ with gene of interest 5 




For the transfection, 7 μl of Lipofectamine 2000 were added into 100 μl of OPTIMEM medium 
and the plasmids were added into another tube with 100 μl of OPTIMEM. The two tubes were 
mixed and incubated for 15 min at room temperature and then added drop-wise on top of the 
cells. On the next day, if the transfection was successful the cells were expressing the Green 
Fluorescence Protein (GFP). The supernatant of the cells was then removed and filtered through 
a 0.45 μM filter and placed on top of 2,5*105 THP-1 cells. The HEK-293T cells were 
supplemented with 2 ml of fresh medium. The THP-1 cells were then centrifuged for 10 min 
and plated into a 6-well plate. The next day the cells were checked under the microscope. The 
presence of GFP positive cell was an indicator of a successful transduction. If there were no or 
few GFP positive cells then the procedure was repeated with the 48 hours virus. Depending on 
the plasmid (or the cell line) the cells started to expres GFP at different time-points or different 
levels. The GFP positive cells were then sorted by fluorescent activated cell sorting (FACS). 
2.2.6.2 Lentiviral production- large scale 
For primary cells or cell lines that are difficult to transduce, large-scale lentiviral production 
was performed. For this purpose, 107 cells were plated into a T175 flask and the confluency 
was checked the next day. If the cell confluency was between 70-85% then the cells were used 
for transfection. For the transfection, 50 μl of Lipofectamine 2000 were added into 450 μl of 
OPTIMEM media and the plasmids were added into a separate tube with another 450 μl of 
OPTIMEM (Table 2.2.18). 
Table 2.2.18: Lentiviral production plasmids for large scale protocol 
Plasmid Amount (μg) 
pCMV-VSVG 7 
psPAX2 20 
SparQ with gene of interest 15 
 
The content of the two tubes was mixed together and incubated for 15 min at room temperature 
and then added on top of the cells, drop-wise. On the next day, if the transfection was successful 
the cells were expressing GFP. The supernatant of the cells was then removed and filtered 
through a 0.45 μM filter and placed into tubes for ultracentrifugation. The supernatants were 
centrifuged either for 3 hours or for overnight at 25000 rpm at 4oC. The pellet was then 
resuspended in 200 μl of PBS and the viral particles were then flash frozen and stored at -80oC. 
Materials and Methods 
85 
 
This was repeated also at 48 and 72 hours post transfection. For primary human macrophages, 
on day 4 of differentiation, the medium was removed and 100 μl of the viral particles were 
added on the top. The cells were then centrifuged at 2200 rpm for 10 min. After 10 min 2 ml of 
medium (for a 6 well plated) were added on top of the cells. Normally, after few hours the cells 
were expressing GFP. On Day 6, the GFP positive cells were FACS sorted. For transduction of 
cell lines, the same protocol was used.  
2.2.7 Genome editing by CRISPR/Cas9 
In order to create lncRNA knock out THP1 cell lines, the CRISPR/Cas9 genome editing method 
was used (Ran et al., 2013). The method adapted to specifically target lncRNAs, because a point 
mutation may not alter the expression or the function of lncRNAs.  To knock out lncRNA genes, 
the PX458 vector (Addgene) was modified in order to express two guide RNAs (gRNAs) 
targeting two distinct positions in proximity to the lncRNA promoter (Figure 2.2.3) (Janga et 
al., 2018). This way a fragment around the transcriptional start site was removed from the 
genomic sequence.  
 
 
Figure 2.2.2: CRISPR/Cas9 strategy to target lncRNA genes. A. Simplified scheme of the 
modified plasmid used for the knock out strategy (Janga et al., 2018). The two gRNAs were 
transcribed from independent U6 promoters. B. Schematic representation of the dual gRNA 
mode of action. The two gRNAs were targeting two distinct regions on the genomic sequence 
of the lncRNA locus. The Cas9 enzyme was thereby able to cut our the desired sequence around 
the transcriptional start site. DNA ends are joined again by non-homologous end joining 
(NHEJ) repair (modified from: https://www.manlitphil.ac.uk/events/molecular-surgery-crispr-
cas9 ).  
Sequence blocks containing the guide RNA pairs separated by a U6 promoter were ordered 
from IDT, with Bbs1 digestion sites at the two ends. For both the LINC00211 and the MaIL1 
locus, two independent guide RNA pairs were designed, to rule out off-target effects.  The 
gRNA pairs are listed below.  
Materials and Methods 
86 
 
Guide RNAs for LINC00211: 
1st pair: CTCTGGACTCATGAGAACGC 
             TTACATGAATAGACAGCTAG            
2nd pair: ACACGGTTCACTCAATGAGT 
              GAGAGTTATAACATAATGGT 
Sequence of the dual gRNA cloning casette (yellow sequence) with the U6 promoter and the 










Guide RNAs for MaIL1: 
1st pair: TTCTTGTGTAACTTACGACA 
              GTGCAGTGGCCAATCATTAG        
2nd pair: ATGAAACAACAAGAGTCATT 









The guide RNA casette was first cloned into a TOPO vector (Strataclone UA PCR cloning kit, 
Agilent), according to the manufacturer’s instructions, and then amplified. The TOPO and the 
pX458 vector were then digested with Bsb1 (Thermo Fisher #ER1011) restriction enzyme 
(Table 2.2.19). 
Table 2.2.19: Restriction digestion reaction  
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Compound   Amount 
pX458 vector  5 μg 
Insert (TOPO vector) 5 μg 
10x FD Buffer (NEB) 3 μl 
Bbs1 1 μl 
H2O Up to 30 μl 
 
The reactions were then incubated for 2 hours or overnight at 37oC.  After the digestion, the 
reactions were run on a 1% agarose gel and bands were purified, by gel extraction. The 
appropriate amounts of the insert (500 ng) and pX458 vector (25 ng) were then ligated (Table 
2.2.20)  
Table 2.2.20: Ligation reaction 
Compound   Amount 
PX458 25 ng 
Insert  500 ng 
10x T4 Ligase Buffer 2 μl 
T4 Ligase 1 μl 
H2O Up to 20 μl 
 
The mixture was incubated for 10 min at room temperature and then transformed into competent 
E. coli bacteria (custom-made). For the transformation, 5 μl of the ligation mixture and 50 μl 
of the competent cells were mixed and incubated on ice for 30 min. Afterwards the cells were 
heat-shocked at 42oC for 45 sec, followed by addition of 100 of LB medium and incubation for 
30 min at 37oC. The mixture was plated on Agar plates with ampicillin and incubated overnight 
at 37oC. After the bacteria were amplified, the plasmids were isolated using the Macherey-
Nagel plasmid isolation kit according to manufacturer’s protocol. The successful insertion was 
tested by Sanger sequencing. Transfection of the plasmid was performed by Lipofectamine 
3000 (2 μl for 5*105 cells and 4 μl for 106 cells), with 15 μl of P3000 Reagent in Opti-MEM 
(100 μl for 5*105 cells and 200 μl for 106 cells) and 5 μg of pX458 plasmid. After incubation 
for 15 min at room temperature, the mixture was placed on the cells, which were subsequently 
centrifuged for 2 h at 37°C at 500 g to achieve maximal transfection efficiency. The next day 
the GFP positive cells were single cell sorted, by FACS (Aria III, BD), into a 96 well plate 
containing RPMI with 10% FCS, 1% pen strep and 1:500 Normocin. The single cells were then 
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grown and cell clones were tested for successful knock out by both genomic PCR and qRT-
PCR. (Table 2.2.21 and Table 2.2.22).  Genomic DNA isolation was performed according to 
the manufacturer’s instructions (Nucleospin Tissue kit, Macherey-Nagel). 
 
Table 2.2.21: Genomic PCR reaction 
Component  Amount (μl) 
10x Taq buffer 5 
Taq polymerase 0.5 
Forward primer  1 
Reverse primer 1 
dNTPs 10 mM 0.2 
DNA template 50-100 ng 
H2O Up to 50 
 
Table 2.2.22: Genomic PCR conditions 
 Cycle step Temperature (oC) Time  
 denaturation 95 3 sec 
       30 cycles denaturation 95 30 sec 
annealing 65 30 sec 
extension 68 1 min 
 final extension 68 5 min 
 
For knock down of PU.1, the dCas9-KRAB repressor system (Gilbert et al., 2013) was 
employed. The cloning of the gRNAs was performed by digesting pLV hU6-sgRNA hUbC-
dCas9-KRAB-T2a-GFP vector with BsmBI (Thermo Fisher #ER0451). Insert strands 
containing cloning overhangs were melted together and ligated as described above. Upon 
lentiviral production, cells were transduced dCas9-KRAB vectors. After the successful 
transduction, the GFP+ cells were sorted and successful knockdown was verified by qRT-PCR.  
The gRNA oligo strands used for PU.1 knock down are listed below.  
PU.1_fw_guide_1: CACCGTACAGGCGTGCAAAATGGAA 
PU.1_rv_guide_1: AAACTTCCATTTTGCACGCCTGTAC 
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2.2.8 RNA antisense purification coupled with mass spectrometry    
(RAP-MS) 
2.2.8.1 Cell preparation  
For identification of MaIL1 protein binding partners an adjusted protocol from McHugh et al. 
was used (McHugh et. al., 2015) (Figure 2.2.2). Primary human macrophages were cultured as 
described before in 15 cm tissue culture plates (2*108 cells per experiment). On day 8 of 
differentiation cells were treated with LPS for 8 h and then the medium was removed and 10 
ml of PBS was added. The PBS was removed and another 10 ml of PBS was added. The plates 
were then UV-crosslinked at 8000 x 100 μJ / cm2 on ice. The cells were scraped off, transferred 
into 50 ml falcons and centrifuged at 1200 rpm for 5 min at 4oC. The pellets were flash-frozed 
in liquid nitrogen and stored at -80oC. 
2.2.8.2 Probe preparation 
The probes were 80-nucleotide long oligos that covered the MaIL1 sequence without overlap. 
Control propes were 80-nucleotide random sequences. To avoid off-target-hybridization, 
BLAST was used to remove sequences with perfect 30 base pair matches or imperfect (90% 
identity) 60 base pair matches within other transcripts or genomic regions. The oligos were 
ordered and then diluted into ultrapure water.  Oligo 3’ biotinylation was performed by 
following the oligonucleotide 3’ mono-biotinylation protocol, using the NEB Terminal 
Transferase reagents (# Μ0315S) and biotin-ddUTP (Jena Bioscience). The reaction is 
described in the following table (Table 2.2.23).  
Table 2.2.23: Biotinylation mixture 
Name Amount  
Oligo 40 pmol 
10x Terminal Transferase Buffer 5 μl 
ddUTP (1mM stock) 0.5 μl 
CoCl2 5 μl 
Terminal Transferase 2 μl 
H2O Up to 50 μl 
 
To determine the appropriate amount of oligos a conversion of pmol to ng was performed. The 
formula is: ng/pmol=0.66xbp. So, for an 80 nucleotide long oligo: 0.55* 80bp=52.8 ng/pmol. 
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For 40 pmol approximately 2 μg of oligo are needed. Because the amount for the RAP-MS 
protocol is 10 μg per replicate the labelling reaction was performed 5 times in parallel. The 
labeling mix was incubated in a PCR machine at 37oC for 1.5 hours. Then, 50 μl of H2O and 
100 μl of PCI for nucleic acid isolation were added on the mixture. The samples were vortexed 
and centrifuged a max speed for 15 min at 15oC. To remove free nucleotides Illustra G-25 
microspin columns (#27532501, GE Healthcare Life Sciences) were used. The caps of the 
columns were removed and the bottom closures were snapped off. Columns were then 
transferred to collection tubes. The columns were then centrifuged at 730 x g for 1 min at room 
temperature and then transferred to 1.5 ml tube and the aqueous phase from the PCI-sample 
mixtures were placed in the centre of the columns. The columns were centrifuged at 730 x g for 
2 min at room temperature. Three volumes of 30:1 Ethanol: NaAcetate and 1 μl of GlycoBlueTM 
were added to the flow-through. The next steps were the same as after DNAseI digestion (see 
section 2.2.2.3). The amount of the probe was quantified and to check the incorporation rate the 
oligoes were incubated with strepatividn coated magnetic capture beads and incubated and the 
bound and flow-through fraction was run on an agarose gel. The higher the incorporation rate 
the less strong the flow-through band appeared on the gel. The incorporation rate was usually 
more than 90%. 
2.2.8.3 Cell lysis 
Frozen pellets with 1.8-2*108 cells were lysed with 900 μl of Total Cell Lysis Buffer (Table 
2.2.24).  
Table 2.2.24: Total Cell Lysis buffer 
Name Concentration Company Ordering number 
Tris-HCl pH 7.5 10 mM Life 
Technologies 
1567-027 
LiCl 500 mM Sigma L7026 
Dodecyl maltoside 
(DDM) 
0.5% Sigma D4641 
Sodium dodecyl 
sulfate (SDS) 
0.2% Ambion AM9820 
Sodium 
Deoxycholate  
0.1% Sigma 06750 
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After the lysis 4.6 μl and 23 μl of 1x proteinase inhibitor (Thermo Fisher) and RNase inhibitor 
(Promega), respectively, were added. The cells were incubated for 10 min on ice while they 
were passed through a 26-gauge needle attached to a 1 ml syringe. For further lysis the cells 
were sonicated for 10 sec at 5 watts. After the sonication 4.8 1X DNase salt stock (Table 2.2.25) 
and 20 U (15 μl) of TurboDNase (Ambion) were added and incubated for 10 min at 37oC. The 
samples were returned onto ice and 19.6 μl of 500 mM EDTA, 9.8 μl of 500 mM EGTA and 
4.9 μl of 500 mM TCEP were added. At this step the cell lysate was split into two tubes and 
490 μl of 1.5X hybridization buffer (Table 2.2.26) was added and incubated on ice for 10 min. 
The mixture was centrifuged at 16.000 x g for 10 min at 4oC. 
 
Table 2.2.25: 200x DNase salt stock 
Name Concentration Company Ordering number 
MgCl2 500 mM Life 
Technologies 
AM9530G 
CaCl2 100 mM Sigma 21115 
 
Table 2.2.26: Hybridization Buffer (2X) 
Name Concentration Company Ordering number 
Tris-HCl pH 7.5 20 mM Life 
Technologies 
1567-027 
LiCl 1 M Sigma L7026 
Dodecyl maltoside 
(DDM) 
1% Sigma D4641 
Sodium dodecyl 
sulfate (SDS) 
0.4% Ambion AM9820 
Sodium 
Deoxycholate  
0.2% Sigma 06750 
Urea 8 M   
TCEP 5 mM   
EDTA 10 mM   
 
2.2.8.4 Pre-clearing of lysates 
To remove the proteins that have no specific binding to the beads the lysate was incubated with 
streptavidin-coated magnetic beads. An appropriate amount of beads (200 μl per 108 cells) was 
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transferred into a tube and placed on a magnet. The storage liquid was removed and the beads 
were washed 4 times with 1 ml 10 mM Tris-HCL pH 7.5 and 2 times with 1 ml of 1x 
hybridization buffer. The lysate was mixed with the beads and incubated for 30 min at 37oC 
with intermittent mixing at 1100 rpm on a thermomixer (30 sec shaking, 30 sec off). Afterwards 
the beads were magnetically separated and the lysate was transferred into a new tube. A sample 
of 100000 cells worth of lysate was transferred to a PCR tube (RNA input sample). 
2.2.8.5 Hybridization, capture and protein elution  
To hybridize the proteins and MaIL1 with the biotinylated probes, 10 μg of control and anti-
MaIL1 probes were heated at 85oC for 3 min. The probes were mixed with the Lysate and 
incubated for 2 hours at 67oC with intermittent mixing at 1100 rpm on a thermomixer (30 sec 
shaking, 30 sec off). During the 2 hours incubation 600 μl of beads (300 μl per 108 cells) were 
washed as described in the section 2.2.5.3. At the end of the 2 hours incubation 100000 cells 
worth of lysate was transferred to PCR tube (RNA input plus probe sample). The beads were 
mixed with the lysate and incubated for 30 min at 67oC with intermittent mixing at 1100 rpm 
on a thermomixer (30 sec shaking, 30 sec off). This was followed by magnetic separation of 
beads and from the flow-through again 100000 cells worth of lysate was transferred to a PCR 
tube (RNA flow-through sample). Afterwards the beads were washed 3 times with 1x 
Hybridization buffer. After each wash the samples were incubated for 5 min at 67oC. A sample 
of beads (around 1% of the total volume) was removed and transferred into a PCR tube (RNA 
elution sample). At this step, the beads with the captured proteins were stored at -80oC in order 
to be send later for Mass Spectrometry analysis. The RNA samples collected were used for the 
validation of MaIL1 pull down. More specifically the RNA elution samples were magnetically 
separated and the buffer was removed. The beads were resuspended into 20 μl of NLS Elution 
buffer (Table 2.2.22) and heated for 2 min at 95oC. The supernatant was then magnetically 
separated and transferred into a new tube. All other RNA samples were also filled up to 20 μl 
with NLS Elution buffer and incubated at 55oC for 1 hour with 1mg/ml proteinase K. 
Table 2.2.27: NLS Elution Buffer 
Name Concentration Company Ordering number 
Tris-HCl pH 8 20 mM Life 
Technologies 
1567-027 
EDTA 10 mM   
NLS 2%   
TCEP 2.5 mM   




After the proteinase K treatment an RNA extraction with PCI was performed (see section 
2.2.2.3). After RNA isolation and DNaseI digestion qRT-PCR was performed to validate the 
MaIL1 pull-down by the biotinylated antisense DNA oligo pools.  
 
Figure 2.2.3: Simplified scheme of the RAP-MS procedure. UV-cross-linked primary 
human macrophages that were stimulated with 100 ng/ml LPS for 8 h, were lysed and incubated 
with biotinylated anti-sense DNA oligo pools against MaIL1 or random DNA oligo pools. Later 
the mixtures were further incubated with strepativdin-coated magnetic beads and separated via 
magnet. The MaIL1-protein complexes were eluted from the beads and the samples were sent 
for mass-spectrometry.   
2.2.9 RNA Immunoprecipitation (RIP)  
RNA immunoprecipitation (RIP) was used as a method to validate protein binding partners of 
lncRNAs after the sass spectrometry analysis of RAP-MS samples.  
2.2.9.1 Preparation of cell lysate  
The cells were cultured in 150 cm2 cell culture plates, approximately 20*106 cells/plate. After 
washing with PBS, the cells were UV crosslinked at 300mJ/cm2 on ice. The cells were scraped 
of and frozen in liquid nitrogen and stored at -80 oC. On the day of the experiment the cell 
pellets were lysed in 1 ml of NP40 lysis buffer (Table 2.2.28), plus 1 μl of RNAse inhibitor, 
protease inhibitor and 0.5 mM DTT. Then the mixtures were incubated on ice for 15 min. To 
completely lyse the cells 5 cycles of sonication with 10 sec on and 30 sec off sonication steps 
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were performed. In order to clear the lysate, the samples were centrifuged at 13000 x g for 15 
min at 4oC. 
Table 2.2.28: NP40 lysis buffer (pH 7.5) 
Name Concentration 
HEPES pH 7.5 50 mM 
KCL 150 mM 
EDTA 2 mM 
NaF 1 mM 
IGEPAL® 0.5% 
 
2.2.9.2 Preparation of Magnetic Beads  
For RIP 60 μl of Dynabeads were used (Dynabeads coated with Protein G from Invitrogen for 
antibodies produced in mouse or goat and Dynabeads coated with Protein A for rabbit 
antibodies were used). The beads were washed 2 times with 1 ml of citrate-phosphate buffer 
(Table 2.2.29) using the magnetic separator and resuspended in 120 μl of citrate-phosphate 
buffer. The appropriate amount of antibody (2.5-10 μg) was added to the beads followed by 60 
min incubation with shaking at room temperature. To remove the unbound antibody the beads 
were washed again 2 times with 1 ml of citrate-phosphate buffer. Finally, the beads were 
resuspended in 120 μl of lysis buffer. 
Table 2.2.29: Citrate-phosphate buffer 
Name Concentration 
Citric acid  4.7 g/L 
Na2HPO4 9.2 g/L 
 
2.2.9.3 Immunoprecipitation 
Before the immunoprecipitation 60 μl for protein analysis and 60 μl for RNA extraction were 
kept aside from the total cell lysate. The clear lysate of the cells was resuspended with 2 ml of 
NP40 lysis buffer and the beads, and incubated for 4 hours at 4oC while rotating. After the 
incubation the lysate was removed and kept and the beads were washed with 3 ml of IP wash 
buffer (Table 2.2.30) for 15 min while rotating.  
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Table 2.2.30: IP wash buffer 
Name Concentration 
HEPES-KOH pH 7.5 50 mM 
KCL 300 mM 
NP40 0.05% 
DTT 0.5 mM  
Protease Inhibitors 0.5% 
 
After the wash the beads were diluted in 300 μl of IP wash buffer and from this dilution 50 μl 
were kept aside for protein analysis. From the rest of the beads, the IP wash buffer was removed 
and replaced with 250 μl of RIP elution buffer (Table 2.2.31) containing 1 μl of RNAse inhibitor 
and 2.5 μl of 20 mg/ml Proteinase K. The mixture was incubated for 40 min at 60oC. Finally, 
250 μl of PCI were added and RNA extraction was performed.  
Table 2.2.31: RIP elution buffer 
Name Concentration 
Tris-HCl pH 8  100 mM 
EDTA  10 mM 
SDS 1% 
 
2.2.10 Glycerol Gradient 
For analysis of co-sedimentation of proteins and RNA molecules a 10%-60% glycerol gradient 
centrifugation was performed. The original method was described first by Dignam et al. in 
1983. In this study it was performed with some modifications. To prepare the glycerol gradient 
a buffer was prepared according to the table 2.2.32. 
Table 2.2.32: Glycerol Lysis buffer solution 
Solution Concentration  




Triton  0.5% 






The different glycerol concentrations were prepared according to the Table 2.2.33 from a 
buffered stock solution of 60% glycerol.  
Table 2.2.33: Glycerol gradient preparation 
Final 
concentration 60 % Glycerol buffer (μl) Buffer (μl) 
55% 4.58 0.42 
50% 4.17 0.83 
45% 3.75 1.25 
40% 3.33 1.67 
35% 2.92 2.08 
30% 2.50 2.50 
25% 2.08 2.92 
20% 1.67 3.33 
15% 1.25 3.75 
10% 0.83 4.17 
 
The different gradient solutions were layered into an ultracentrifuge tube with a cup. To this 
end, the tube was placed inside an ethanol / dry-ice slurry and 3.6 ml of the different glycerol 
solutions were added in decreasing concentration. Each concentration was added after the 
previous was frozen. The tubes were stored at -80oC and transferred at 4oC the day prior the 
experiment, to allow the formation of a continuous gradient. For the experiment, 108 BDMs 
were harvested and washed once with PBS. The cell pellet was then lysed in lysis buffer (Table 
2.2.32) and incubated on ice for 10 min. During this incubation the lysate was passed through 
a 26 Gauge needle 5 times and the nuclei were broken by Dounce homogenizer with 8-10 strokes. 
Next, 2 µl of RNase inhibitor was added and samples were centrifuged briefly to remove the 
cellular debris. The supernatants were carefully layered onto the glycerol gradients, which were 
centrifuged at 50.200 x g (Sorvall S-34 rotor), acceleration 1, brakes off, for 20 hours at 4°C. 
After the centrifugation, 900 μl fractions were transferred into 2 ml tubes. From this 900 μl, 
100 µl were kept for SDS-Page and silver staining. The rest was used for protein and RNA 
isolation via PCI. The RNA was extracted from the aqueous phase as described before. The 
protein (lower phase) was diluted with 800 μl of H2O, to remove the glycerol and allow the 
protein to precipitate. The sample was then centrifuged for 30 min at 15 °C and 17000 x g and 
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the aqueous phase was discarded.  To the lower phase, 1.2 ml ice cold acetone were added and 
incubated, overnight at -20°C. The next day, the samples were centrifuged for 30 min at 17000 
x g at 4°C. The pellets were dried and resuspended in 0.5-1 ml mass-spec grade 8 M urea. RNA 
samples were then sent for RNA sequencing and the protein samples for Mass Spectrometry.   
2.2.11 Protein Analysis 
2.2.11.1 Western blot 
To analyse the expression levels of several proteins the Western blot method was used. For this 
purpose, cells were washed with PBS and lysed in RIPA buffer (without SDS). Lysed cells 
were centrifuged at maximum speed for 15 min at 4°C to remove cell debris. Protein 
concentration was measured by bicinchoninic acid assay (BCA assay) using the PierceTM BCA 
Protein Assay Kit. Samples were diluted 1:10 and all steps were performed according to 
manufacturer´s protocol. Optical density was measured at the Tecan Infinite M200 PRO plate 
reader (Thermo Fisher) at a wavelength of 595 nm, and protein concentration was calculated. 
Samples were prepared by adding 5X Laemmli‐buffer and denatured for 5 min at 95°C. For 
protein separation, 10% SDS gels were used, and 20 to 30 µg of protein were loaded. A marker 
was included as a size reference. To run the proteins through the stacking gel, 80 V was applied, 
which then was increased to 120 V to run the proteins through the separation gel. Proteins were 
transferred to a nitrocellulose membrane by wet blot transfer for 1 h at 90 V. Afterwards, the 
membrane was blocked for 1 h at room temperature with 10% milk-powder and 3% Bovine 
serum albumin (BSA) in TBS-T solution. Primary antibody was added at a 1:1,000 dilution in 
TBS-T and incubated overnight at 4oC under rotation. Unbound protein was removed by several 
washing steps in TBS‐T. HRP‐conjugated secondary antibody was then added for 1 h at room 
temperature under rotation. After removal of excess antibody by washing, protein signal was 
detected on the Bioluminescence and Chemoluminescence Imager (INTAS). When required, 
quantification of signal was performed by densitometric analysis, using the LabImage 1D 
software (Kapelan Bio‐Imaging GmbH). 
2.2.11.2 Enzyme Linked Immunosorbent Assay (ELISA) 
For analysing proteins that are secreted into the supernatant of cells, enzyme‐linked 
immunosorbent assay (ELISA) was used (Engvall and Perlmann, 1971). ELISAs were 
performed to determine secreted IFNA protein in supernatants of control and L. pneumophila 
infected samples with or without MaIL1 knock-down. Supernatants were used undiluted 
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because the secretion levels of IFNA proteins are relatively low. The plates were coated with 
50 µl/well 1:1000 dilution of anti-human IFNα antibody (PBL, Cat-no.21100-2-10, 100 µg/ml), 
overnight at 4°C. The antibody was discarded and the plate was blocked with 250 µl/well block-
buffer (1x PBSdef., 0,05% Tween20, 1% BSA) for 1 h at room temperature. Logarithmic 
dilution series 1:1 (1 Std. 4 µg/ml) of standard protein in block-buffer were prepared and 50 
µl/well were added (human-IFNα, Peprotech, cat-no.300-02A, 20 µg/ml). 50 μl of samples 
were added too and incubated for 1,5 hours at room temperature. After washing for 3 times, 50 
μl/well of detection antibody at a dilution of 1:1000 was added and incubated at room 
temperature for 1.5 hours (anti-human-IFNα HRP-conjugate, eBioscience, Cat-no.: 
BMS216MSTK). After washing three times, 50 µl/well substrate-solution (1 OPD-tablet 
(20mg)(Sigma, Cat-no: P7288) in 20 ml substrate-buffer (35mM Citric acid x H2O, 67mM 
Na2HPO4 x 2H2O in d.H2O) + 20 µl 30% H2O2 (AppliChem, A0626, 2500) were added. After 
colour development, the reaction was stopped by adding 25µ/well 2M H2SO4. Plate 
measurements were carried out using the photometer Emax SofMaxPro5 at 650 nm wavelength 
and the analysis was performed according to manufacturer´s instructions.  
2.2.11.3 Quantification of expression levels by flow cytometry  
To measure the expression levels of receptors on the surface of cells flow cytometry was used. 
The stainings were performed in 50 μl of PBS containing 0.1% FCS for 1 h on ice in the dark. 
The antibodies that were used are indicated in the respective experiment. After the staining, the 
cells were washed with PBS, resuspended in 400 μl of PBS and measured on the Guava® 
easyCyte flow cytometer (Merck Millipore). The data were analysed using FlowJo v. 7.6.5. 
2.2.12 Transfection of BDMs with siRNAs 
On day 7 of differentiation, primary human macrophages were transfected with siRNAs against 
MaIL1 or with control siRNA (see Table 2.1.8). The siRNAs were designed using a web tool 
(Naito et al., 2004). Transfection was performed using Lipofectamine 2000 (2 μl for 5*105 cells 
and 4 μl for 106 cells) in Opti-MEM (100 μl for 5*105 cells and 200 μl for 106 cells) and 50-200 
nM siRNA again in Opti-MEM (100 μl for 5*105 cells and 200 μl for 106 cells). The two 
mixtures were added together and incubated for 15 min at room temperature and added to the 
cells. Afterwards, cells were centrifuged for 2 h at 37°C for 2,000 rpm to achieve maximal 
transfection efficiency. Knockdowns mediated by the siRNAs were validated by qRT-PCR. 
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2.2.13 Stimulation of BDMs 
2.2.13.1 Treatments with pro-inflammatory stimuli 
For stimulation of human macrophages, several compounds were used. Lipopolysaccharide 
(LPS) (Sigma, # L6143-1MG) was used at concentrations of 1, 10,100 and 1000 ng/ml and the 
simulations were performed for different time-points depending on the experiment. Poly I:C 
(Invivogen, # tlrl-pic) was used at a concentration of 20 μg/ml for different time-points 
depending on the experiments). IFNγ (Peprotech #300-02, 20μg) was used at a concentration 
of 100 ng/ml for 8 and 16 hours. Stimulations with Pam3csK4 (Invivogen, #tlrl-pms, 100 
ng/ml), M-TriDAP (Invivogen, #tlrl-mtd, 1 μg/ml) and Resiquimod (Invivogen, # tlrl-r848, 1 
μg/ml) were performed for 8 h. All reagents were resuspended according to the manufacturer's 
instructions. 
2.2.13.2 Treatments with inhibitors 
Different inhibitors were used to investigate the pathway dependency of MaIL1. For NF-kB  
inhibition, NF-kB activation inhibitor was used (NF-AI, 6-Amino-4-(4-
phenoxyphenylethylamino)quinazoline, Calbiochem #481406) at concentrations of 10 nM or 
50 μM. For the inhibition of MEK1/2 and p38, U0126 and SB 203580 were used respectively. 
Both inhibitors werepurchased form Calbiochem MerkMillipore (#66205 and #559389) and 
were used at concentrations of 10 μM or 50 μM. For TBK1 inhibition, Amlexanox was used at 
a concentration of 10 or 50 μM (Abcam #ab142825). 
2.2.14 Infection of BDMs with Legionella pneumophila 
Primary human macrophages were infected with Legionella pneumophila. Three days prior to 
infection, GFP positive Legionella pneumophila were plated onto a charcoal agar plate and 
incubated at 37oC. On the day of infection, bacteria were scraped from the prepared plate and 
resuspended in PBS (1:1) to an OD=0.5 which equals 2 x 109 bacteria or colony forming units 
(CFUs) per ml. The ratio of bacteria to cells is defined as the multiplicity of infection (MOI). 
From the OD=1 suspension a dilution 1 to 10 was prepared and then 2.5 ml of this dilution were 
added into 7.5 ml of RPMI to achieve an MOI of 10, to infect 5*105 cells. From this dilution 
100 μl were used to reach an MOI=10. For MOI 1, this solution was further diluted 1 to 10. 
From this dilution 10 μl were used to infect the cells to achieve an MOI of 0.1. For determination 
of the exact MOI, 50 μl of the 10-4 and 10-5 dilutions from the infection solution were streaked 
on BCYE agar plates and incubated for 3 days at 37°C. After incubation, colony forming units 
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(CFUs) were counted and the precise MOI was calculated (CFU/ml = counted colonies x 
dilution factor). 
2.2.15 Determination of infection efficiency by flow cytometry 
In order to identify infection efficiencies of human macrophages incubated with Legionella 
pneumophila, flow cytometry was used. Primary human macrophages were infected with a 
GFP‐expressing strain of Legionella pneumophila at MOI 0.1 according to section 2.2.14. After 
24 hours of infection, cells were washed once with PBS and scraped off and transferred to a 
tube. Subsequently, cells were centrifuged for 5 min at room temperature at 300 x g. The pellet 
was resuspended in PBS with 0.1% FCS and cells were measured on a Guava® easyCyte flow 
cytometer (Merck Millipore). The data were analysed using FlowJo v. 7.6.5. 
2.2.16 MTT assay 
To assess cell proliferation of LINC00211 knock out and overexpression cells MTT assays 
were performed.  To this end, cells were cultured in 96 wells in triplicates. Because the THP1 
cells are non-adherent, and this can be a problem for the measurement, two hours prior to the 
measurement 20 nM of PMA were added on top of the cells. After the two hours 10 μl MTT 
solution was added into the wells. The cells were incubated for 3 hours and then the medium 
was removed and replaced with 200 μl of 1:1 DMSO: Ethanol. After 15 min, the absorbance 
was measured at 570 nm an the Tecan Infinite M200 PRO plate reader (Thermo Fisher).  
2.2.17 RNA sequencing 
High quality RNA, isolated by mirVanaTM miRNA isolation kit (total RNA isolation 
procedure), was send to the in-house transcriptomics core facility of the medical faculty of the 
Philipps-University Marburg for generation of Illumina stranded mRNA libraries or to Vertis 
Biotech (Freising, Germany) for total RNA library generation. Barcoded libraries were 
generated using the TruSeq Stranded mRNA Kit (Illumina) or Vertis Biotech in-house kits. 
Libraries were sequenced (single-ends) on a HiSeq1500 machine in rapid mode with 50 bp 
read-length or a NextSeq500 device with 75 bp read-length. Prof. Dr. Leon Schulte performed 
the RNA sequencing data analysis. Briefly, demultiplexed reads (fastq-files) were imported into 
the CLC genomics workbench (Qiagen), and following TruSeq adapter- and quality-trimming 
mapped to the GRCh38 human reference genome annotation with standard settings (mismatch 
cost = 2; insertion cost = 3; deletion cost = 3; length fraction = 0.8; similarity fraction = 0.8). 
Differential gene expression analysis was done using DeSeq2, based on uniquely mapped reads. 
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Cluster (Eisen lab) was used for Hierarchical clustering and JAVA TreeView for generating the 
Heatmaps. To analyse the subcellular localization data, a correction was applied to the RPKM 
values taking into account the different RNA content of nucleus and cytosol. The percentage of 
Gapdh mRNA subcellular distribution was determined by qRT-PCR and applied to the 
following equation in order to calculate the correction factor (CF), which was then applied to 
all cytosolic RPKMs. 
𝐶𝐹𝑅𝑃𝐾𝑀𝑐𝑦𝑡𝑜𝑠𝑜𝑙 =
(
𝑅𝑃𝐾𝑀𝑛𝑢𝑐𝑙𝑒𝑢𝑠  ×  %𝑐𝑦𝑡𝑜𝑠𝑜𝑙





715.03 ×  0.8876




The percent subcellular distribution was calculated by division of the corrected cytosolic RPKM 
and the sum of corrected cytosolic and the nuclear RPKM of a given gene. The results were 
validated by qRT-PCR. For the analysis of the RNA profiles of different human tissues the 
Human BodyMap 2.0 data sets were used (http://www.ensembl.info/2011/05/24/human-
bodymap-2-0-data-from-illumina/). The RNA sequencing data of different leucocyte 
populations were obtained from the NCBI GEO source (GEO series GSE62408 and 
GSE60424). These data were obtained as fastq-files and treated as described above. 
2.2.18 Proteomics 
Prof. Dr. Linne Uwe and his research group performed Proteomics analysis. Samples bound to 
(magnetic) beads were washed three times with 100 µl 0.1 M ammoniumbicarbonate solution. 
They were digested "on-bead" by the addition of Sequencing Grade Modified Trypsin (Serva) 
and incubated at 37 °C for 45 min. Subsequently, the supernatant was transferred to fresh tubes. 
Peptides were desalted and concentrated using Chromabond C18WP spin columns (Macherey-
Nagel, Part No. 730522). Finally, Peptides were dissolved in 25 µl of water with 5% acetonitrile 
and 0.1% formic acid. The mass spectrometric analysis of the samples was performed using an 
Orbitrap Velos Pro mass spectrometer (ThermoScientific). An Ultimate nanoRSLC-HPLC 
system (Dionex), equipped with a custom end-fritted 50cm x 75µm C18 RP column filled with 
2.4 µm beads (Dr. Maisch GmbH) was connected online to the mass spectrometer through a 
Proxeon nanospray source. 1-15 µl (depending on peptide concentration and sample 
complexity) of the tryptic digest were injected onto a 300µm ID x 1cm C18 PepMap pre-
concentration column (Thermo Scientific). Automated trapping and desalting of the sample was 
performed at a flowrate of 6 µl / min using water / 0.05% formic acid as solvent. Separation of 
the tryptic peptides was achieved with the following gradient of water / 0.05% formic acid 
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(solvent A) and 80% acetonitrile / 0.045% formic acid (solvent B) at a flow rate of 300 nl / min: 
holding 4% B for five min, followed by a linear gradient to 45% B within 30 min and linear 
increase to 95% solvent B in additional 5 min. The column was connected to a stainless steel 
nanoemitter (Proxeon, Denmark) and the eluent was sprayed directly towards the heated 
capillary of the mass spectrometer using a potential of 2300 V. A survey scan with a resolution 
of 60000 within the Orbitrap mass analyzer was combined with at least three data-dependent 
MS/MS scans with dynamic exclusion for 30 s either using CID with the linear ion-trap or using 
HCD combined with orbitrap detection at a resolution of 7500. Data analysis was performed 
using Proteome Discoverer 2.2 (Thermo Scientific) with SEQUEST search engine. Uniprot 
databases were used. For gradient samples, abundance values were normalized to the relative 
protein content in each fraction (determined using the BCA-method and silver-gel 
quantification).  
2.1.19 Conservation analysis 
Sequence conservation was determined using NCBI BLASTN. The sequence of interest was 
compared to the Reference Genomic Sequence of selected species. BLASTN hits located within 
a genomic range of max. 100 kb were considered. All matching nucleotides were counted as 1 
and all mismatches were considered as 0. The missing nucleotides from the reference sequence 
were also count as 0, whereas missing nucleotides from the input sequence were neglected. 
2.2.20 Bronchoalveolar lavage (BAL) and patient selection  
Bronchoalveolar lavage fluid (BALF) samples were obtained from patients (Table 2.2.34) at 
the Department of Infectious Diseases and Respiratory Medicine of Charité University Hospital 
Berlin, through Prof. Dr. Leif E Sander. All patients underwent bronchoscopy including 
bronchoalveolar lavage (BAL) on clinical indication and had provided oral and written 
informed consent. The study was approved by the local Ethics Committee (EA2/086/16). BAL 
fluids from healthy donors as controls for the IPF study were obtained by means of an American 
Thoracic Society consensus procedure and in accordance with local ethics regulations 
(Marburg: 87/12). The lung fluids from resected IPF tissue (tissue provided by DZL biobank 
Giessen) were obtained by flushing the tissue with pre-warmed PBS. Obtained fluids were 
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Table 2.2.34: Patient information 
No Gender Age Infection 
1 m 53 control 
2 m 49 control 
3 m 38 control 
4 w 71 control 
5 w 49 control 
6 m 62 control 
7 m 28 control 
8 m 29 control 
9 w 27 control 
10 m 64 control 
11 w 25 bacterial 
12 m 45 bacterial 
13 w 64 bacterial 
14 w 19 fungal 
15 w 64 fungal 
16 w 42 fungal 
17 w 68 nd 
18 w 59 nd 
19 w 52 nd 
20 w 58 nd 
21 w 73 nd 
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2.2.21 Statistical Analysis  
Statistical analysis was carried out with GraphPad Prism (Version 7). For data with multiple 
comparison variables One-way ANOVA (Analysis of variance) was performed followed by 
either Dunnett or Bonferroni comparison test. For comparison of two data columns, the 
unpaired t‐test was used. For all tests, a Gaussian distribution was assumed, and the confidence 
interval was set to 95%. P‐values ≤ 0.05 were considered as indication for significance. All 





3.1 Results - LncRNAs in myeloid cell differentiation 
3.1.1 Identification of lncRNAs differentially expressed in distinct immune 
cell subsets 
Due to limited research advances on the involvement of lncRNAs in haematopoiesis and 
leukocyte differentiation, a central aim of this study was to investigate cell-type specific 
lncRNA expression patterns in distinct leukocyte populations and investigate the functions of 
individual of these lncRNAs. For identification of lncRNAs that are specifically expressed in 
leukocytes, external high throughput RNA sequencing data from different organ systems were 
analysed. mRNA and lncRNA expression levels in leukocytes were compared to the expression 
levels in lymph nodes, adrenal, lung, adipose, prostate, ovaries, testes, breast, kidney, liver, 
brain, thyroid, colon, heart and skeletal muscle tissue, using publicly available Illumina Human 
Bodymap 2.0 data (Figure 3.1.1.A).  Interestingly, leukocytes displayed a unique lncRNA and 
mRNA transcriptome signature. Most of these Leukocyte-expressed transcripts were also 
highly expressed in lymph nodes, which are rich in immune cells. Skeletal muscle tissue 
displayed the lowest expression of the leukocyte lncRNA and mRNA cluster. When the 
leucocyte specific mRNAs were analysed by KEGG (Kyoto Encyclopaedia of Genes and 
Genomes) pathway analysis, the results suggested that most of these genes are involved in 
immune related functions, such as hematopoietic lineage determination, NK cell mediated 
cytotoxicity, cytokine-cytokine receptor interaction, osteoclast differentiation, chemokine 
signalling pathway, T-cell receptor signalling pathway, platelet activation and cell adhesion. 
Furthermore, leukocyte specific mRNAs have been implicated in infections, like infections by 
tuberculosis, measles, trypanosoma cruzi (chagas disease) and influenza A (Figure 3.1.1.B). 
Thus, Human Bodymap 2.0 data analysis accurately detects transcripts implicated in leukocyte 
biology. In order to infer, which leukocyte subpopulations express the identified leukocyte 
marker transcripts, three replicates of independent, publically available monocyte, granulocyte, 
NK-, B- and T-cell high throughput RNA sequencing data (NCBI GEO series GSE62408 and 
GSE60424) were analysed. Principal component analysis with the RPKMs of leukocyte-
specific mRNAs or lncRNAs in these cells revealed that all datasets segregated according to 
the underlying cell types (Figure 3.1.1.C). In line with this result, hirachical clustering of 




specific to CD66+ granulocytes, CD14+ monocytes, CD19+ B-cells, CD56+ NK cells, CD4+ 
T-cells and CD8+ T-cells (Figure 3.1.1.D). Thus, besides mRNA markers, leukocytes express 
distinct clusters of lncRNAs, which may serve as novel non-coding markers of the major 
immune cell sub-populations. 
 
Figure 3.1.1. Transcriptome analysis of leukocytes. A. RPKM values of leukocyte specific 
mRNAs and lncRNAs in different tissues. B. KEGG pathway analysis of leucocyte specific 
mRNAs. C. PCA of the leukocyte specific mRNAs and lncRNAs expressed in granulocytes, 
monocytes, B-cells, NK cells, CD4+ T-cells and CD8+ T-cells. D. Heat maps of Z-scores of 
leucocyte specific mRNAs and lncRNAs in granulocytes, monocytes, B-cells, NK cells, CD4+ 
T-cells and CD8+ T-cells (3 highest expressed, -3 lowest expressed). 
 
3.1.2 Validation of the expression levels of leukocyte specific lncRNAs 
 
The top 10 myeloid- and lymphoid-cell specific lncRNAs were selected for further validations 
(Table 3.1.1). To this end, immune cell populations were enriched from buffy coats of human 




negative) and memory (CD45RO-positive) cells. Furthermore, monocytes were differentiated 
into macrophages and dendritic cells, based on classical differentiation protocols with GM-CSF 
and IL-4. 
 
Table 3.1.1: Top 10 differentially expressed myeloid and lymphoid markers. The numbers represent 
fold changes compared to brain tissue expression and standard deviations.   
 
 
The top 3 myeloid and lymphoid cell specific lncRNAs (Z-score shown in Figure 3.1.2.B) were 
selected for qRT-PCR validations (Figure 3.1.2.C). LINC00211, LUCAT1 and AC064805.1 
were more highly expressed in the myeloid cell lineage and LINC02295, LINC02446, 
LINC00861 more in the lymphoid cell lineage. Interestingly, LINC02295 was present only in 
the T-cell population and low or absent from B-cells or NK-cells, which indicates that the 
expression is induced very late in hematopoietic development, when small lymphocytes give 
rise to B-cells and T-cells (see Figure 1.2). Other interesting expression patterns were observed. 
For example, the expression of LINC02446 seems to vanish from memory CD4+ T-cells 
(CD4+/CD45RO+ T-cells), while it is present in all the other T-cell populations, including the 
naïve CD4+ T-cells. Furthermore, expression levels of this lincRNA seem to be higher in CD8+ 
T-cells than in CD4+ T-cells. These findings indicate that the expression of leukocyte lncRNAs 
is highly cell-type specific. LINC00211 had a clear myeloid-specific expression pattern, and 





Figure 3.1.2: Differential expression of lncRNAs in immune cells. A. FACS plots of immune 
cell populations isolated from peripheral human blood. Anti-CD14, anti-CD66, anti-CD56, 
anti-CD19, anti-CD4 and anti-CD8 antibodies were used for staining of monocytes, 
granulocytes, NK cells, B-cells, CD4+ T-cells and CD8+ T-cells, respectively. The percentages 
were calculated after gating according to the unstained control for each population. B. Heat map 
of Z-scores of the top differentially expressed lncRNAs. C. qRT-PCR validations of the 
expression of the top differentially expressed lncRNAs. The expression levels were normalised 
to the expression levels of the lncRNAs in brain tissue.  
 
3.1.3 Characterisation of LINC00211  
LINC00211 is an uncharacterized intergenic lncRNA (lincRNA), located on chromosome 2. 
Due to the preliminary nature of present GENCODE lncRNA annotations, RACE-PCR and 
Sanger sequencing was performed to map the exact 5’ and 3’ ends and the exon structure of the 
transcript. The results characterized LINC00211 in BDMs as a 1879 bp long RNA with two 
exons, differing from the existing GENCODE prediction (1923 bp and three exons, Figure 
3.1.3.A). Furthermore, using Ensembl (BLAST) evolutionary conservation LINC00211 was 




compared against the genomes of chimpanzee, macaque, lemur, tree shrew, rabbit, mouse, dog, 
cow and pig. Whereas the lincRNA sequence was found to be highly conserved in primates, 
conservation dropped to approximately 20% in rodents. However, in other mammals, with 
greater evolutionary distance from primates, (cows and pigs), sequence similarity increased 
back to 60%-70%. These results indicate that the LINC00211 locus constitutes an anancient 
RNA-gene of unknown function within the mammalian lineage. 
Figure 3.1.3: Characterisation of LINC00211. A. Schematic representation of full length 
LINC00211 structure, based on RACE results obtained from RNA of BDMs, in comparison to 
ENCODE annotation. B. Species-conservation analysis. The graph show the percentage of 
LINC00211 conservation in the NCBI reference genomes of indicated species compared to the 
human sequence (100%). C. Coding potential of LINC00211, as expressed by the CPC score. 
D. qRT-PCR based cellular localisation pattern of LINC00211. RNA from cytosolic and 
nuclear fractions of BDMs mock-treated or stimulated with LPS (100ng/ml) for 8 hours was 
used (n=3).  
 
To verify the non-coding nature of the LINC00211 RNA, the coding potential was calculated 
using the online coding potential calculator (CPC) (http://cpc2.cbi.pku.edu.cn/) (Kang et al., 
2017). As controls, two well-characterised lncRNAs, XIST and HOTAIR, and two known 
protein-coding genes, ACTB and GAPDH, were used. The CPC analysis of the RACE-PCR 
refined cDNA sequence revealed no relevant coding potential for LINC00211 (CPC score ̴ +1), 
similar to XIST and HOTAIR (CPC scores ̴ -1 and ̴ -1.5 respectively), and different from ACTB 
and GAPDH, (CPC scores ̴ +14 and ̴ +12 respectively), (Figure 3.1.3.C). Next, subcellular 
localisation of the lncRNA was determined by cytoplasm / nucleus fractionation. Real-time 
PCR revealed that LINC00211 locates mostly, but not entirely to the nucleus ( ̴ 70%), both in 
resting and LPS-activated BDMs (Figure 3.1.3.D). 
 
3.1.4 Functional characterisation of LINC00211 
In order to reveal its cellular function, LINC00211 loss- and gain of function experiments were 
performed. Due to the technically difficult manipulation of primary human myeloid cells, a 
monocytic cell line model, THP1, was employed. Using lentiviral transduction LINC00211 was 




GFP+ cells were flow-sorted and qRT-PCR was used to confirm succesfull overexpression 
(OE) of the lincRNA in THP1 cells (Figure 3.1.4.B&D). As a control, cells were transduced 
with a lentivirus containing a scrambled transgene sequence.  
 
Figure 3.1.4: LINC00211 gain and loss of function experiments. A. Schematic 
representation of CRISPR/Cas9 knock out strategy and lentiviral overexpression strategy. B. 
Flow cytometry panels showing GFP+ cell gates used for cell sorting to enrich cells transduced 
either with a scrambled or the LINC00211 sequence. C. Agarose gel analysis of genomic PCR 
products from the control and knock out clones generated by CRISPR/Cas9. The band at ̴ 200bp 
represents the product after the deletion was introduced by CRISPR/Cas9 and the band ̴ 2000 
bp represents the wild type band.  D. qRT-PCR analysis of the expression levels of LINC00211 
in the overexpressing and knock down (+/-) and knock out (-/-) cell lines. The expression levels 
were compared to THP1 cells transduced with scrambled control for the overexpression cells 
and to the empty CRISPR/CAS9 vector (wt) transfection for the +/- and -/- cells. Black circles 
represent independent replicates. For statistical analysis an unpaired t-test was performed for 
the overexpression and a one-way ANOVA for the knock down and knock out experiments 
(***p ≤ 0.001, ****p ≤ 0.0001). E. Heatmap of the RPKMs of the top differentially regulated 
genes upon overexpression and knock out of LINC00211. F. Volcano plot fold changes in 
association with the p-value of the differentially regulated genes. “Supressed” relates to genes 
elevated upon LINC00211 knockout and reduced upon LINC00211 over-expression (the latter 
values were transformed from down to up-regulations for this plot). Vice versa for “induced” 
genes. G.  Fold changes of LINC00211-controled genes from F) in PMA-versus mock-treated 
THP-1 cells, determined by RNA-Seq. Genes under negative control by LINC00211 are down-
regulated upon PMA-treatment, while genes under positive control by the lncRNA are induced 





To generate LINC00211 loss-of-function 
THP1 cells, a CRISPR/Cas9 approach 
previously published by our group was 
used (Janga et al., 2018). Briefly, the 
pX458 CRISPR vector, expressing two 
gRNAs cleaving before and behind the 
LINC00211 transcriptional start-site 
(TSS) was transfected into THP1 cells. 
Using a first set of gRNAs a 
heterozygous (+/-) clone for LINC00211 
TSS deletion was generated and with a 
second independent set of gRNAs two 
homozygous (-/-) clones was generated. 
For control, an empty pX458 vector 
(without gRNAs), expressing Cas9 was 
transfected into THP1 cells and the cells 
were treated the same way as the 
genetically modified clones (for more 
details see the methods section). 
Genomic PCR and Sanger sequencing 
(Figure 3.1.4.C) validated the successful 
TSS deletions and the clones were used 
for further experiments. Upon lentiviral 
transduction the expression levels of 
LINC00211 increased approximately 30-
fold compared to the scramble control 
and in +/- and -/- TSS knockout clones 
expression levels sharply decreased (̴ 10 
fold less for the +/- clone and ̴ 100 fold 
less for the -/- clones). RNA-Seq analysis 
revealed genes with altered expression 
levels in overexpression and knock out 
cells compared to the control cells. 
Interestingly, expression of several genes 
Figure 3.1.5: Gene expression profiling. A. 
Validation of differentially expressed genes 
upon overexpression of LINC00211 in THP1 
cells by qRT-PCR. The graphs show the fold 
enrichment of genes compared to THP1 cells 
transduced with scramble control.  B. qRT-PCR 
analysis of differentially expressed genes upon 
LINC00211 knock down (+/-) and knock out in 
THP1 cell lines (-/-). The expression levels were 
compared to cells transfected with empty 
CRISPR/CAS9 vector. C. Analysis of 
differentially expressed genes upon THP1 
differentiation for 72 hours with PMA (20nM). 
The data are displayed as fold changes in 
comparison to undifferentiated THP1 cells. 
Circles represent independent replicates. For 
statistical analysis, one-way ANOVA was 
performed (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, 




changed into opposite directions upon LINC00211 overexpression and knock out, respectively 
(Figure 3.1.4.E), thus illustrating genes under positive or negative control by LINC00211 
(Figure 3.1.4.F).  
The specific expression of LINC00211 in myeloid cells suggests that this lincRNA plays a role 
in myeloid cell identity or terminal differentiation. Thereforen genes were narrowed down, 
which are regulated during terminal differentiation by comparative RNA-Seq analysis of 
monocytic and PMA-differentiated macrophage-like THP1 cells. Interestingly, genes which are 
under negative control by the lincRNA were mostly supressed during terminal differentiation 
and vice versa, genes under positive control by LINC00211 were mostly up-regulated during 
differentiation (Figure 3.1.4.G). This suggests that LINC00211 functions to facilitate the 
expression of genes involved in myeloid cell terminal differentiation.  To further follow up this 
hypothesis, validation of the sequencing results was performed. Real-time PCR analysis 
revealed that in the overexpression cell line S100A8 and S100A9 were downregulated and 
KLF4, MMP9, CHI3L1, TREM2 and IGBP2 were upregulated as expected from the sequencing 
results (Figure 3.1.5.A). For the partial and full knock out cell lines only S100A8 and CHI3L1 
were up and downregulated respectively as expected from the sequencing results. One of the 
two knock out cell lines also exhibited an upregulation of S100A9, but the result was not 
replicated in the partial knockout or the second full knockout cell line. The clonal nature of the 
knock out cells may be a possible explanation for the phenotypic differences that were 
observed. Next, the expression levels of the same genes were measured after PMA stimulation 
and differentiation of THP1 from monocytes to macrophage-like cells. Interestingly, 
LINC00211 was downregulated upon differentiation. S100A8, S100A9, MMP9, CHI3L1 and 
TREM2 showed the same pattern of expression compared to the overexpression cell line. Thus, 
the results validated that genes that are suppressed upon differentiation are also supressed by 
the lincRNA and genes that are induced upon differentiation are induced by the lincRNA, too. 
 
3.1.5 LINC00211 is involved in monocyte terminal differentiation 
Since differential gene expression results from knock out and overexpression cells indicated 
that LINC00211 may play role in monocyte to macrophage differentiation LINC00211 OE cells 
were analysed for morphological changes as well. To this end, cells were treated with PMA, 
stained with DAPI for nuclear visualization and analysed at the fluorescent microscope. 
Interestingly, LINC00211 OE cells showed a different morphology compared to control THP1 
cells overexpressing a scrambled RNA, following PMA-differentiation (Figure 3.1.6.A). The 




which is commonly observed after differentiation into macrophages. The morphological 
changes observed in the LINC00211 OE cells, were also inspected at the protein level. b-actin 
expression levels were much higher in the OE cells compared to the control cells, which 
suggests that cytoskeletal changes occur in these cells (Figure 3.1.6.B). 
 
Figure 3.1.6: LINC00211 is involved in monocyte to macrophage differentiation. A. 
Fluorescent macroscopy analysis of THP1 cells either overexpressing the scrambled RNA 
sequence or LINC00211. Prior to the analysis, the cells were differentiated with PMA (20nM) 
for 72 hours. B. Top: western blot and bottom: Ponceau staining of protein samples obtained 
from THP1 cells over-expressing either the scramble RNA or LINC00211. The blot was stained 
with anti-b–actin antibody. C. MTT assay of scramble, LINC00211, wt, +/-, -/- a) and -/- b) 
cells for 24, 48 and 72 hours. For statistical analysis two-way ANOVA was performed: ***p ≤ 
0.001, ****p ≤ 0.0001. D. FACS data presented as percentage of positive cells. Different cell 
clones (wt, +/- and -/- a) and-/- b)) were stained for CD11b, CD33, CD169 and HLA-DR both 
in THP1 cells and in differentiated THP1 cells (PMA for 72 hours) (n=3). E. FACS blots and 
quantification of scramble, LINC00211, wt, +/- and -/- a) and -/- b) cells stained with anti-
CD11c antibody (n=3-4). One-way ANOVA and unpaired t-test were performed for the first 





Next, the proliferation rate of the OE and partial and full knock out cells was inspected using 
an MTT assay. The assay showed that OE cells proliferate much slower than the control cells. 
On the other hand, there were no significant differences in proliferation rates of knock out cells, 
compared to the wild type control cells (Figure 3.1.6.C). To further investigate differentiation-
associated changes, LINC00211 knock out and overexpression cells were stained with a panel 
of fluorescent antibodies against myeloid surface markers. Because the overexpressing cells 
also express GFP from the lentiviral backbone, these cells could not be stained with all available 
antibodies. Surface expression of proteins CD11b, CD33, CD169 and HLA-DR showed no 
difference between the control, LINC00211 +/- and LINC00211 -/- cells (Figure 3.1.6.D). 
Differentiation marker CD11c was significantly reduced in undifferentiated LINC00211 knock 
out cells compared to control cells. On the other hand, when the LINC00211 was overexpressed 
the levels of CD11c were increased.  Since CD11c is a known myeloid marker, increasing 
during terminal differentiation there is evidence for LINC00211 to be involved in the monocyte 
to macrophage differentiation process, by priming monocytes for this final differentiation step.  
 
3.1.6 LINC00211 is regulated by the PU.1 transcription factor 
Co-expression network analysis showed that LINC00211 is co-expressed with genes that are 
regulated by the PU.1 transcription factor (Figure 3.1.7.A), which plays a major role in 
haematopoiesis and myeloid cell differentiation (McKercher et al., 1996, Scott et al., 1994, 
Colucci et al., 2001). To investigate the relationship between PU.1 and LINC00211, PU.1 
knock down THP1 cells were generated using the dCas9-KRAB repressor system (Gilbert et 
al., 2013). The PU.1 knock down cells were not able to expand, in line with previous 
observations (Antony- Debré et al., 2017, Zhou et al., 2015). To overcome this limitation, RNA 
was isolated immediately after sorting of cells transduced with a PU.1 repressor lentivirus, co-
expressing GFP. Importantly, besides PU.1 mRNA, expression levels of LINC00211 were 
significantly reduced in PU.1 knock down THP1 cells compared to control cells transduced 
with a control repressor virus not expressing any gRNAs (Figure 3.1.7.B). Furthermore, the 
expression levels of S100A9 and CHI3L1 were tested upon PU.1 knock down. Interestingly, 
similar to the expression trend seen upon LINC00211 overexpression (Figure 3.1.7.B), CHI3L1 
was upregulated whereas S100A9 was downregulated upon PU.1 knock down.  Thus, PU.1 is 
not only required for monocytic cell expansion but also promotes the expression of LINC00211 
and S100A9, whereas it reduces CHI3L1 levels. Given the negative regulation of S100A9 and 
the positive control of CHI3L1 expression by LINC00211 these results suggest the following 




as a negative feedback regulator of PU.1, inhibiting proliferation (see Figure 3.1.6.C) and lifting 




Figure 3.1.7: Regulation of LINC00211 by PU.1. A. Co-expression network analysis of 
LINC00211. B. qRT-PCR analysis of the expression levels of PU.1, LINC00211, CHI3L1 and 
S100A9 upon PU.1 knock down compared to control cells and normalised to U6 snRNA levels. 
For statistical analysis one-way ANOVA was performed (***p ≤ 0.001, ****p ≤ 0.0001). C. 
Schematic representation of LINC00211 regulatory network.  
 
3.1.7 LINC00211 is a biomarker of the inflamed lung 
Since lung inflammation is characterised by high myeloid cell infiltration, broncoalveolar 
lavage fluids (BAL) from infected and control-group patients were tested for LINC00211 
expression. Healthy controls (n=10) and patients with different lung infections (n=12) were 
tested (see Table 2.2.34). The expression levels of LINC00211 in the infected individuals were 
much higher than in the control group (Figure 3.1.8.A) and correlated with the numbers of 
infiltrating neutrophils found in the BALs (R2= 0.8204) (Figure 3.1.8.B). Furthermore, to test 
if the expression levels of the lincRNA are altered not only during acute inflammation but also 
in a chronic inflammatory setting, fluid flushed from lung tissue obtained from Idiopathic 
pulmonary fibrosis (IPF) patients was investigated. Idiopathic pulmonary fibrosis (IPF) is the 
most common form of the idiopathic interstitial pneumonias and it is age-related, chronic, 
irreversible and lethal (King et al., 2011). The disease is characterised by extracellular matrix 
deposition and inflammatory responces play critical role in the desease formation and 
progration (Piguel et al., 1993, Kolb et al., 2001, Richter et al., 2011, Kinder et al., 2008,).  As 
control, fluids from healthy tissue were also incorporated in the analysis. The samples were 
tested for cellular composition by flow cytometry and the results revealed that the levels of 




consistent with previous studies (Richter et al., 2011). In line with the results from BALs, 
LINC00211 in IPF tissue fluid was linearly correlated with the percentage of granulocytes (R2= 
0.8327) (Figure 3.1.8.D). This suggests, that LINC00211 may serve as a diagnostic biomarker 
of both acute and chronic inflammatory lung conditions and myeloid cell infiltration.  This 
finding also underpins the high specificity of LINC00211 expression towards myeloid cells. 
    
Figure 3.1.8: LINC00211 is elevated in BALs from infected patients and correlates with 
granulocyte numbers in IPF patients. A. qRT-PCR analysis of LINC00211 expression, 
relative to U6 snRNA and compared to median CT value in BALF pellets of 10 control 
individuals compared to 12 patients with bacterial or fungal infection  (unpaired t-test, ****p≤ 
0.0001). B. Correlation of LINC00211 expression with the percentage of neutrophils in BALF 
samples of healthy and infected individuals (controls= red dots, infected= grey dots). C. FACS 
data from fluid flushed from non-diseased or IPF tissue. Stainings: alveolar macrophages: anti- 
HLA-DR and CD206; granulocytes: anti-CD66b; T-cells: anti-CD4 anti-CD8; NK cells: anti-
CD56; B-cells: anti-CD19. D. Correlation of LINC00211 expression with the percentage of 









3.2 Results - LncRNAs in macrophage activation 
3.2.1 Resting and activated BDMs differentially express lncRNAs 
To identify novel functions of  lncRNAs in human macrophage immunity multiple approaches 
including RNA-Seq, RNA antisense purification coupled with mass spectrometry (RAP-MS) 
and subcellular fractionation techniques were employed (Figure 3.2.1.A). Firstly, lncRNA 
profiles of resting and immune-activated macrophages were recorded followed by analysis of 
lncRNA abundances in macrophage subcellular fractions in order to discriminate between 
nuclear and cytoplasmic riboregulators and finally glycerol-gradient centrifugation was used to 
chart lncRNA co-sedimentation with cellular protein machineries. These approaches generate 
a macrophage map of lncRNAs with subcellular resolution, which may guide detailed 
mechanistic investigations. To record immune-responsive lncRNAs, human blood-derived 
macrophages were challenged with LPS from Salmonella Typhimurium and successful 
immune-activation was verified by qRT-PCR analysis of IL1β and CD80 mRNA induction 
(Figure 3.2.1.B). The samples were then used for RNA-Seq analysis of poly(A)-enriched RNA. 
This analysis confirmed that mRNAs (~94 %) and lncRNAs (~4 %) are the predominant classes 
of poly(A)-RNA (Figure 3.2.1.C). Differential gene-expression analysis using DeSeq2 revealed 
that 773 mRNAs were up- and 460 were down-regulated with a fold-change ≥ 2 and adjusted 
P-value ≤ 0.05 (Figure 3.2.1.D). Notably, using the same strict cut-offs, 43 lncRNAs were up- 
and 14 were down-regulated, suggesting an essential involvement of this RNA-class in 
macrophage immunity (Figure 3.2.1.D and E). These lncRNAs were further investigated. 
Inhibition of MAPK and NF-κB using chemical inhibitors, such as U0126 (MEK1/2/ERK1/2 
inhibitor), SB203580 (p38 inhibitor) and NF-AI (NF-κB inhibitor), diminished the up-
regulation of LPS-induced lncRNAs (Figure 3.2.1.G), confirming their depentance on TLR4 
activation. AP003354.2 (henceforth MaIL1, for Macrophage Interferon-regulatory LincRNA 
1), LINC01215, NRIR and LUCAT1 were highly upregulated upon LPS simulation (Figure 
3.2.1.G).  LncRNA MaIL1 and LINC01215 induction was also observed upon macrophage 
infection with the gram-negative bacterial pathogen Legionella pneumophila (Figure 3.2.1.G). 
Notably, NRIR expression was not regulated during L. pneumophila infection, which mainly 
induces inflammatory responses downstream the TLR2 receptor, suggesting a strict and highly 





Figure 3.2.1: Analysis of the primary human macrophage lncRNA landscape uncovers 
uncharacterized immune genes. A. Outline of the experimental approach. LncRNA 
expression profiling in resting and immune-challenged blood-derived human macrophages is 
followed by investigation of lncRNA distribution in cytosol and nucleus and co-sedimentation 
on glycerol gradients with protein machineries. Additionally, RAP-MS was employed to 
investigate the mechanism of function of selected lncRNAs. B. Fold-change of IL1β and CD80 
mRNA expression upon 8 h LPS (100 ng/ml) compared to mock-treatment, determined by 
qPCR. C. RNA-class distribution in LPS-treated macrophages from B, determined by RNA-
Seq and averaged over 3 replicates. D. DeSeq2 reported fold-changes and number of regulated 
mRNAs and lncRNAs in samples from B. (Padj ≤ 0.05, fold-change ≥ 2 or ≤ 0.5). 6 independent 
experiments were performed and pooled RNA from of each two experiments was analysed in 
3 RNA-Seq runs. E. Volcano plot with lncRNA fold-changes and adjusted P-values from RNA-
Seq datasets described in D. F. Top 10 up- and down-regulated lncRNAs from D) (row Z-score 
heatmap; columns 1-3: mock-treatment; columns 4-6: LPS-treatment). G. Fold-changes of 
lncRNAs as obtained from RNA-seq data of BDMs treated with 50nM of U0126, SB203580 
and NF-AI for 2h and then stimulated with 100 ng/ml LPS for another 2 hours H. Macrophages 
were stimulated with IFNγ (100 ng/ml), LPS (100 ng/ml) and Legionella pneumophila (L.pn.; 
MOI 10) for 8 h. Mean fold-change compared to mock-treatment and individual data-points 





3.2.2 Macrophage lncRNAs predominantly localize to the cytosol.  
In order to determine the subcellular localisation of lncRNAs, nuclear and cytosolic fractions 
of BDMs were submitted for RNA-seq. The results revealed that most lncRNAs, similar to 
mRNAs, are found in the cytosol (Figure 3.2.2.A and B). Importantly, the data recapitulate the 
known subcellular distribution of well-characterized lncRNAs such as NEAT1, MALAT1 (both 
nuclear) (Bhatt et al., 2012) and ZFAS1 (cytosolic) (Hansji et al., 2016) (Figure 3.2.2.A). Only 
few LPS-induced changes in subcellular lncRNA distribution were recorded. Potential shifts in 
lncRNA Hotairm1 and BIC subcellular distribution however did not reach significance at the P 
≤ 0.05 level. qRT-PCR validated the localisation results obtained from RNA-seq analysis. 
Controls like GAPDH, MALAT1 and Hotairam1 were found in nucleus and cytosol  
respectively, as expected (Figure 3.2.2.C). 
 
Figure 3.2.2: Cellular localisation of immune responsive lncRNAs. A. RNA-Seq analysis 
(two averaged replicates) of mRNA and lncRNA localization to nucleus and cytosol (in percent) 
in 8 h mock- or LPS-treated (100 ng/ml) macrophages. B. LncRNA cytosolic localization (in 
percent) in mock- compared against LPS-datasets from A. qRT-PCR of Hotairm1, MALAT1 
and GAPDH in cytosolic and nuclear fractions. Individual data-points from three independent 
experiments are shown 
. 
3.2.3 Gradient profiling reveals distinct sedimentation-profiles of RNA 
classes and protein machineries  
To increase subcellular resolution and narrow down potential interactors of the predominantly 
cytosolic and LPS-responsive macrophage lncRNAs, cellular fractionation by 10-60 % glycerol 
gradient ultracentrifugation was performed. Gradients were loaded with lysates of LPS-
stimulated macrophages and, upon centrifugation, divided into consecutive fractions, which 
were analysed for their respective RNA and protein content by RNA-Seq and mass-




increase towards the last fractions (Figure 3.2.3.A), which contain the heavy ribosomal 
complexes. For transcriptome and proteome analysis, the 44 obtained gradient fractions were 
reduced to 22 fractions. qPCR analysis confirmed the expected peak of U6 snRNA in the early 
gradient fractions (light-weight spliceosome complexes), while Gapdh mRNA spiked in the late 
(ribosomal) fractions (Figure 3.2.3.B). Furthermore, RNA-Seq confirmed the differential RNA 
class distribution along the gradient. mRNA and rRNA spiked in the last fraction while snRNA 
and miscRNA were predominantly found in the first fractions (Figure 3.2.3.C). Pseudogenes 
primarily occupied later fractions than snRNAs and miscRNAs and different from mRNA and 
were found in very low levels in the last gradient fraction (Figures 3.2.3.C), which verifies their 
non- coding nature. Previously, lncRNAs had been sub-categorized into intergenic lncRNAs 
(lincRNAs) and lncRNAs transcribed from coding gene loci (coding gene-associated lncRNAs; 
here galncRNAs). Both lincRNAs and galncRNAs, however, displayed a very similar gradient 
profile, similar to pseudogenes (Figure 3.2.3.C). Interestingly, lncRNA abundance in the last, 
ribosomal fraction was reduced but not completely absent when compared to mRNA, implying 
coding potential of some lncRNAs.  
At the protein level, successful separation of cellular complexes was initially confirmed by 
silver-staining (Figure 3.2.3.D). To enable global co-sedimentation analysis of lncRNAs with 
protein machineries, proteome profiles of all gradient fractions were recorded. Ribosomal 
proteins mainly occupied the last gradient fraction (fraction 22), with a secondary peak in 
fraction 15 (Figure 3.2.3.E). This pattern could be explained by the localization of EIF3 
proteins, which are involved in ribosomal recycling, in fraction 15 (Figure 3.2.3.E). Taking into 
account the RNA-Seq profiles, ribosomes co-localised with rRNAs and mRNAs in the last 
fraction. Spliceosomal proteins were more spread across the gradient, but predominantly 
occupied the first fractions, matching the pattern observed for snRNA. hnRNP proteins, which 
are involved in mRNA processing, were primarily found in the first fractions (Figure 3.2.3.E). 
The proteasome proteins peaked between fractions four and eight (Figure 3.2.3.E). In summary, 
the approach accurately portrays the distinct migration patterns of functional protein and RNA-
classes, a requirement for global co-sedimentation analysis of macrophage lncRNAs and 
protein machineries.  
In order to identify functional subgroups of lncRNAs the co-sedimentation patterns with 
cellular protein machineries were further investigated. Hierarchical clustering of mRNAs 
revealed a uniform co-sedimentation pattern with the expected peak in the last (ribosomal) 




different gradient profiles (Figure 3.2.3.F): a group of low abundance in the ribosome-
containing fraction 22 (group I) accounted for 76.6 % of all macrophage lncRNAs, while 23.4 
% of lncRNAs (group II) displayed a pattern similar to mRNA (Figure 3.2.3.G, upper panel), 
in line with their largely cytosolic localization (Figure 3.2.2.A). Both the percentage of 
lncRNAs characterised as “coding” by the CPC2 algorithm and the average CPC2 coding score 
were elevated in group II in comparison to group I lncRNAs (Figure 3.2.3.H). When restricting 
the analysis to LPS-responsive lncRNAs, the percentages changed, with group II even rising to 
49 % (Figure 3.2.3.G lower panel). These results are in line with other recent reports, claiming 
that several lncRNAs are actually ribosome-associated (Carlevaro-Fita et al., 2016, van Heesch 
et al., 2017). For the remainder of the present work the focus was then on LPS-responsive group 
I lncRNAs, which are absent from the ribosomal fraction and therefore likely to constitute true 
non-coding RNAs. LncRNAs of group I were highly heterogeneous, implying diverse 
associations with cellular machineries. Among group I, a subgroup (group Ia) of lncRNAs with 
similar migration behaviour was identified. (Figure 3.2.3.F). LncRNAs of group Ia mostly co-
sedimented with proteins involved in proteasomal function. Furthermore, the well-
characterized lncRNA NEAT1, which is a known innate immune regulator of type I interferon 
expression (Morchikh et al., 2017), belonged to group Ia. Additionally, group Ia contained other 
lncRNAs that were upregulated upon pro-inflammatory stimulation of human macrophages, 
like MaIL1 and LUCAT1. Due to the reduced likelihood of coding potential, the study was 
further focused on these lncRNAs. 
3.2.4 MaIL1 lincRNA is a novel TLR-responsive gene 
One of the lncRNAs found in group Ia was MaIL1, which was identified as one of the most 
highly induced transcripts in response to LPS (Figure 3.2.1.H). MaIL1 was not only expressed 
in macrophages but also in monocytes, dendritic cells, B cells and naïve T cells (Figure 
3.2.4.A), suggesting a broader function in the immune system. RACE-PCR largely verified the 
predicted 4-exon transcript architecture, however revealed extended 5’ and 3’ terminal exons 








Figure 3.2.3: Glycerol gradient analysis reveals co-sedimentation of macrophage lncRNAs 
with major cellular machineries. A. A260 absorbance measurement in 44 successive 10-60 
% glycerol gradient fractions (2 h LPS-stimulated macrophage lysates). B. Gapdh mRNA and 
U6 snRNA fold-change compared to fraction # 1 in samples from A, reduced to 22 successive 
gradient fractions, quantified by qPCR. C. Row Z-score heatmap (left) and fold-change plots 
(right, inner two quartiles shown, relative to fraction 1) depicting the sedimentation pattern of 
major RNA-classes, determined by RNA-Seq using samples from B. D. Representative silver-
stained SDS gel illustrating protein content and differential protein sedimentation, using 
samples from B. E. Top: same as C but displaying major protein classes based on proteomics 
measurements. Bottom: Representative Western Blot confirming the differential sedimentation 
of major macrophage protein components. F. Hierarchical clustering of mRNA and lncRNA 
data from C). Major lncRNA clusters (I, Ia and II) are indicated. G. Percentages of lncRNAs in 
cluster I and II, identified in panel F). Top: percentages calculated based on all detected 
lncRNAs; bottom: percentages calculated based on LPS-responsive lncRNAs. H. Top: box-plot 
representation of CPC2 coding-scores of cluster I and II lncRNAs. Bottom: Percentages of 
lnRNAs deemed “protein-coding” in CPC2 analysis for cluster I and II. Where applicable, 
standard deviations and individual measurement points derived from three independent 





Figure 3.2.4: Characterisation of MaIL1 as a TLR-responsive ncRNA. A. qPCR analysis 
of MaIL1 lncRNA abundance in different immune-cell subsets and liver tissue relative to brain 
tissue. B. RACE PCR-determined MaIL1 exon architecture. C. Full length MaIL1 PCR. D. 
CPC2 coding-score of RACE-PCR refined MaIL1 RNA and indicated GRCh38 reference 
RNAs. E. Percent-localization of indicated RNAs to cytosol (white) and nucleus (black) in both 
RNA-Seq replicates from Fig. 3.1.2. F. qPCR-determined fold-changes of indicated control 
RNAs and MaIL1 upon macrophage stimulation with the indicated immune-agonists for 8 h, 
compared to mock-treatment (LPS, 100 ng/ml, Pam3CSK4 100 ng/ml, M-TriDAP1 μg/ml, 
Resiquimod 1 μg/ml, poly I:C 20 μg/ml). G. MaIL1 inhibition in 8 h LPS- stimulated 
macrophages pre-treated with indicated pathway inhibitors (50 μM) (fold-change compared to 
LPS + DMSO).  Where applicable, standard deviations and individual measurement points 
derived from at least three independent experiments are shown. P values (*** ≤ 0.0001, ** ≤ 
0.01, * ≤ 0.05) were calculated using a one-way ANOVA test. 
Re-analysis of the RACE-refined RNA sequence by the CPC2 algorithm confirmed a low 
coding score, similar to well-characterized non-coding RNAs and different from mRNA 
(Figure 3.2.4.D). RNA-Seq analysis of subcellular fractions suggests that the majority of these 
copies are exported to the cytosol (Figure 3.2.4.E). Besides with LPS, MaIL1 was also induced 
upon stimulation with agonists of TLR2 (Pam3csk4) and TLR7/8 (Resiquimod) (Figure 
3.2.4.F), which sense microbial lipoprotein and RNA, respectively. Interestingly, MaIL1 
induction was also triggered by poly I:C, (Figure 3.2.4.F), an agonist of the TBK1-IRF3 
pathway, involved in type I interferon activation. Overall, however, LPS caused the strongest 
MaIL1 induction (Figure 3.2.4.F). Since the macrophage response to LPS is controlled by 
transcription factors such as NF-κB, AP-1 and IRF3, inhibition of these may reveal the 
dependence of MaIL1 on the distinct TLR signalling cascades. Successful inhibition of 




significantly attenuated MaIL1 induction by LPS (Figure 3.2.4.G). TBK1 kinase inhibition 
upstream of IRF3 on the other hand did not affect MaIL1 expression (Figure 3.2.4.G). Thus, 
MaIL1 is a novel immune-responsive, cytoplasmic non-coding RNA, triggered by NFκB and 
MAPK but not TBK1 signalling downstream of TLR activation. 
3.2.5 Functional characterisation of MaIL1 by CRISPR/Cas 9 
In order to mechanistically characterise MaIL1, CRISPR/Cas9 was employed. Two pairs of 
gRNAs were designed and introduced into the pX458 vector (See section 2.2.7). The plasmids 
were transfected into THP1 cells and single cell sorted. The sucesfull knock out was tested by 
genomic PCR and qRT-PCR both in resting and LPS stimulated macrophages (Figure 3.2.5.A). 
A monoallelic knock out from one gRNA pair (MaIL1+/-) and a biallelic knock out from the 
second gRNA pair (MaIL1-/-) were used for further experiments. Two replicates (each 
representing a pool of four independent replicates) of PMA differentiated wild type (wt) 
(transfected with empty pX458 vector), MaIL1+/- and MaIL1-/- cells, were sent for RNA 
sequencing. The results verified the successful inhibition of MaIL1 expression in the MaIL1+/- 
and MaIL1-/- cells in a dose dependant manner (Figure 3.2.5.B). In PCA analysis, the generated 
cells lines clustered together and were far from the control cells under mock and LPS conditions 
(Figure 3.2.5.C). Interestingly, the sequencing results revealed that most of the LPS regulated 
genes were dysregulated in the MaIl1+/- and MaIL1-/- cells compared to the control cells in a 
dose dependent manner (Figure 3.2.5.D). Deeper investigation of the regulated genes unveiled 
that most of the genes are targets of two major inflammatory response transcription factors, p65 
and the AP-1 (Figure 3.2.5.E). The majority of the genes that are upregulated by these two 
transcription factors are reduced in MaIl1 +/- and MaIL1-/- cells in a MaIL1-dose depended 
manner. Further analysis of the MaIL1+/- and MaIL1-/- cells showed an impaired p65 
activation.  P65 phosphorylation was lower in knock out cells upon LPS stimulation compared 
to the wt cells (Figure 3.2.6.A). Surprisingly, phosphorylation of ERK1/2, a major kinase 
downstream the TLR4 pathway, was higher in the knock out cells compared to the wild type, 
both in resting and LPS activated differentiated THP1 cells (Figure 3.2.6.A). P65 
phosphorylation was also tested by flow cytometry and the results verified the low levels of p65 






Figure 3.2.5: Functional characterisation of MaIL1 by CRISR/Cas 9. A. Left: agarose gel 
of genomic PCR products. On the left gel, bands are obtained after transfection with the first 
gRNA pair. On the right gel bands are obtained from the second gRNA pair. Right: qRT-PCR 
for MaIL1 in the wt and knock out cell lines in resting and LPS (100 ng/ml for 16h) activated 
differentiated THP1 cells (PMA 20nM for 24h). B. RPKMs of MaIL1 obtained from RNA 
sequencing analysis. C. PCA analysis of the different cell types under resting or LPS-
stimulation conditions. D. Z-score heat map of the inflammatory genes up or downregulated 
upon LPS stimulation. E. Z- scores of the p65 and AP-1 inducible genes in the wt and knock 
out cells. For statistical analysis one-way ANOVA was performed (**p-value ≤ 0.01, ***p-
value ≤ 0.001, ****p-value ≤ 0.0001). 
Major cytokines released upon TLR4 activation were also tested. The expression levels of IL-
8, IL-6 and IL-1β were significantly reduced in MaIL1+/- and MaIL1-/- compared to wt cells 
(Figure 3.2.6.C). Furthermore, IL6 protein levels were significantly lower in the supernatants 
of the knock out cells (Figure 3.2.6.D). Taken together, MaIL1 lincRNA has a major influence 





Figure 3.2.6: Characterisation of MaIL1 -/- cells. A. Western blot analysis of p-p65, p65, p-
ERK1/2, ERK1/2 and b-actin in wt ant MaIL1+/- and MaIL1-/- cells after LPS (100 ng/ml) 
treatment for 10 min, 30 min and 1 hour. B. FACS analysis of p-p65 upon LPS (100 ng/ml) 
stimulation for 1 hour. C. qRT-PCR of IL-8, IL-6 and IL-1b after LPS (100 ng/ml) stimulation 
for 16 hours. D. IL6 release after 16 hours of LPS stimulation in wt ant MaIL1+/- and MaIL1-
/- cells. E. FACS analysis of  L. pneumophila infected cells (GFP+ cells) (MOI=10 for 24 
hours). F.  FACS analysis of S. Typhimurium infected cells (GFP+ cells) (MOI=10 for 24 
hours). For statistical analysis one-way ANOVA was performed (**p-value ≤ 0.01, ***p-value 
≤ 0.001, ****p-value ≤ 0.0001). 
 
Finally, functional assays were performed in order to check the role of the lincRNA during the 
course of infection. Inflection of differentiated THP1 cells with GFP+ L. pneumophila revealed 
that the MaIL1+/- and MaIL1-/- cells were more susceptible to infection compared to the wt 
cells (Figure 3.2.6.E). These results are in line with the impaired pro-inflammatory responses 




performed with GFP+ Salmonella Typhimurium (S. Typhimurium) (Figure 3.2.6.F). The results 
were similar to what was observed for L. pneumophila infections. 
The strong phenotype observed after CRISPR/Cas9-mediated knock out of MaIL1, raised the 
question whether it might represent a cell-line artefact. Therefore, functional investigation of 
MaIL1 was extended to primary human macrophages, using siRNAs. 
3.2.6 MaIL1 lincRNA controls TLR-induced type I interferon production 
To investigate the role of MaIL1 during LPS stimulation, RNAi was performed in primary 
human BDMs, followed by RNA-Seq analysis (Figure 3.2.7.A). Inhibition of LPS-induction of 
MaIL1, but not IL6 was observed with two different siRNA designs, with si#1 having stronger 
silencing capacity (Figure 3.2.7.A). Intriguingly, RNA-Seq analysis revealed a ≥ 2-fold 
reduction of type I interferon expression upon MaIL1 knockdown in LPS-stimulated 
macrophages (Figure 3.2.7.B and C). When relaxing the regulation cut-off below 2-fold this 
effect extended to LPS-responsive genes in general (Figure 3.2.7.D) and vice versa genes 
sensitive to MaIL1 knockdown were mostly LPS-inducible (Figure 3.2.7.E). Reactome analysis 
of MaIL1-controled genes revealed an enrichment of type I IFN and TP53-related pathways 
(Figure 3.2.7.F). Furthermore, network analysis predicted an underlying IRF and TP53 
transcription factor network (Figure 3.2.7.G). Moreover, genes belonging to the IRF3 or TP53 
but not the MAPK pathway, were down-regulated upon MaIL1 knockdown (Figure 3.2.7.H), 
in line with the known activation of TP53 genes by type I interferon (Rivas et al., 2010). 
Analysis of IFNA1, IFNB1, IFNA8, IFNA2, IFNA13, IFNA14 and IFNL1 expression by qPCR 
verified a pronounced suppression of type I interferon induction upon MaIL1 knockdown, but 
did not significantly alter the expression of  other TLR-response genes such as IL23 or CD70 
(Figure 3.2.7.I). In order to investigate the role of MaIL1 during activation of other TLR 
pathways, poly(I:C) was used to stimulate TLR3 in BDMs after MaIL1 knock down. Similar 
to LPS treatment, type I interferon responses were reduced compared to the control, but the 
effect was milder (Figure 3.2.7.J). To summarise, MaIL1 lincRNA constitutes a TLR-induced 
positive regulator of type I interferon gene expression. Importantly, MaIL1 knockdown in 
primary cells did not recapitulate the effect of MaIL1 on the NFkB pathway, seen in THP1 cells 





Figure 3.2.7: Identification of MaIL1 lncRNA as a novel type I IFN regulator. A. Left: 
MaIL1 knockdown-strategy using two independent siRNA designs. Right: qRT-PCR validation 
of MaIL1 knockdown and IL6 expression after 8 h LPS stimulation (100 ng/ml) of BDMs. B. 
RNA-Seq plot showing mean fold-changes and standard deviation (MaIL1 siRNA 1 or 2 vs 
control siRNA knockdown). Genes with fold-changes ≥ 2 or ≤ 0.5 in both RNA-Seq runs are 
highlighted (orange colour). C. Fold-change heatmap for orange labelled genes from B. The 
resulting top 5 up and top 10 down-regulated genes are shown to the right. Type I IFN genes 
are highlighted. D. Box-plot showing expression changes of LPS-response genes (RNA-Seq-
determined, fold-change ≥ 2, LPS vs. mock) upon MaIL1 compared to control knockdown. E. 
Box-plot showing RNA-Seq-determined regulation of MaIL1 controlled genes from C in 
response to LPS. F. Reactome pathway analysis using down-regulated genes from C. G. 
ConsensusPathDB network analysis using down-regulated genes from C, revealing potential 
transcription factors driving the indicated gene subsets. H. Regulation of known MAPK, TP53 
and IRF3 dependent genes upon MaIL1 compared to control knockdown (data from B). I. qRT-
PCR validation of diminished type I IFN mRNA induction upon MaIL1 knockdown (values 
compared to control siRNA and mock stimulation). J. Left panel: MaIL1 knock down upon 
poly I:C stimulation, right panel: IFNA8 expression upon poly I:C stimulation after MaIL1 
knockdown. Standard deviations and individual data points from three independent experiments 





Therefore, the effect of MaIL1 on the TLR-NFkB axis was considered to represent a potential 
long-term effect resulting from MaIL1 dificiency over several cell passages, which does not 
explain the role of elevated MaIL1 expression during acute macrophage immune-activation. 
While the cell-line effect of MaIL1 on the NFkB pathway was not further followed up, the 
effect on the type I IFN pathway, observed in primary cells was investigated mechanistically. 
3.2.7 MaIL1 promotes TLR4 induced IRF3 phosphorylation through 
interaction with Optineurin 
Type I interferon induction downstream of TLR4 relies on signal transduction through the 
intracellular adapter TRIF and subsequently on TBK1 and IRF3 phosphorylation (Kawai and 
Akira, 2011). In order to investigate the involvement of MaIL1 in the activation of this pathway 
the gradient results were further investigated to screen for potential interaction partners.  One 
of the lncRNAs co-sedimenting with MaIL1 on glycerol gradients was NEAT1 (Figure 
3.2.8.A), which has been implicated in type I IFN signalling through association with splice-
regulatory protein SFPQ. RNA-immunoprecipitation confirmed the interaction of NEAT1 with 
SFPQ and revealed an additional interaction with MaIL1 (Figure 3.2.8.F). Western blot 
confirmed a co-localization of SFPQ with the first glycerol-gradient peak of MaIL1, but not 
with the second, and major peak (Figure 3.2.8.A), suggesting that SFPQ does not represent the 
main interactor of MaIL1. In order to find specific MaIL1 interactors RNA affinity 
chromatography was performed. Recently, RAP-MS was introduced as a sensitive approach to 
co-purify endogenous RNAs and bound proteins using UV-crosslinking and biotinylated 
antisense oligo pools, complementary to the RNA of interest (McHugh et al., 2015) (Figure 
3.2.8.B). This approach was used to purify MaIL1 RNA and potential interactors from 
crosslinked primary macrophage lysates, followed by RNA-Seq (RAP-Seq) and mass-
spectrometry (RAP-MS) analysis. To confirm the specificity of the approach, eluates from 
chromatographies with MaIL1 antisense oligonucleotide probes and random oligonucleotides 
were sent for RNA-seq. The results revealed that MaIl1 was highly enriched in MaIL1-1 
eluates, but not other RNA molecules, suggesting that MaIL1 in not an RNA- binding lncRNA 
(Figure 3.2.8.C). Proteomics (RAP-MS) analysis revealed multiple MaIL1 co-purified proteins 
(Padj ≤ 0.05, fold-change ≥ 2, Fig. 3.2.8.C). Intriguingly, the essential TLR4-TRIF signal 
transduction component Optineurin (OPTN) ranked highest. Ubiquitinated Optineurin (Ubi-
OPTN) forms a platform mediating the progression of the TLR4-TRIF signalling arm via 
phospho-TBK1 to phospho-IRF3, which activates the type I interferon genes (Gleason et al., 





Figure 3.2.8: MaIL1 lncRNA interacts with OPTN and controls TLR-triggered IRF3 
phosphorylation and OPTN ubiquitination.  A. Top: qRT-PCR validation of NEAT1 and 
MaIL1 lncRNA profiles on 10-60 % glycerol gradients (2 h LPS-stimulated macrophage 
lysates, relative to fraction 1). Bottom: representative Western blots (Ubi = ubiquitinated 
protein form). Proteins detected on independent blots, with the same protein samples. B RNA 
affinity purification (RAP) procedure: UV-crosslinking of RNA-protein contacts is followed 
by hybridization of biotinylated DNA oligos to the target RNA and streptavidin-based 
purification. C. Left: RNA-Seq analysis of eluate fractions from control and MaIL1 RAP 
(RPKM values, two colour-coded replicates). Enriched MaIL1 lncRNA is highlighted. Dashed 
lines indicate 10-fold-enrichment over perfect-correlation line. Right: volcano-plot showing 
results from protein mass-spectrometry analysis of eluate fractions from tree independent 
control and MaIL1 RAPs. Dashed lines indicate 2-fold cutoff (MaIL1 vs control RAP 
comparison) and Padj ≤ 0.05 cutoff, respectively. OPTN is highlighted as the top hit. D. Pull 
down blots of SFPQ and p62. E. Left: pull down blot of OPTN stained with anti-OPTN 
antibody. Right: pull down blot of OPTN stained with anti-Ubi antibody. F. qRT-PCR analysis 
of MaIL1, NEAT1 and 5S rRNA levels in SFPQ, OPTN (two different antibodies) and p62 
(control protein) CoIP eluates compared to control (IgG) CoIPs. G. Western blot from RAP-
MS control and MaIL1 eluates. . H. Quantification of phospho-TBK1 and -IRF3 signals (three 
independent Western blots, relative to actin). I. Quantification of OPTN and OPTN-Ubi levels 
after MaIL1 knock down (three independent replicates, relative to actin). Statistical 




In agreement with these results, selective enrichment of Ubi-OPTN in MaIL1 RAP-MS eluates 
was observed in Western blot analysis (Figure 3.1.8.G). Furthermore, glycerol gradient analysis 
by Western blot revealed Ubi-OPTN to peak at fraction 10, which is the same fraction as the 
highest peak of MaIL1 (Figure 3.2.8.A). In contrast, the non-Ubi-OPTN form peaked in later 
gradient fractions and coincided with the MaIL1 smaller peaks, between fractions 14 and 18 
and fraction 22. The interaction of MaIL1 with OPTN could be confirmed by RNA-immuno-
precipitation (RIP) experiments (Figure 3.2.8.E and F). Both OPTN and Ubi-OPTN were 
successfully pulled down (Figure 3.2.8.E) and q-PCR analysis revealed that MaIL1 was 
specifically enriched in the OPTN pull down compared to a control RNA, 5S. 
Furthermore, when RNA immuno-purification was performed for p62, a known regulator of 
OPTN, MaIL1 was not enriched, inderpinning once again the specificity of the binding between 
OPTN and MaIL1 (Figure 3.2.8.F). pTBK1 and pIRF3, which are downstream of the signalling 
cascade were also found in the same fractions as the second peak for MaIL1 and OPTN on 
glycerol gradients (Figure 3.2.8.A). More specifically, pTBK1 was found in fraction 9 and 15 
and IRF3 between fractions 1-3 and 14-18. Since OPTN promotes TBK1-to-IRF3 
phosphorylation in the TLR4-TRIF cascade, MaIL1 lncRNA deficiency was expected to impact 
at the same step. Indeed, Western blot analysis confirmed a significant reduction of IRF3 but 
not TBK1 phosphorylation in MaIL1 silenced LPS-challenged macrophages (Figure 3.2.8.H). 
Intriguingly, MaIL1 silencing coincided with reduced OPTN ubiquitination (Figure 3.2.8.I), 
suggesting that interaction with MaIL1 lncRNA serves to maintain the ubiquitinated state 
required for TLR4-TRIF signal transduction. Interestingly, the levels of the total OPTN did not 
significantly change upon MaIL1 knock down. 
3.2.8 MaIL1 is an infection biomarker promoting antimicrobial defence 
To determine the contribution of MaIL1 to cell-autonomous innate defence bacterial infections 
of human macrophage cultures were performed. Classically regarded to act predominantly in 
antiviral defence, type I interferons are increasingly recognized as regulators of antimicrobial 
immunity as well (Boxx and Cheng, 2016). Legionella pneumophila for instance is a human-
pathogenic bacterium, which preferentially replicates inside human macrophages and is 
sensitive to type I interferon (Lippmann et al., 2011). To test whether silencing of type I 
interferon positive-regulator MaIL1 influences antimicrobial defence, macrophages were 
infected with GFP-expressing L. pneumophila at a low MOI, comparable to the one used in a 
previous study (Lippmann et al., 2011). MaIL1 knockdown resulted in a  ̴ 2-3 fold increase in 




stronger with siRNA design #1, which is in agreement with the previous observation that the 
design #1 had better MaIL1 silencing capacity (Figure 3.2.9.A). Importantly, this effect was 
rescued by exogenous supplementation of the infection cultures with recombinant IFNβ (Figure 
3.2.9.A). ELISA confirmed the expected induction of type I interferon IFNα upon challenge of 
control-siRNA treated macrophages with the pathogen (Figure 3.2.9.B). In contrast, in MaIL1 
knockdown cultures IFNα levels were blunted with siRNA design # 1 and highly reduced with 
siRNA design # 2 (Figure 3.2.9.B).  
 
Figure 3.2.9: MaIL1 affects bacterial replication and is elevated in BALs from infected 
patients. A. Left: experimental layout: primary macrophages are transfected with siRNAs, 
followed by GFP-Legionella infection and FACS quantification of GFP-positive and -negative 
cells. Middle: representative FACS plots, showing GFP-positive L. pneumophila infected (high 
green-fluorescence) and uninfected (background-green-fluorescence) macrophages upon 
control-siRNA, MaIL1 siRNA (si#1 and si#2) and IFNβ (IFN) treatment. Right: FACS-
quantification of Legionella infection rates in percent (MOI 0.1, 24 h), upon control- or MaIL1 
knockdown with or without recombinant IFN treatment. Left: experiment with MaIL1 siRNA 
1; right: experiment with MaIL1 siRNA 2. Three independent replicates and one-way ANOVA 
test. B. IFNα ELISA with supernatants from mock- or L. pneumophila treated macrophages 
(MOI 0.1, 24 h), transfected with control siRNA or MaIL1 siRNA 1 or 2. Three independent 
replicates and one-way ANOVA test. C. qRT-PCR analysis of MaIL1 (left) and IFNβ1 (right) 
expression, relative to U6 snRNA and compared against median CT value in BALF pellets of 
10 control individuals compared to 12 patients with bacterial or fungal infection (two-tailed 
students t-test, assuming equal variances). D. Correlation of MaIL1 and IFNβ1 mRNA 
expression in the same BALF samples. 
 
In order to test whether MaIL1 plays a role in human disease, the expression of MaIL1 was 




pulmonary infection and in samples from healthy controls. Expression of MaIL1 was 
significantly increased in the infection group, as compared to healthy non-infected controls, 
suggesting that MaIL1 is specifically induced upon infection in vivo (Figure 3.2.9.C). The same 
was observed for IFNβ and in line with the critical role of MaIL1 in IRF3 activation, qRT-PCR 
analysis revealed a linear relationship between IFNβ1 and MaIL1 expression in BAL samples 
(R2= 0.92) (Figure 3.1.7.D). 
In summary, MaIL1 lncRNA is induced upon activation of the TLR-MyD88 axis and functions 
as a critical riboregulator of TBK1-IRF3-IFN signalling, by fostering ubiquitination of OPTN 
and promoting downstream IRF3 phosphorylation (Figure 3.2.10). 
 
Figure 3.1.10: Summarizing model of MaIL1 regulation and function. Upon activation by 
TLR-Myd88 signalling MaIL1 expression is induced. The induction facilitates the activation of 
TLR-TRIF pathway via interaction with Optineurin. The interaction leads to Optineurin 








4. Discussion  
4.1 Discussion - LncRNAs in myeloid cell differentiation 
Regulation of haematopoiesis and leukocyte differentiation is a strictly controled process that 
is regulated by many cellular components. It is now evident that several lncRNAs are also 
involved in the regulation of haematopoiesis and immune cell differentiation (Venkatraman et 
al., 2013, Whang et al., 2014, Luo et al., 2015). As there are relatively few examples of 
functional long noncoding RNAs acting in the development of immune cells (Ranzani et al., 
2015, Spurlock et al., 2015, Kotzin et al., 2016), in this study the lncRNA landscape of six 
subsets of human primary leukocytes was investigated. LncRNAs have been reported to have 
higher tissue specificity than mRNAs (Derrien et al., 2012). In line with this observation 
specific clusters of lncRNAs expressed in the different primary human leukocyte subsets, 
respectively were identified. In this analysis, LINC00211 was identified as a novel lincRNA 
involved in differentiation of monocytes to macrophages, by influencing PU.1 dependent gene 
expression. Besides LINC00211, other signature lncRNAs were identified, which might be 
exploited to distinguish leukocyte populations at the molecular level.  
Other studies have addressed the roles of lncRNAs in the differentiation of hematopoietic cell 
lineages as well (Guttman et al., 2011). In the mouse immune system, during differentiation of 
naïve into memory CD8+ T-cells the expression of several lncRNAs changes (Pang et al., 
2009). In the present study a similar observation was made in human naïve and memory CD4+ 
T-cells, were LINC02446 is absent from memory CD4+ T-cells, while it is expressed in naïve 
CD4+ T-cells. In another study in mouse, lnc-DC was highly upregulated during the 
differentiation of monocytes into dendritic cells (Wang et al., 2015). Lnc-DC regulates the 
expression of several genes that are key players in dendritic cell differentiation, maturation and 
function, by binding to STAT3. Another study identified Lnc-MC as a PU.1-regulated lncRNA 
that competes with miR-199a-5p and alleviates repression of the mRNA of activin A receptor 
type 1B (ACVR1B), an important regulator of monocyte to macrophage differentiation (Chen 
et al., 2015). Similarly, in the present study, PU.1 dependent lncRNA LINC00211 was found 
to be downregulated upon differentiation of monocytes to macrophages and it regulates several 
genes that have been associated with the differentiation process. For example, S100A8 and 
S100A9, two proteins that were dysregulated upon LINC00211 overexpression or knock out, 
are myeloid related proteins that have been involved in several aspects in myeloid cell 
differentiation and function (Ingersoll et al., 2010, Edgeworth et al., 1991). Notably, expression 




nonclassical CD14+CD16++ monocytes (Ingersoll et al., 2010). This suggest that these proteins 
may be involved in controlling cell lineage fate. Furthermore, S100A8 and S100A9 are more 
abundant in neutrophils and constitute ~45% of all cytosolic proteins,  compared to only about 
1% in monocytes (Edgeworth et al., 1991), which again correlates with the expression levels of 
LINC00211 that is higher in granulocytes compared to monocytes. Additionally, another 
protein, CHI3L1, was upregulated upon overexpression of LINC00211. This gene is expressed 
in a variety of cells, including neutrophils and macrophages (Nordenbaek et al., 1998, Rahli et 
al., 2003). It has been reported to be upregulated during monocyte to macrophage differentiation 
and during polarisation into an ‘M1’-like phenotype of macrophages (Di Rosa et al., 2013). 
Together, these data suggest that LINC00211 is essential for the physiological development 
and differentiation of immune cells. Moreover, LINC00211 may serve as a novel biomarker for 
myeloid immune cell infiltration, as it is upregulated in lung fluid from patients with acute 
infection or IPF as a chronic inflammatory disease (see above). Interestingly LINC00211 
controlled gene S100A9 has been suggested as a biomarker for IPF. Hara et al., demonstrated 
that patients with IPF have higher levels of S100A9 in their BAL fluids compared to healthy 
controls (Hara et al., 2011). The present study shows that, LINC00211, expression of which is 
also elevated in IPF lungs, negatively regulates the expression of S100A9, probably in a 
feedback-manner through PU.1. 
Myeloid cell development critically depends on the PU.1 transcription factor. PU.1 knock out 
mice die during the late stage of embryonic development or immediately after birth and show 
impaired granulocyte, monocyte, B-cell and NK cell, but not megakaryocyte and erythrocyte 
development (McKercher et al., 1996, Scott et al., 1994, Colucci et al., 2001). The regulation 
of LINC00211 by PU.1 suggests an involvement of this lincRNA in the development and 
differentiation of myeloid cells. Furthermore, genes that are downregulated or upregulated upon 
LINC00211 overexpression are also downregulated and upregulated in the same manner upon 
PU.1 knock down, respectively.  This suggest a negative feedback regulation of PU.1 by 
LINC00211. Negative feedback loops are very common in nature, and other non-coding RNAs 
function through this regulation mode. For example, miR-146a is upregulated by the TLR-NF-
κB pathway but inhibits the same signalling axis by targeting TRAF6 and IRAK1 (Taganov et 
al., 2006). Recently, lincRNA p-21 has been shown to be part of a double negative feedback 
loop involving p53, the miR-181 family and PKC-δ during microglia activation (Ye et al., 
2018). Another lncRNA, Lethe, feed-back regulates NFkB, by directly binding to this protein 




mode of negative feed-back control by interacting with its upstream transcription factor PU.1 
directly. 
The limited knowledge about the roles of lncRNAs in leukocyte differentiation and the 
mechanistic nature of lncRNAs in general, suggests that this topic will be of high interest to the 
community in the years to come. In the current project, previously unknown lncRNAs were 
characterised as specific leukocyte markers and LINC00211 was revealed as an important 
regulator of monocyte to macrophage differentiation. The presented data and previous reports 
suggest that more lncRNAs might be involved in the regulation of haematopoiesis than 
currently known. This prediction is also in line with the notion that the number of lncRNA but 
not mRNA genes increases with the cellular complexity of an organism (Mattick et al., 2018, 
Liu et al., 2013, Taft et al., 2007). The immune systems of higher vertebrates represent a good 
example of such cellular complexity, requiring precise control mechanisms to prevent from 
defects in the formation of the different lineages. PU.1 for instant primes cells to enter a specific 
hematopoietic differentiation program, but the exact PU.1 dose determines the eventual 
terminal cell fate (Mak et al., 2011). Thus, precise stabilization of the levels of transcription 
factors generating cellular heterogeneity, such as PU.1, is required, for instance through 
negative feedback control by lncRNAs such as LINC00211. Understanding the involvement of 
further lncRNAs in this process may not only refine our knowledge about immune cell 
development, but also aid the fight against pathologies, were this process is impaired or 
dysregulated. 
 
4.2 Discussion - LncRNAs in macrophage activation 
During the past few years, it has become evident that lncRNAs play major roles in a variety of 
cellular processes. The recent methodological advantages made it possible to unveil the 
functions of several lncRNAs and acknowledge their importance as cellular biomolecules, 
similar to mRNAs and other well-characterised RNA classes. This study was focused on 
lncRNAs that are involved in macrophage activation by inflammatory stimuli. Probably due to 
the heterogeneity in lncRNA function, and the lack of methodological consensus regarding their 
characterization, most of the robustly LPS-induced lncRNAs that were identified in this study 
have remained largely uncharacterised (Figure 3.2.1.F). Previously, lncRNAs were sub-
classified as cis- or trans-acting or genic and intergenic depending on their mode of action and 
their site of origin in the genome, respectively (Spurlock et al., 2016, Rinn and Chang, 2012). 
In agreement with previous published findings, this study suggests that lncRNAs can be further 




their coding potential. In macrophages, 23.4 % of all lncRNAs co-sedimented with ribosomes 
and among the LPS-inducible lncRNAs the percentage found in the ribosomal fraction was 
increased to 49%. In line with this observation, lncRNAs were found to be located 
predominantly in the cytoplasm (Figure 3.1.2.A). While the classic narrative assumes lncRNAs 
to function mostly in the nucleus, recent literature supports the notion that lncRNAs may locate 
to and act in the cytoplasm (Bouvrette et al., 2018, Carlevaro-Fita et al., 2019).Furthermore, 
large numbers of lncRNAs are found to be associated with ribosomal mono- and polysome 
fractions in sucrose gradient studies (Carlevaro-Fita et al., 2016, Van Heesch et al., 2014). 
Recently, > 35 % of lncRNAs in bacterially challenged murine macrophages were reported to 
associate with ribosomes (Jackson et al., 2018). The authors also found non-canonical open 
reading frames in a number of ribosome-associated lncRNAs, questioning their non-coding 
nature. On the other hand, cytoplasmic lncRNAs might associate with ribosomes to regulate 
translation rather than being translated. LncRNAs, which do not co-sediment with ribosomes, 
exhibit highly heterogeneous glycerol-gradient sedimentation profiles, which indicates 
association with distinct protein complexes and thus suggests their involvement in various 
cellular processes. In contrast to sucrose gradients, glycerol gradients can resolve molecular 
complexes lighter than the heavy ribosomal complexes, and they have been used to investigate 
other lncRNAs. NEAT1 lincRNA was found to co-sedimentate with paraspeckle and immune-
regulatory proteins after glycerol gradient sedimentation (Morchikh et al., 2017). Recently, 
glycerol gradient profiling was also applied to illustrate the differential association of bacterial 
regulatory RNA with RNA-binding proteins (Smirnov  et al., 2016) and in this study, a similar 
strategy was adopted to extend lncRNA subcellular resolution from the presently available 
polysome profiles to light-weight molecular machineries. The distinct migration profiles of 
ribosome-independent lncRNAs match the expected diversity of lncRNA functions and 
subcellular localization patterns. The datasets of this study provide a rich resource to investigate 
the functional properties of many uncharacterized macrophage lncRNAs based on their 
subcellular localization and co-migration with cellular machineries. 
The subcellular profiling approach was used in this study to select ribosome-independent, 
previously uncharacterized lncRNAs for further mechanistic investigation. From the datasets, 
MaIL1 was chosen, due to several criteria like high upregulation upon LPS stimulation, 
ribosome-independence and cytosolic localisation. MaIL1 was identified as a novel positive 
regulator of TLR4-triggered type I IFN induction and antimicrobial defence. Very recently, 
lncRNA Lnczc3h7a was described as a positive regulator of type I IFN induction in antiviral 




TRIM25 ubiquitin-ligase and induces RIG-I ubiquitination, similar to the control of OPTN 
ubiquitination by MaIL1. Thus, several lncRNAs may be involved in the control of 
ubiquitination-dependent immune signal transduction. Another very recent report characterizes 
NRIR, a top-induced transcript in the datasets generated during the present study, as a positive 
regulator of the autocrine response to type I IFNs in human monocytes (Mariotti et al., 2019). 
These findings suggest that TLR4-TIRF or RIG-I activation involves different lncRNAs such 
as Lnczc3h7a or MaIL1 to promote type I IFN production and later other lncRNAs, such as 
NRIR, to promote the autocrine response. Other lncRNAs, such as Lnc-Lsmb3, lnc-ITPRIP-1 
and NEAT1, have previously been implicated in type I IFN responses as well. Lnc-Lsmb3 for 
instance negatively regulates type I IFN, by antagonising the binding of exogenous RNAs to 
RIG-I. The binding prevents the conformational changes of RIG-I and thus the downstream 
signalling (Jiang et al., 2018). Lnc-ITPRIP-1 on the other hand positively regulates type I IFN 
production through binding to the viral RNA sensor MDA5 and boosting its oligomerisation 
and thus promoting IRF3 phosphorylation (Xie et al., 2018). LncRNA NEAT, which was also 
found to co-sedimentate with MaIL1 on the glycerol gradient, binds to SFPQ and HEXIM1 and 
mediates the formation of a protein complex that facilitates the production of type I IFNs 
(Morchikh et al., 2017). MaIL1 though, is the first lncRNA shown to be required for TLR-
signalling in primary human cells to promote IFN expression and antimicrobial immunity. 
Type I IFN genes, which are activated by IRF transcription factors, are also co-regulated by the 
NF-κB transcription factor. It has been reported that NF-κB activity is also controlled by several 
non-coding RNAs in myeloid and non-myeloid cells. Micro RNAs, such as miR-146 and mir-
155, are known to be involved in the regulation of the NF-κB signal transduction by targeting 
several components of the signal cascade (Taganov et al., 2006, Schulte et al., 2012. Janga et 
al., 2018). Besides miRNAs, several lncRNAs have also been implicated in the NF-κB 
signalling pathway. For example, PACER directly interacts with NF-κB repressive subunit p50 
and prevents it from binding to the Cox-2 promoter (Krawczyk et al., 2014). Lethe on the other 
hand acts as a negative feedback regulator of the NF-κB pathway. The NF-κΒ signalling 
pathway induces Lethe, which subsequently interacts with the p65 NF-κB subunit and inhibits 
its activity (Rapicavoli et al., 2013). Another example is the cytoplasmic lncRNA Carlr, which 
promotes NF-κB dependent immune gene expression and has been associated with Celiac 
disease (Castellanos-Rubio et al., 2017). Taken together these different studies suggest a 
complex lncRNA network regulating the innate immune signalling pathways in order to balance 




asociated lncRNAs, the RNA-Seq profiles of this study suggest that only a small fraction of 
immune-responsive lncRNAs in human macrophages has been characterized to date.  
The present work fosters an improved understanding of lncRNAs involved in inflammatory 
responses in general and human macrophages specifically. The recorded RNA sequencing data 
provide a comprehensive catalogue of mostly uncharacterised lncRNAs with potential 
implications in the pathophysiological responses of macrophages. Furthermore, the gradient co-
seidimentation data are a valuable resource for further functional characterisation of these novel 
lncRNAs. The characterisation of MaIl1 as an important regulator of the type I interferon 
production may serve as a blueprint for further studies. In the light of emerging antisense drug 
chemistry, riboregulators, like MaIL1, might also constitute superior target-candidates to 
prevent from or control malfunctions of the immune system due to their strict spatiotemporal 
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